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Microalgae have gained increasing interest over the last ten years for their 
exploitation for biotechnological applications. A commonly used model organism is 
Chlamydomonas reinhardtii and many recombinant proteins have been successfully 
expressed in this green microalga. The chloroplast is of special interest as it allows 
rather high expression levels and targeted gene integration. Tools for chloroplast 
transformation and expression systems have advanced remarkably over the last years 
and the field is developing increasingly faster. 
In this thesis, existing tools for genetic modification of C. reinhardtii were used 
to expand further the toolkit, mainly for the synthesis of high-value diterpenes of plant 
origin, and to examine the potential of using these microalgae in an industrial setting. A 
strain expressing a large recombinant enzyme, a diterpene synthase, resulting in in vivo 
synthesis of the diterpene cis-abienol, was generated. The potential for light-driven 
product synthesis via a chloroplast re-located cytochrome P450 was successfully 
shown. It was also demonstrated that typically fragile, wall-deficient transgenic strains 
can be grown on a 100 L pilot scale. This is an important finding as the gap between 
lab- and large-scale studies needs to be closed to allow a transition to an industrial 
setting. It was also shown that there is still untapped potential in the algal chloroplast – 
by utilising a bacterial export signal peptide the chloroplast toolkit was expanded to the 
thylakoid lumen for recombinant protein production. 
 Three proof of concept studies presented herein and one study looking at pilot 
scale cultivation of previously generated transgenic strains show that the potential seen 
in microalgae for biotechnological applications is justified and further developments 
and improvement of the existing strains could make this a viable competitive platform 






Chapter 1: Introduction – genetic 
engineering and biotechnological 
applications of microalgae 
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1.1. The model organism Chlamydomonas 
 
Algae are a polyphyletic class of significant diversity. Currently organisms 
considered to be algae belong to four different kingdoms. The definition of “an alga” is 
therefore a rather broad term. Michael D. Guiry gives a definition that is widely 
accepted by phycologists: 
“…generally algae are considered to be aquatic, oxygen-evolving photosynthetic 
autotrophs that are unicellular, colonial or are constructed of filaments or composed of 
simple tissues.” (Guiry, 2012). 
 
All experiments of this PhD thesis were performed using Chlamydomonas 
reinhardtii. Macroalgae will be excluded as it is far beyond the scope of this thesis. If 
appropriate, references to observations and studies in cyanobacteria will be given. In 
this thesis the focus will be on eukaryotic microalgae, in particular green algae – the 
direct relatives of the organism used in this thesis. C. reinhardtii has a history as a 
model organism for many decades. Most of the commonly used lab strains are thought 
to originate from isolates back in 1945 (Harris, 2001). C. reinhardtii is a biflagellate, 
unicellular chlorophyte with a large single chloroplast. The alga has a fast doubling 
time, is easy to grow and it can reproduce sexually and asexually. Cultivation is 
possible under various regimes from photoautotrophic over mixotrophic to 
heterotrophic. All these features make it a popular model organism of choice in various 
fields of research. In more recent years it was increasingly subjected to genetic 
modification studies. Compared to other microalgae, we know a lot about its physiology 
and metabolism (due to its history as a model organism) enabling us to introduce 
foreign metabolic pathways and investigate its use for novel applications. This is also 
the reason why C. reinhardtii was the organism of choice for the studies described in 
this PhD thesis. 
This introduction will give a broad overview of the current and potential future 
exploitation of microalgae. A focus is set on high-value compound synthesis by 
engineering recombinant proteins (pathways) into the alga. The state of the art of 
genetic modification tools for microalgae (with a focus on Chlamydomonas sp.) will be 
summarised. Potential applications and the current situation of large-scale cultivation 
systems and markets for algal products will be discussed. 
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1.2. Exploitation of microalgae 
1.2.1. Historical use of microalgae 
 
The first known use of microalgae in human culture was approximately 2000 
years ago, when the cyanobacterium Nostoc sp. was consumed, in China, for food due 
to famine (Spolaore et al., 2006). Also, other cyanobacteria such as Spirulina sp. and 
Aphanizomenon sp. have been used for food purposes over thousands of years (Jensen 
et al., 2001). The consumption of algae as food or nutritional supplement is fairly 
common in Asia (Pryadarashni and Rath, 2012), but a more recent occurrence in the rest 
of the world. Another microalgae traditionally used for food purposes is the green alga 
Chlorella. Around the time of the first and second world war it became popular due to 
its putative power to solve problems of hunger and an increasing world population 
(given its nutritional value and high protein content) (Belasco, 1997) and algal mass 
cultivation systems started to develop (Walker et al., 2005). In the middle of the last 
century the development of microalgae for biotechnological applications started 
(Spolaore et al., 2006). 
 
 
1.2.2. Modern applications of microalgae 
 
This section is divided into three major fields of applications for microalgae. 
First, the potential use of algae for commodity – more specifically biofuels – production 
is discussed, then the production of in algae naturally abundant high-value compounds 
will be introduced. Finally, an overview of why microalgae are considered a promising 
host for industrial biotechnology is given. 
 
 
1.2.2.1. Microalgae for biofuel production 
 
Research on microalgae for oil production has started several decades ago 
(Oswald and Golueke, 1960). In 1978, the U.S. Department of Energy started the 
“Aquatic Species Program” to investigate the potential of over 150 microalgal species 
as a renewable energy source. This project was, however, terminated in 1996 (Sheehan 
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et al., 1998). In the year 2007 these plans of biofuel production from microalgae were 
revived, most likely due to an increase in oil price. A review paper that claimed 
microalgae could have up to 70 % of oil content (by weight) and would be the only crop 
for the future capable of replacing fossil fuels for biodiesel production probably played 
a major role in this revival (Chisti, 2007). Up to October 2015 this paper has been cited 
nearly 3000 times according to Web of ScienceTM. However, the numbers mentioned in 
the paper have been doubted many times and biodiesel production from microalgae is 
still not feasible. A lot more research followed up on this claim and the field has since 
progressed substantially. Generally, microalgae are still regarded as one of the most 
promising crops for biofuel production (Wijffels and Barbosa, 2010). 
The idea of using microalgae for biofuels is plausible – fossil fuels are finite and 
alternative, sustainable energy sources have to be found to satisfy increasing demand 
and tackle climate change. Currently, biofuels are mainly made from plants, but there is 
increasing concern with the use of edible crops for fuel production (Georgianna and 
Mayfield, 2012; Adenle et al., 2013). These “first generation biofuels” have several 
more problems such as low-land use efficiency, poor carbon balance and competition 
for arable land (Schenk et al., 2008; Andersson et al., 2014). Microalgae have several 
advantages over terrestrial crops such as cultivation on non-arable land, year round 
cultivation and higher productivities (Moody et al., 2014). There is even potential to 
grow algae for biofuel production on wastewater (reviewed for Chlorophyta in 
(Abinandan and Shanthakumar, 2015)). 
In general, three different fuels can be made from microalgae: biodiesel (via 
transesterification), petrol or jet fuel (Georgianna and Mayfield, 2012). This type of 
renewable jet fuel is made via transesterification of triacylglycerols and fatty acids with 
subsequent hydrocracking and hydroprocessing (Kallio et al., 2014). Diatoms are 
considered to be one of the most promising candidates for biofuel production 
(Ramachandra et al., 2009), but also many other microalgae have been considered. 
A general consent between scientists is that biofuel production from microalgae 
needs considerable improvements such as an increase in productivity, reduction of 
production costs (including downstream processing and algal cultivation) and increase 
of lipid content. The potential to achieve this is given through several routes, including 
metabolic and genetic engineering of microalgal strains of interest, screening of natural 
isolates and selection of strains by adaptation (Schenk et al., 2008). Another idea to 
increase the feasibility is a combined biorefinery approach where several different 
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products from the algal biomass can be extracted (Wijffels et al., 2010; Markou and 
Nerantzis, 2013; Lee Chang et al., 2014). 
Estimations of how long it will take to develop algal biofuel production into an 
economically viable process vary substantially. The next five to ten years will show if a 
common effort could significantly improve the process and bring algae production of 
biofuels to a commercial scale. Not only further scientific and technical development 
will be needed, but, specifically for genetically modified strains, also policy and 
legislation hurdles will have to be overcome. 
 
 
1.2.2.2. Microalgae for natural high-value compound production 
 
In contrast to biofuels, natural high-value compounds are already produced in 
algae on an industrial scale. The molecules produced include carotenoids such as β-
carotene (mainly produced in Dunaliella salina) (Borowitzka, 2013) and astaxanthin 
(mainly from Haematococcus pluvialis (Lorenz and Cysewski, 2000)), phycocyanin 
from cyanobacteria (produced in Arthrospira platensis, previously described as 
Spirulina platensis) (Borowitzka, 2013) or ω-3 fatty acids such as eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA). Omega-3 fatty acids are produced from 
various hosts such as Nannochloropsis (an eustigmatophyte), Crypthecodinium (a 
dinoflagellate) (Mendes et al., 2009), Schizochytrium and Ulkenia. Further interesting 
products are proteins, antioxidants and other pigments. Several of these high-value 
compounds are ingredients to a variety of pharmaceutical and cosmetic products (Gangl 
et al., 2015a). Spirulina and Chlorella are also produced as feed, food additive and diet 
supplements directly sold in a dried form (Enzing et al., 2014). The microalgal product 
global market value is estimated at 1.5 million US dollars per year worldwide (Verdelho 
Vieira, 2014). 
In addition to high-value compounds that are already produced in microalgae, 
many more have been investigated at lab scale. Microalgae are considered to have 
considerable antioxidant properties and contain phenolic compounds of interest for 
pharmaceutical and food applications. The cyanobacterium Fisherella ambigua and the 
microalga Chlorella vulgaris have been highlighted for these properties (Hajimahmoodi 
et al., 2010). Microalgae produce a variety of other compounds such as sterols, 
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polyhydroxyalkanoates, polysaccharides and further bioactive molecules with antibiotic, 
antiviral, anticancer, anti-inflammatory or antihypotensive properties (Borowitzka, 
2013). For many of these products lab scale studies are available, but the feasibility of a 
transition to industrial production remains to be proven. This will also largely depend 
on market demands and improvements of biomass production costs for microalgae. 
 
 
1.2.2.3. Potential of microalgae as a biotechnological production platform 
 
Microalgae have great potential as a biotechnological host because of several 
reasons that will be discussed in the following section. Their diversity in cellular 
architecture and biosynthetic capacity (Scaife et al., 2015) provides a versatile 
background for various applications in biotechnology. So called ‘molecular farming’ in 
algae has been discussed for many years as an attractive, “green” and sustainable 
alternative with future. 
Most green algae (e.g. Chlorella vulgaris and Chlamydomonas reinhardtii) are 
classified under the GRAS (generally regarded as safe) status. This is a clear advantage 
for cultivation. Complying with environmental, as well as health and safety regulations, 
aids the development of edible products for food and feed from microalgae 
(Johanningmeier and Fischer, 2010). Chlamydomonas has previously been described as 
a ‘planimal’ referring to the mixture of traits from both, the plant and animal kingdoms 
(Redding and Cole, 2008) which can provide a valuable addition to industrial 
biotechnology. Another important feature is the compartmentalisation present in 
eukaryotic microalgae. The chloroplast, specifically, is of interest for protein and high- 
value compound production (Potvin and Zhang, 2010; Purton et al., 2013). The 
chloroplast facilitates folding of recombinant proteins (Chebolu and Daniell, 2009) and 
relatively high gene expression levels can be achieved. Studies have reported levels of 
up to 10 % of total soluble protein (TSP) (Manuell et al., 2007) or 20.9 ± 1.2 % total 
cellular protein (TCP) (Surzycki et al., 2009). Regarding recombinant protein 
production, the ability of post-translational modification (PTM) is a further desirable 
trait for more complex protein production. The algal chloroplast is capable of disulphide 
bond formation (Kim and Mayfield, 1997; Mayfield et al., 2003) and hosts many 
chaperones which assist protein folding (Schroda, 2004). Glycosylation does not occur 
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in the chloroplast (Mayfield and Franklin, 2005) but occurs in the cytosol even though 
our knowledge about the processes of glycosylation in microalgae is still very limited 
(Mathieu-Rivet et al., 2014). 
To date, microalgae are not properly established as a biotechnological host, 
although some researchers are convinced of the maturity of the platform (Specht et al., 
2010). Considerable progress has however been made over the last years and important 
milestones were reached. This is specifically the case for C. reinhardtii: all three 
genomes, the nuclear, mitochondrial and chloroplast genome, are sequenced 
(Vahrenholz et al., 1993; Maul et al., 2002; Merchant et al., 2007), all genomes can be 
genetically manipulated and an impressive collection of mutants is available (Neupert et 
al., 2009). Genetic modification techniques and achievements of high-value compounds 
produced in microalgae will be reviewed in more detail in section 1.3 and 1.4. with a 
focus on C. reinhardtii.  
In summary, there is great potential of microalgae as cell factories in 
biotechnology, but the details of how to implement this are still not entirely clear. A 
widely spread opinion proposes microalgae as a good replacement for conventional and 
already established hosts due to their supposedly lower production costs (the idea is that 
algae can essentially be grown only with light and don’t need many other resources). 
Other cell factories such as yeast or mammalian cell cultures have been advanced over 
many years according to the needs of biotechnology and are highly competitive. It 
seems more likely that a ‘niche’ for microalgae will have to be found. This niche would 
ideally complement other production platforms utilising unique microalgal traits and 
potentials instead of attempting to replace those. 
 
 
1.3. Genetic modification techniques and tools in microalgae 
 
The genetic modification of microalgae is an essential tool to develop 
microalgae for future exploitation, not only as cell factories in industrial biotechnology, 
but also for enhancing traits of algal metabolism (e.g. faster growth or higher lipid 
yields). To date, the transformation of over 40 different microalgal species has been 
reported (Gangl et al., 2015a). Most reports of successful transformation are found for 
C. reinhardtii, although transformation systems are also advanced for the diatom 
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Phaeodactylum tricornutum, several Chlorella species and Volvox carteri (Walker et 
al., 2005), and progress has been made in species such as Haematococcus pluvialis 
(Sharon-Gojman et al., 2015), Nannochloropsis (Cha et al., 2011; Kilian et al., 2011) 
and Schizochytrium (Cheng et al., 2012). Chlamydomonas is a widely preferred 
organism of choice for genetic modification studies in microalgae, not only because of 
the fairly established tools available, but also because stable transformation lines can be 
generated in a comparably short timeframe of a few weeks from gene design to scale up 
(Mayfield et al., 2007). 
In the following section the basics of genetic modification for eukaryotic 
microalgae will be reviewed with a focus on recombinant proteins, DNA delivery 
methods, integration sites for the transgene and their advantages and disadvantages and 
examples of promoters, reporter genes and selectable markers available. The focus will 
be on C. reinhardtii since this is most relevant for this thesis and the techniques and 
tools are the most advanced, but systems in other microalgae will also be introduced. 
 
 
1.3.1. DNA delivery methods 
 
The transformation of microalgae is not a novelty as such – the first successful 
transformation dates back more than 30 years when a yeast DNA fragment encoding 
arg4 was expressed in C. reinhardtii to complement arginine auxotrophy (Rochaix and 
van Dillewijn, 1982). The first successful transformation of the C. reinhardtii 
chloroplast genome was reported in 1988 using the method of tungsten microparticle 
bombardment (biolistics) (Boynton et al., 1988). Shortly afterwards it was shown that 
this method can also be used to transform the nuclear genome (Debuchy et al., 1989). 
Biolistics have proven to be a very popular way of DNA delivery and have also been 
used to transform other microalgae such as Phaeodactylum tricornutum (Apt et al., 
1996; Falciatore et al., 1999), Haematococcus pluvialis (Teng et al., 2002; Sharon-
Gojman et al., 2015), Nannochloropsis sp. (Kilian et al., 2011) and Chlorella 
sorokiniana (Dawson et al., 1997). 
Only two years after biolistics were introduced for Chlamydomonas 
transformation, an alternative method by agitation of a cell and DNA mixture with glass 
beads was developed. First, the nuclear genome was targeted (Kindle, 1990) and shortly 
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afterwards the method was also shown to work for modifying the chloroplast genome 
(Kindle et al., 1991). The basic principle behind this transformation method is the 
generation of transient holes in the cell by the glass beads where the DNA can then be 
incorporated into the cell interior. 
These two methods are still the most commonly used ones to deliver DNA for 
Chlamydomonas transformation and the techniques have been optimised and matured 
over the years. Whereas the glass bead method has a lower transformation efficiency, 
the particle bombardment method needs expensive equipment not available to every 
researcher. Cell wall deficient strains are routinely used for transformation (Potvin and 
Zhang, 2010), especially with the glass bead method. Alternatively, the 
Chlamydomonas cell wall can be removed with autolysin prior to the transformation 
procedure (Kindle, 1990). 
A third common DNA delivery method is via electroporation (Brown et al., 
1991). Transformation efficiencies for this method were initially rather poor, but later 
improvements made this method a respectable alternative to particle bombardment and 
the glass bead method in Chlamydomonas (Tang et al., 1995; Shimogawara et al., 
1998). Electroporation has also been used for nuclear (Miyahara et al., 2013; Zhang and 
Hu, 2014) and chloroplast transformation (Xie et al., 2014) of the diatom 
P. tricornutum and other microalgae such as Chlorella vulgaris (Chow and Tung, 1999; 
Niu et al., 2011) and Dunaliella salina (Geng et al., 2003).  
In addition to the classical delivery procedures, other methods have been 
explored over the years. One transformation method, which is very well established in 
plants, is mediated by Agrobacterium tumefaciens. This system has been used to 
transform several algae including C. reinhardtii (Kumar et al., 2004; Pratheesh et al., 
2014), Haematococcus pluvialis (Kathiresan et al., 2009), Chlorella vulgaris (Cha et 
al., 2012), Nannochloropsis sp. (Cha et al., 2011) and Schizochytrium sp. (Cheng et al., 
2012). Silicon carbide whiskers have also been tested to transform Chlamydomonas 
(Dunahay, 1993) and dinoflagellates (ten Lohuis and Miller, 1998), but this method, to 
date, has not been further established. This might also be due to inhalation hazards 
associated with the silicon carbide whiskers (Qin et al., 2012). The most recently 
reported new method uses positively charged nanoparticles coated with the DNA for 
transformation (Kim et al., 2014). Moreover, this method can be used to transform the 
nuclear genome of walled C. reinhardtii strains and is supposedly more efficient, 
cheaper and easier than particle bombardment. 
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Other DNA delivery methods that have been used, and are proposed to have 
potential for further application in microalgae, are microinjection and use of an artificial 
transposon (Qin et al., 2012). To sum up, several methods have been developed for the 
transformation of microalgae over the years. Efficiencies of transformation have been 
improved, but DNA cannot always be integrated at a specific site meaning that it 
integrates randomly which is a major constraint. This will have to be addressed in future 
research; details of this will be discussed in the next section for Chlamydomonas. 
 
 
1.3.2. Integration of transgenes: nuclear vs. chloroplast genome 
 
 The mechanisms of how a transgene can be integrated into the targeted genome 
can vary significantly between microalgal species, genomes targeted and transformation 
methods used. In theory, three different genomes can be targeted in eukaryotic 
microalgae: the nuclear genome, the chloroplast genome and the mitochondrial genome. 
In the case of C. reinhardtii, transformation of all three genomes has been reported 
(Boynton et al., 1988; Debuchy et al., 1989; Randolph-Anderson et al., 1993). Fig. 1.1. 
gives an overview of the targeted integration sites and advantages and disadvantages 
each gene integration and expression site bears (especially for more complex 
recombinant protein expression). In most cases, either the nuclear or the chloroplast 
genomes have been targeted. In the following sections these will both be discussed in 




Fig. 1.1. Overview of genomes targeted for transgene insertion in Chlamydomonas reinhardtii. 
Major advantages (+) and disadvantages (–) for transgene expression from the respective 
genome are indicated in the figure. 
 
The nuclear genome of Chlamydomonas consists of 17 haploid chromosomes 
and is approximately 111.1 Mb in size (Blaby et al., 2014). A first annotated draft 
sequence had been published in 2007 (Merchant et al., 2007) and major improvements 
have been implemented since then. The nuclear genome is relatively G+C rich with an 
approximate overall GC content of 64 % (Merchant et al., 2007) and encodes a 
predicted number of 17 741 genes (Blaby et al., 2014). Over the years classical genetic 
techniques have been established (Harris, 2009) and many mutants have been generated 
to study the physiology, biochemistry and reproduction of Chlamydomonas using a 
variety of mutagens and insertional mutagenesis methods (reviewed in more detail in 
e.g. (Jinkerson and Jonikas, 2015)). More targeted methods of editing the nuclear 
genome have also been reported for C. reinhardtii, but are, especially concerning the 
event of homologous recombination, not very efficient and would need further 
development to be of any use for heterologous gene insertion (reviewed in (Mussgnug, 
2015)). The recently discovered CRISPR/Cas9 technology (Jinek et al., 2012) might 
also be a new route to manipulate microalgae in the future. A first study applied this 
method to genetically modify Chlamydomonas (Jiang et al., 2014) but considerable 
further improvements will be necessary to make this a viable option to transform this 
organism. 
nuclear genome (111.1 mb):
+:  haploid, secretion, glycosylation
–:   random gene insertion 
      (gene silencing, position effects)
plastome (204 kb):
+:  high expression levels,
      targeted gene insertion
      disulphide bond formation
–:   polyploid
      no glycosylation




Homologous recombination seems to be a frequently occurring event in the 
nucleus of Nannochloropsis sp. (Kilian et al., 2011) and can, therefore, be taken 
advantage of for targeted insertion of transgenes. However, in Chlamydomonas 
reinhardtii homologous recombination occurs much less frequently in the nuclear 
genome and is, thus, of no use for genetic engineering. Integration of heterologous 
genes into the nuclear genome occurs essentially at random and epigenetic gene 
silencing is a frequently observed issue (Cerutti et al., 1997). Often, truncation of the 
cassette or genomic deletions, genomic rearrangements and others are thought to take 
place. How and why this occurs is not entirely known, but models of potential 
mechanisms exist (Zhang et al., 2014). 
Several ways of improving nuclear transformation efficiencies such as codon 
optimisation (Fuhrmann et al., 1999) or the usage of introns in coding regions 
(Lumbreras et al., 1998; Eichler-Stahlberg et al., 2009) have been shown, but stable 
expression levels remain a difficult task and levels are low – Neupert et al. (2009) 
reported a relatively high level, 0.2 % of TSP, for fluorescent proteins using a new 
genetic screening method. More recently, approaches for a more modular and 
systematic design of expression systems from the nuclear genome have been developed 
for C. reinhardtii (Lauersen et al., 2015) and further improvements using modular 
systems with a synthetic biology approach have been proposed (Scaife et al., 2015). 
The chloroplast genome has, in contrast, a very different nature. It is thought to 
have derived from a single event of endosymbiosis from a cyanobacterial ancestor 
(Kowallik, 1994). In C. reinhardtii the single plastid chromosome is approximately 204 
kb in size with a G+C content of 34.6 % coding for approximately 99 expressed genes 
(Maul et al., 2002). Most of these genes are encoding photosynthesis components or 
components of the translation machinery. The plastome also encodes rbcL, the large 
subunit of RuBisCO, probably the most abundant protein found on Earth. 
Approximately eighty copies of the plastome are found in C. reinhardtii (Boynton et al., 
1988) in multiple confirmations (both, circular and linear) (Maul et al., 2002). This 
polyploidy depicts a challenge in itself for heterologous gene integration – homoplasmy 
is essential to ensure a stable genetic background of transformants. 
Homologous recombination allows targeted gene integration in the chloroplast, 
which is a major advantage for genetic engineering (Bock, 2015). The levels of 
transgene expression in chloroplasts are much higher than from the nuclear genome, the 
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highest number reported to date is approximately 10 % TSP (Surzycki et al., 2009), but 
usually levels achieved are not more than 5 % TSP (Potvin and Zhang, 2010). 
Major factors affecting levels of protein accumulation in the chloroplast have 
been identified: codon optimisation (Franklin et al., 2002; Wu et al., 2011), protein 
degradation (the exposure to proteases) and genotypic modifications resulting from the 
transformation procedure (referred to as ‘transformosomes’) (Surzycki et al., 2009). The 
toolkit has been developed remarkably over the last years, with various selectable 
markers, promoters and expression vectors now available (Purton et al., 2013). 
Depending on the nature of the heterologous gene one wants to express, the 
correct choice of integration site is crucial. Whereas the chloroplast offers higher 
expression levels and the amount of proteases acting on the heterologous protein is 
comparably low, the ability of PTM is rather limited: the chloroplast is capable of 
disulphide bond formation (Mayfield et al., 2003), phosphorylation (Rasala and 
Mayfield, 2015) and N-acetylation of endogenous proteins has been observed frequently 
(Bienvenut et al., 2011), but other PTMs such as N-glycosylation do not occur. 
Therefore, advances in expression of transgenes from the nuclear genome are very 
important. If the chloroplast capabilities are limited, there is a good chance that nuclear 
expression will offer a solution. For example, it is possible to secrete recombinant 
proteins to the culture medium (Rasala et al., 2012; Lauersen et al., 2013) or target them 
to various subcellular compartments (Hayashi and Shinozaki, 2012; Rasala et al., 2014). 
Correct glycosylation of a recombinant protein, human erythropoietin, is expected when 
expressed from the nuclear genome of C. reinhardtii due to the intrinsic glycosylation 
properties of the organism. However, this could not be fully confirmed due to low 
protein yields and, therefore, missing experimental evidence (Eichler-Stahlberg et al., 
2009). A monoclonal antibody against Hepatitis B, produced in P. tricornutum was 
characterised biochemically demonstrating the diatom’s glycosylation capabilities 
(Vanier et al., 2015). 
Understanding the properties of the specific recombinant protein targets is a first 
important step of choosing a suitable integration site. Microalgae offer various 
possibilities of expressing recombinant proteins and are considered of great potential for 
future applications. Rasala and Mayfield recently wrote a good review of what aspects 




1.3.3. Promoters for nuclear and plastome expression in C. reinhardtii 
 
 The most commonly used promoters (5’ untranslated region (UTR)) for nuclear 
expression are the HSP70 and HSP70/RBCS2 hybrid promoter (Schroda et al., 2000). 
Another commonly used one is PSAD, which drives the expression of the photosystem I 
subunit PsaD (Fischer and Rochaix, 2001). Recently, a study used promoter trapping to 
identify further promoter sequences that are promising for nuclear expression systems 
(Vila et al., 2012) and the ARG7 promoter from argininosuccinate lyase was found to 
enable good expression levels (Specht et al., 2015). 
 In the chloroplast several promoters have been used to drive transgene 
expression. Promoters from highly expressed endogenous algal genes turned out to 
result in the highest yields of recombinant protein (Walker et al., 2005). Examples are 
the rbcL 5’UTR from the large subunit of RuBisCO (Blowers et al., 1990; Franklin et 
al., 2002), the ATP synthase subunit alpha promoter atpA (Blowers et al., 1990; 
Mayfield et al., 2003; Michelet et al., 2011; Economou et al., 2014), psbA (Michelet et 
al., 2011; Gimpel and Mayfield, 2013), psaA-exon1 (Michelet et al., 2011; Young and 
Purton, 2014), the 16S rRNA promoter (Rasala et al., 2011) or more recently petA, the 
promoter driving the expression of cytochrome f (Young and Purton, 2014).  
 The choice of promoter has a big impact on expression levels of a transgene and 
is itself regulated by external factors such as light in case of the psbA promoter for 
example. This has to be taken into account when choosing a 5’UTR for a heterologous 
gene construct. Re-engineering of the 5’UTR has shown to increase protein expression 
levels in the chloroplast of C. reinhardtii by bypassing feedback control mechanisms 
acting on the 5’UTR (Specht and Mayfield, 2013). Recently, a review was published 
that gives an extensive and far more complete overview of promoters used in 
C. reinhardtii for both chloroplast and nuclear expression (Mussgnug, 2015). 
 
 
1.3.4. Selectable markers and reporter genes available for C. reinhardtii 
 
Selectable markers and reporter genes are an important tool to detect if a 
heterologous gene has been integrated successfully. Whereas reporter genes such as 
fluorescent proteins or an antibiotic resistance cassette are used to select transformants 
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across all kingdoms, other markers are more specific for the respective organism 
transformed. Here, important markers and reporters described in both, the nuclear and 
the chloroplast genome of C. reinhardtii are introduced. 
In C. reinhardtii positive transformation markers and reporter genes can be 
divided into the following categories (Mussgnug, 2015): 
 
a) auxotrophy and complementation markers 
b) antibiotic and herbicide resistance cassettes 
c) reporter genes (colour or light emission detection) 
 
Selectable markers for nuclear transformation in category a) are, for example, 
ARG7 (Debuchy et al., 1989) which complements arginine auxotrophy and NIT1 
(Kindle et al., 1989) for restoring growth on nitrate as a nitrogen source. For chloroplast 
transformation, selectable markers of category a) are usually used for restoring 
photosynthetic capacities, for example atpB (Boynton et al., 1988) or psbH (Cullen et 
al., 2007). Category b) includes the aadA cassette from Escherichia coli lending 
resistance to streptomycin and spectinomycin. This marker has been used in both, the 
chloroplast genome (Goldschmidt-Clermont, 1991) and the nuclear genome (Cerutti et 
al., 1997). Other antibiotic resistance cassettes used for nuclear transformation include a 
ble cassette for resistance to bleomycin, phleomycin and zeocin/zeomycin (Stevens et 
al., 1996), resistance to chloramphenicol via integration of the cat gene into the nuclear 
genome (Tang et al., 1995) or resistance to hygromycin via expression of the hpt gene 
from E. coli (Butanaev, 1994; Kumar et al., 2004). 
A reporter gene used for detecting ‘colour’ is for example β-Glucuronidase 
(uidA gene from E. coli) (Kumar et al., 2004) expressed from the nuclear genome. A 
variety of fluorescent proteins have been expressed in C. reinhardtii in various 
compartments including GFP (and modified versions thereof) (Fuhrmann et al., 1999; 
Franklin et al., 2002; Kumar et al., 2004; Neupert et al., 2009) and other fluorescent 
proteins (Rasala et al., 2013; Lauersen et al., 2015) and also chemiluminescent proteins 
(Fuhrmann et al., 2004; Shao and Bock, 2008). A more detailed overview of selectable 
markers and reporter genes is given in (Gangl et al., 2015a) and Supplementary 




1.3.5. The chloroplast transformation vectors pASapI and pSRSapI 
 
In this section the details of the chloroplast transformation vectors used to make 
the transformants described in this thesis will be introduced. The constructs were made  
in the lab of Saul Purton (University College, London, UK). PASapI and pSRSapI have 
been developed for chloroplast transformation of C. reinhardtii using the glass bead 
method (Economou et al., 2014). The transformation method uses a strain, previously 
generated by genetic engineering, named TN72 (cw15, psbH::aadA, mt+). Upon 
transformation, the aadA cassette disrupting psbH in TN72 is exchanged with a 
functional copy of psbH and simultaneously the heterologous gene gets recombined into 
the chloroplast genome. This allows the generation of marker free transformants that 
essentially only contain the gene of interest (GOI) of foreign DNA. 
Positive transformants are selected via growth on minimal medium because by 
integrating a functional copy of the psbH gene, which encodes a subunit of photosystem 
II, the photosynthetic capacity of the strain is restored. TN72 has to rely on an organic 
carbon source for growth because of the disrupted psbH gene whereas the then 
generated transformants can grow photoautotrophically. Selection for autotrophic 
growth is a strong selection pressure, thus homoplasmic transformants are relatively 
easy to obtain with this method.  
PASapI (Economou et al., 2014) and pSRSapI (Young and Purton, 2014) are 
almost identical vectors: they integrate into the same site in the chloroplast genome and 
for both, TN72 is used as a recipient strain. The heterologous gene can be cloned into 
the vectors rather easily with a classical restriction digest and subsequent ligation of the 
insert into the vector using the restriction enzymes SapI (LguI) and SphI (PaeI). The 
difference between pASapI and pSRSapI is the 5’UTR. In pASapI an atpA promoter 
drives expression of the heterologous gene whereas in pSRSapI a psaA promoter is 
used. The psaA promoter should result in approximately a 2-fold increase of expression 
compared to the atpA promoter (Saul Purton, personal communication). An overview of 
the vector elements of the vectors is given in Fig. 1.2 for pASapI (A) and pSRSapI (B). 
Fig.1.3 schematically represents the procedure for obtaining C. reinhardtii chloroplast 





Fig. 1.2. pASapI and pSRSapI vector elements. Elements of the pASapI (Economou et al., 
2014) (A) and pSRSapI (Young & Purton, 2014) (B) vectors for chloroplast transformation of 
C. reinhardtii are shown. An example GOI (gene of interest) of 500 bp is cloned into the vector. 
Upon integration of the GOI, the restriction site SapI (LguI) gets destroyed and is therefore not 
shown in the schematic drawing. The size of the vector elements is in proportion with their 
length in base pairs. Vector diagrams were assembled using the software Gene Designer (DNA 




Fig. 1.3. Overview of C. reinhardtii chloroplast transformation procedure using 
pASapI/pSRSapI. An overview of the chloroplast transformation and transformant selection 
procedure using the method described in Economou et al. (2014) is shown. Details are 
































1.3.6. Future challenges in genetically modifying microalgae 
 
One of the major challenges associated with more complex genetic engineering 
in the future will be to coordinate the expression of several genes. In the case of 
metabolic pathway engineering, the expression levels might also have to be fine-tuned 
to allow for effective product synthesis. Expressing several heterologous genes, 
simultaneously, in eukaryotic microalgae is to date not established. Engineering of 
complex operons with polycistronic constructs, which is possible in cyanobacteria, is 
not advanced and might not be possible due to a different organisation of the genetic 
information (this is especially the case for nuclear expression systems).  
Theoretically, the expression of multiple genes in the chloroplast of e.g. 
C. reinhardtii should be possible by inserting transgenic operons (Purton et al., 2013), 
but this method has, to date, not been used with a lot of success and only very few 
studies report the expression of several genes (Su et al. 2005, Chaogang et al., 2010). 
Methods for multiple gene expression in the chloroplast of C. reinhardtii (Noor-
Mohammadi et al., 2012) and also in the nuclear genome (Noor-Mohammadi et al., 
2014; Rasala et al., 2014) have been proposed. However, all these studies did not 
engineer true biochemical pathways but only used reporter and selectable marker genes. 
Therefore, this is not comparable with actual metabolic pathways that will have a 
considerable impact on the cellular metabolism. In another study, editing the chloroplast 
genome, simultaneously at several sites, is proposed by assembling a full chloroplast 
genome exogenously and subsequent transformation into the chloroplast (O'Neill et al., 
2012). The method has many problems with DNA stability, for example due to the 
repetitive nature of the chloroplast genome, and, if this is to be of use for genetic 
engineering, further improvements are needed. Another study shows the successful use 
of a FMDV 2A self-cleavage peptide for expressing two genes as one construct from 
the nuclear genome in C. reinhardtii (Rasala et al., 2012). However, this self-cleavage 
site is unfortunately not recognised in a prokaryotic environment, as found in the 
chloroplast of microalgae, and is, therefore, of no use for expressing several genes from 
the chloroplast genome. 
Other challenges have been addressed in more detail in previous studies and 
remarkable progress was already made, such as improved protein expression levels and 
identification of major factors impacting protein expression levels (Manuell et al., 2007; 
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Surzycki et al., 2009). Recently, selenocystamine was reported to increase accumulation 
of recombinant proteins containing disulphide bonds in the chloroplast, probably by 
assisting with disulphide bond formation (folding) (Ferreira-Camargo et al., 2015). The 
synthesis of toxic substrates (Tran et al., 2013a; Tran et al., 2013b; Young and Purton, 
2015) or challenges such as secretion of products into the culture medium (Rasala et al., 




1.4. Genetic engineering of microalgae for biotechnological 
applications 
 
In Section 1.3 important tools and techniques for genetically modifying 
microalgae have been introduced. The following section will focus on the products that 
have been made in microalgae for biotechnological applications using those tools. The 
production of recombinant proteins will be discussed separately from high-value 
compounds for C. reinhardtii and an overview of high-value products (including 
recombinant proteins) in other eukaryotic microalgae will be given. 
 
 
1.4.1 Expression of recombinant proteins in C. reinhardtii 
 
The expression of recombinant proteins in microalgae has advanced 
significantly over the last 10 years, especially for C. reinhardtii. To date, over 50 
proteins have been expressed successfully in the chloroplast of Chlamydomonas (Purton 
et al., 2013). First reports of recombinantly expressed proteins occurred shortly after 
transformation protocols had been developed. Later on, in 1991, the functional 
expression of a heterologous gene, aadA from E. coli was shown in C. reinhardtii by 
conferring resistance to the transformants (Goldschmidt-Clermont, 1991). The first 
report of a therapeutic protein of interest for biotechnological applications expressed in 
microalgae only occurred more than ten years later (Mayfield et al., 2003) – the 
transformant was made by particle bombardment and expressed an HSV8-lsc single-
chain, monoclonal human antibody driven by atpA and rbcL 5’UTRs. After this, the 
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number increased rapidly. Most of the recombinant proteins produced in 
Chlamydomonas for biotechnological applications can be classified in the following 
categories: 
 
a) Antibodies and immunotoxins, vaccines 
b) Other therapeutic proteins (including hormones) 
c) Enzymes 
 
After the first scFv (single chain Fragment variable) antibody was produced, 
Tran et al. showed that it is also possible to assemble a full-length antibody in the 
chloroplast of C. reinhardtii. The human IgG1 antibody against anthrax was shown to 
have very similar binding activities to an antibody produced in mammalian cell culture 
(Tran et al., 2009). The chloroplast of C. reinhardtii has also been used for expressing 
immunotoxins. Immunotoxins are conjugates of an antibody fused to a eukaryotic toxin 
domain used in cancer therapeutics. The antibody domain recognises the targeted cell 
and the toxin then initiates killing of the cancer cell (Alewine et al., 2015). The 
production of these molecules is not possible in eukaryotic cells (yeast, Chinese hamster 
ovary (CHO) cells, insect cells) due to toxicity. They can be produced in E. coli, which 
is, however, not capable of all necessary PTMs. C. reinhardtii has been shown to be 
capable of assembling functional immunotoxins, both monomeric and dimeric, using 
the PE40 domain of exotoxin A from Pseudomonas aeruginosa (Tran et al., 2013a) and 
also a eukaryotic ribosome inactivating protein, gelonin (Tran et al., 2013b), as the 
toxin unit. The microalgal chloroplast offers a unique opportunity to produce these 
toxins due to the prokaryotic translation machinery coupled with eukaryotic capabilities 
in regard to PTMs and protein stability. Several patent applications for the production of 
these immunotoxins in microalgae have been filed by the authors, but only the 
European patent was granted recently (Mayfield and Tran, 2014). The group of S.P. 
Mayfield recently also produced camelid antibody fragments that act as an antitoxin 
against the botulinum neurotoxin in the chloroplast of C. reinhardtii (Barrera et al., 
2015). 
 The most reported therapeutic proteins produced in C. reinhardtii are various 
kinds of vaccines. This is possibly due to the potential of oral vaccination using 
lyophilised harvested biomass (if the microalga used for production has GRAS status) 
(Rosales-Mendoza, 2013). Oral administration of vaccines allows to target mucosal and 
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systemic immunity simultaneously, and vaccines produced in algae pose a lower risk of 
pathogen contamination when compared to vaccines produced in mammalian cells 
(Specht and Mayfield, 2014). Very early on, in recombinant protein production systems 
developed in microalgae, a virus VP1 protein (fused with a Cholera toxin subunit) 
against Foot-and-Mouth disease virus was produced in the chloroplast accounting to 3 
% of TSP in the chloroplast, however, the generated strains were not homoplasmic (Sun 
et al., 2003). The first demonstration of an oral vaccine produced in algae was a vaccine 
protecting mice from Staphylococcus aureus infections upon oral administration 
(Dreesen et al., 2010). Subsequently vaccines against the classical swine fever virus 
(even though oral application to mice did not result in a response, only when applied 
subcutaneously) (He et al., 2007), an antigen against hGAD65 for diabetes type I 
treatment (Wang et al., 2008) and a white spot syndrome virus VP28 protein (Surzycki 
et al., 2009) were reported. Further vaccines expressed in C. reinhardtii include an E7 
vaccine against the human papilloma virus (Demurtas et al., 2013) and a vaccine against 
angiotensin II for hypertension treatment (although no immunological assays showing 
activity are given) (Soria-Guerra et al., 2014). There is also evidence from several 
studies that vaccines for malaria treatment can be made in C. reinhardtii (Dauvillée et 
al., 2010; Gregory et al., 2012; Gregory et al., 2013; Jones et al., 2013) and again, 
patents for the production of malaria transmission blocking vaccines have been filed by 
authors of the studies, but have not been granted to date (patent applications: US 
20140219971, WO 2012170125, WO 2012170125). 
 Other therapeutic proteins expressed in C. reinhardtii include human hormones 
such as proinsulin (at very low levels only detectable by immunoprecipitation of 50 mL 
cultures) (Rasala et al., 2010), vascular endothelial growth factor (Rasala et al., 2010) 
and erythropoietin (Eichler-Stahlberg et al., 2009). One of the first attempts at co-
expression of two genes in one construct from the chloroplast genome was made in 
2005; two subunits of allophycocyanin, apcA and apcB were expressed at 
approximately 25 µg per mg of TSP. Potential inhibition of S-180 carcinoma cells in 
mice by this recombinant allophycocyanin is indicated, but no data are presented (Su et 
al., 2005). Yang et al. produced a non-codon optimised TRAIL (tumor necrosis factor-
related apoptosis inducing ligand) protein that selectively causes apoptosis in tumor and 
virus-infected cells (Yang et al., 2006). In a study replacing the coding region of psbA 
in the chloroplast directly with the coding sequence of bovine mammary-associated 
serum amyloid (M-SAA), high levels of up to 5 % TSP of the recombinant protein were 
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reported. M-SAA is a protein that is able to stimulate mucin production in epithelial 
cells of the human gut for enteric bacterial and viral infection prophylaxis (Manuell et 
al., 2007), the expression system has also been patented by the authors (Mayfield, 2010; 
Mayfield, 2015). Purton et al. showed that endolysins, an alternative to traditional 
antibiotics, can be produced in C. reinhardtii (Taunt (2013), Saul Purton et al., 
unpublished, patent application 704751). 
 In line with using microalgae as functional foods, a study examined the 
feasibility of expressing milk-derived bioactive peptides in C. reinhardtii with 
antihypertensive, opioid, antimicrobial and hypocholesterolemic activities. The study 
showed that the chimeric proteins could be expressed in microalgae, but the levels were 
variable (Campos-Quevedo et al., 2013). 
 Enzymes expressed in C. reinhardtii include various classes. Yoon et al. 
produced a phytase from E. coli that increased phytate phosphorus utilisation as a feed 
additive when fed to boiler chickens (although chicken tests were conducted with only 
n=3 chickens and supplementing the chicken’s diet with lyophilised WT C. reinhardtii 
(strain CC-125) also resulted in decreased phytate levels) (Yoon et al., 2011). Other 
enzymes expressed include ADH1, alcohol hydrogenase, which resulted in ethanol 
production in the transformed C. reinhardtii strains (Chen and Melis, 2013) and an 
industrially relevant enzyme, xylanase (produced in the cytosol and secreted to the 
medium) (Rasala et al., 2012). 
An enzyme expressed in the chloroplast by Fukusaki et al. is of major interest 
for this thesis as it encodes a GGPP synthase that generates GGPP, the universal 
precursor of diterpenes. A gds gene from a thermophilic archaeon was introduced with 
the aim to engineer the secondary metabolism of C. reinhardtii. The enzyme, GGPP 
synthase, was detected but differences between WT and the transformant were only 
found at higher temperatures (possibly due to the enzyme originating from a 
thermophilic organism) which can be a problem for the normal cellular metabolism of 
C. reinhardtii (Fukusaki et al., 2003). 
This section only highlighted major achievements in recombinant protein 
production, several reviews provide a deeper insight into what proteins have already 
been made in algae (e.g. (Mayfield et al., 2007; Specht et al., 2010; Rosales-Mendoza et 




1.4.2. Other high-value compounds produced in C. reinhardtii 
 
Studies reporting the production of high-value compounds (by genetic 
engineering) other than recombinant proteins in C. reinhardtii are, to date, very rare. 
Expression of the β-carotene hydroxylase from Haematococcus pluvialis in 
C. reinhardtii resulted in an elevated carotenoid content compared to the WT when 
exposed to high light (Tan et al., 2007). In 2010, Chaogang et al. showed that PHB, a 
biodegradable polyester, can be produced and accumulated in C. reinhardtii. PHB 
production costs are still very high and microalgae could provide an alternative, 
cheaper, production system (Chaogang et al., 2010). One study reports the production 
of xylitol, an artificial sweetener, in the chloroplast by expression of a xylose reductase 
from Neurospora crassa and feeding of xylose into the culture medium (Pourmir et al., 
2013). However, the sugar can be produced easily in yeast and E. coli and NAD(P)H 




1.4.3. High-value compounds produced in other microalgae 
 
Most reports of genetic modification in microalgae are in C. reinhardtii. In more 
recent years, increasingly other microalgae have been subject to genetic modification 
studies. Model organisms studied are mainly species that have already been used in an 
industrial setting and that are known to be scalable. In most cases metabolic engineering 
studies focus on engineering for improved lipid synthesis towards biofuel production in 
microalgae (e.g. in P. tricornutum (Hamilton et al., 2015), Nannochloropsis oceanica 
(Kaye et al., 2015), Schizochytrium sp. (Yan et al., 2013) and Fistulifera solaris (Muto 
et al., 2015)). Recently several reviews have been published summarising developments 
in lipid synthesis engineering in microalgae (De Bhowmick et al., 2015; Gimpel et al., 
2015a; Levering et al., 2015). 
In Phaeodactylum tricornutum a monoclonal antibody against Hepatitis B was 
produced. The antibody was expressed at 8.7 % of TSP from the nuclear genome in the 
ER (Hempel et al., 2011b) and later on it was shown that the IgG antibody can also be 
secreted to the medium (Hempel and Maier, 2012). In a second follow-up study, the 
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quality of the produced antibodies was characterised biochemically and found to be of 
high and consistent quality (Vanier et al., 2015). Similarly, HBsAg has been produced 
in Dunaliella salina (Geng et al., 2003) and more recently, haemagglutinin has been 
produced in the microalga Schizochytrium sp. (Bayne et al., 2013). 
The expression of hormones has been reported for other eukaryotic microalgae. 
Human growth hormone has been expressed in Chlorella (Hawkins and Nakamura, 
1999). A flounder growth hormone produced in Chlorella ellipsoidea increased 
flounder fry growth by 25 % when fed with zooplankton that had incorporated the 
transgenic Chlorella (Kim et al., 2002). 
As with what has been done in C. reinhardtii by Chaogang et al. (2010), a study 
also investigated PHB biosynthesis in P. tricornutum (Hempel et al., 2011a). The 
synthesis of engineered high-value compounds other than naturally abundant high-value 
compounds in microalgae (see section 1.2.2.2) is still rare. 
 
 
1.5. Utilising the microalgal metabolism for biotechnological 
applications 
 
This section will highlight aspects of the microalgal metabolism that have 
potential for future biotechnological applications. The focus will be on traits that have 
been investigated and proposed for genetic engineering targets as part of this thesis. 
 
 
1.5.1. Isoprenoid synthesis in microalgae 
 
Isoprenoids are hydrocarbons of enormous chemical and structural diversity 
found in all living organisms. They serve, for example, as pigments, hormones, 
defensive agents, constituents of membranes and photoprotective agents (Sacchettini 
and Poulter, 1997). The greatest diversity is however found in plants where isoprenoids 
are synthesised as secondary metabolites (Englund et al., 2015). Isoprenoids are also 
referred to as terpenes or terpenoids, names that are used interchangeably (Lohr et al., 
2012). 
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 There are two known pathways in nature for isoprenoid synthesis: the 
mevalonate (MVA) pathway (HMG~CoA reductase pathway) and the methylerythritol 
phopshate (MEP) (the MVA-independent) pathway. The MVA pathway forms IPP 
(isopentenyl diphosphate, the active precursor molecule of all isoprenoids) from 
acetyl~CoA, whereas IPP is synthesised from pyruvate and glyceraldehyde-3-phosphate 
(GA3P) via the MEP pathway. 
The MVA pathway was long thought to be the only route for isoprenoid synthesis as the 
MEP pathway was only fully elucidated and accepted in more recent years (Eisenreich 
et al., 2004). In both cases, the three major stages for the biosynthesis of isoprenoids are 
as follows (Lohr et al., 2012):  
 
1. Formation of active isoprene (IPP or DMAPP (dimethylallyl diphosphate)) 
2. Linear condensation of C5 units to polyprenyl diphosphates (variable chain length) 
3. Further modification of the polyprenyl diphosphates 
 
The general consensus is that the MVA and the MEP pathways operate in 
different cellular compartments. For example in streptophytes (including land plants), 
the MVA pathway operates in the cytosol whereas the MEP pathway operates in the 
plastids, but more recently active metabolite trafficking and cross regulation was 
uncovered from several studies (reviewed in (Lohr et al., 2012)). In many oxygenic 
phototrophs, including chlorophytes (green algae), the MVA pathway is absent. For 
example, in C. reinhardtii no evidence for the pathway was found in its genome 
sequence or in labelling experiments (Disch et al., 1998), whereas in other microalgae 
(especially with secondary plastids) such as the diatom P. tricornutum, both, the MVA 
and the MEP pathway seem to operate (Cvejić and Rohmer, 2000). A model of how 
isoprenoid synthesis metabolites are compartmentalised in eukaryotic green algae, such 




Fig. 1.4. Compartmentation of isoprenoids and trafficking of precursors in eukaryotic 
microalgae where only the MEP pathway operates. This is a hypothetical compartmentation 
based on biochemical and in silico data. Dotted arrows show potential transport of isoprenoid 
precursor units between compartments across membranes. The length of the isoprenoid 
precursor molecule is indicated (CX). GA3P: glyceraldehyde-3-phosphate. Ⓟ: phosphate group. 
Grey colour and question marks indicate putative catalysis (enzymes might be missing). Figure 
was adopted and modified from Fig. 4A in (Lohr et al., 2012).  
 
The smallest isoprenoid is the C5 molecule isoprene. Isoprenoids with a longer 
chain length are all assembled with the 5-carbon unit of IPP (DMAPP) and named 
according to their chain length following the “isoprene rule” (Ruzicka, 1953): 
monoterpenes (C10), sesquiterpenes (C15), diterpenes (C20) and so on. Further 
diversity originates from different degrees of saturation and rearrangements of the 
structure (linearisation, cyclisation, isomerisation and branching) (Davies et al., 2015). 
 Isoprenoids are of major interest for the synthesis of both commodity and high-
value compound production in photosynthetic hosts. However, genetic engineering for 
establishing a photosynthetic isoprenoid production platform is still in its early days. 
Major advances in redirection of carbon flux and complex pathway engineering will be 
necessary (Davies et al., 2015). Synechocystis sp. PCC 6803 has been studied as a 
cyanobacterial model system for isoprene production (Lindberg et al., 2010), β-
carophyllene (a sesquiterpene) (Reinsvold et al., 2011), the monoterpene β-pyllandrene 
(Bentley et al., 2013) and manoyl oxide (a diterpene) (Englund et al., 2015) synthesis. 
 43 
However, to date no studies of recombinant synthesis of terpenes in eukaryotic 
microalgae have been reported, but their potential has been indicated several times 
(Lohr et al., 2012; Work et al., 2013; Davies et al., 2015). 
 
 
1.5.2. Engineered, light-driven isoprenoid (terpene) synthesis in microalgae 
and cyanobacteria 
 
In this section a novel approach of genetic engineering to couple reducing power 
from photosynthesis to high-value compound production is introduced. This field of 
research has been pioneered by researchers from the University of Copenhagen and 
recently great progress has been made. The general idea behind this is to scavenge 
reducing power from the photosynthetic electron transport chain (PET). This is possible 
because energy from light is often harvested in excess compared to what can be further 
metabolised which essentially allows “light-driven in vivo product synthesis” (Jensen et 
al., 2012). The scavenged reducing power can then be used to facilitate catalysis of 
high-value compounds that are of interest for synthetic biology (Lassen et al., 2014b). 
There are several groups of secondary metabolites produced by plants that are of 
interest for production in microalgal photosynthetic hosts, including isoprenoids, 
alkaloids and flavonoids (Marienhagen and Bott, 2013).  
Terpenes from plants are used in a variety of industries – as pharmaceuticals, 
flavours, fragrances, food supplements (vitamins and sweeteners), pesticides and even 
as feedstock for many industrial materials (Bohlmann and Keeling, 2008). Typically 
these compounds are produced at only very low quantities in the natural host (plants) 
and are often too complex for chemical synthesis, therefore, microorganisms are 
considered an attractive alternative production platform (Marienhagen and Bott, 2013). 
Terpene biosynthesis typically involves two major classes of enzymes: terpene 
synthases that form the scaffold of the molecule and cytochromes P450 (P450s), a large 
class of monooxygenases, that functionalise the scaffolds by oxidation (Pateraki et al., 
2015). Most of the P450s involved in terpene synthesis in plants are class II P450s that 
are membrane bound enzymes located in the ER. P450 activity is then typically limited 
by NAD(P)H availability. Therefore, relocation of those P450s to the thylakoid 
membranes where reducing power can be provided by PET could allow increased 
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activity and consequently higher product yields (Lassen et al., 2014b). The relocation of 
P450s has been described in several proof of concept studies: first, by transient 
expression in tobacco and targeting of the P450s to the chloroplast (Nielsen et al., 
2013). Later, in the cyanobacterium Synechococcus sp. PCC 7002 the soluble subunit of 
a P450 (CYP79A1) was anchored to a PSI subunit (PsaM) for targeting to the 
thylakoids allowing catalysis in vitro and in vivo (Lassen et al., 2014a). More recently it 
was shown that the whole pathway for dhurrin synthesis can be engineered into 
Synechocystis sp. PCC 6803 involving relocated P450s (Wlodarczyk et al., 2016). 
Theoretically, the relocation of P450s as shown in other model systems could 
also be used for terpene synthesis in eukaryotic microalgae. A model of how 
recombinant expression of terpene synthases and P450s in the C. reinhardtii chloroplast 
could facilitate in vivo terpene synthesis integrated into the algal metabolism is shown 
in Fig. 1.5.  
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Fig. 1.5. Model of potential light-driven terpene production in the chloroplast of C. reinhardtii. 
A hypothetical model outlining terpene production in the C. reinhardtii chloroplast is depicted. 
Terpene precursor molecules are synthesised via the MEP pathway and a precursor terpene is 
synthesised by terpene synthases that gets functionalised by cytochromes P450 (P450s) that 
were relocated and inserted in the thylakoid membranes. Ferredoxin (Fd) feeds electrons (e–) 
from the photosynthetic electron transport chain (PET) to drive the P450s involved in terpene 
synthesis and the Ferredoxin NADP+ reductase (FNR) at the same time. 
 
 
1.5.3. Protein targeting in the algal chloroplast and the thylakoids 
 
Protein targeting is a highly sophisticated and complex process found in all 
living organisms. The understanding and utilisation of these trafficking mechanisms are 
crucial for proteins to be targeted and produced in the algal chloroplast. Chapter 4 
introduces a novel approach of utilising the thylakoid lumen for recombinant protein 
expression in algae. Here, details of targeting mechanisms across the chloroplast 




1.5.3.1. Targeting of nuclear encoded proteins into chloroplasts 
 
The primary plastids found in members of the Viridiplantae, including 
eukaryotic green microalgae (Chlorophyta) and higher plants (Streptophyta) (Leliaert et 
al., 2012) are thought to have originated from a single endosymbiotic event and to be of 
cyanobacterial ancestry. Plastid import mechanisms are therefore considered to be 
rather similar, although, after an estimated divergence of 725 – 1200 million years 
(Becker and Marin, 2009), differences are not surprising. Most of the proteins operating 
in the chloroplast are nuclear encoded and thus need to be targeted, post translation, to 
the chloroplast by means of transit peptides. Import of proteins into primary plastids 
means that the substrate has to be translocated over the outer envelope membrane and 
the inner envelope membrane that are separated by a soluble intermembrane space. Two 
major complexes, TOC and TIC, located in the outer and inner envelope membranes 
facilitate this process (Jarvis and Soll, 2001). A bioinformatics analysis of the TOC and 
TIC complexes found that the composition of those complexes in C. reinhardtii is very 
similar to Arabidopsis thaliana (Kalanon and McFadden, 2008). A major difference is 
the nature of the transit peptides – in general, chloroplast transit peptides of green 
microalgae often share similarities with mitochondrial presequences of higher plants 
(Franzén et al., 1990). This is a major constraint for subcellular localisation prediction 
using programmes such as TargetP (Emanuelsson et al., 2000) or ChloroP 
(Emanuelsson et al., 1999) designed for higher plants. Efforts to address these 
limitations were already made and software for predicting protein targeting in green 
algae has been developed (PredAlgo, (Tardif et al., 2012)). Upon translocation into the 
stroma of the plastid, the signal peptide is typically cleaved off by the stroma processing 
peptidase (Richter and Lamppa, 2003).  
Many nuclear encoded proteins need to be not only targeted to the chloroplast 
stroma, but across or into another membrane - the thylakoid membrane. This means 
than an additional signal peptide is needed in the preprotein, for which reason these 
proteins have a bipartite N-terminal signal sequence (Ko and Cashmore, 1989). A 
schematic overview of the journey from a nuclear encoded protein into the thylakoid 
lumen is shown in Fig. 1.6. It is crucial to gain a deep understanding of the translocation 
and targeting mechanisms in algae to be able to precisely target proteins to subcellular 
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compartments for designing engineered metabolic pathways and for developing 
microalgae as cell factories. 
 
 
Fig. 1.6. Import of nuclear encoded protein with bipartite N-terminal signal sequence in 
C. reinhardtii. A model of a nuclear encoded protein that is translated in the cytoplasm and then 
imported into the thylakoids is shown. The protein is translocated into the stroma via the TOC 
and TIC complexes in the outer envelope membrane (OM) and the inner envelope membrane 
(IM) of the chloroplast. The TOC membrane complex consists of the subunits Toc159, Toc75 
and Toc34. The TIC complex is formed by the following subunits: Tic20, Tic21, Tic 22, Tic 32, 
Tic40, Tic55, Tic110, Tic62. Additionally the stromal chaperone ClpC binds to the Tic complex 
assisting translocation of the target proteins. Subunits of the complexes are shown in the figure. 
In the stroma the first part of the signal sequence is removed. A second part of the N-terminal 
signal sequence then facilitates translocation into or across the thylakoid membrane, where the 
second part of the signal sequence is removed. The folding state of the protein in which it is 
transported depends on the translocation mechanism (see Fig. 1.7.). The figure is based on 
information from (Kalanon and McFadden, 2008) and (Teixeira and Glaser, 2013). 
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1.5.3.2. Insertion into the thylakoid membrane and targeting to the lumen 
 
 
Fig. 1.7. Protein translocation mechanisms in chloroplast thylakoids. The major components of 
the respective translocation machinery (Sec, Tat, SRP) are shown and the nature of the substrate 
transported (folded / unfolded) is indicated. TL: thylakoid lumen; TM: thylakoid membrane; S: 
stroma. Figure was modified from original (Fig. 3) compiled for a review about protein 
translocation and thylakoid biogenesis in cyanobacteria (Frain et al., 2016). 
 
Generally, proteins are translocated to the thylakoid lumen via either the 
Secretory (Sec) translocation machinery or the Twin-arginine translocation (Tat) system 
(Albiniak et al., 2012). Insertion of proteins into the thylakoids is mainly mediated by 
the signal recognition particle (SRP) pathway, but additionally a (debatable) second 
spontaneous pathway may be operating in thylakoids (Robinson et al., 2001; Aldridge 
et al., 2009). Fig. 1.7 gives an overview of the multiple pathways for protein targeting 
in the thylakoids of chloroplasts and its major components. In addition to the 
mechanisms operating in higher plant chloroplasts, in algae a mechanism for targeting 
to the pyrenoid is required. The RuBisCO large subunit (LSU) has been shown to be 
targeted by a co-translational mechanism using FISH (Uniacke and Zerges, 2009), but 
many factors are still unknown. 
 Understanding the organelle targeting and protein translocation mechanisms in 
microalgae is an important tool to enable complex targeting and engineering of 
recombinant proteins in an algal host cell. Chapter 4 gives an overview how this could 
be utilised for future biotechnological applications. 
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1.6. Transition of microalgal culture from laboratory to pilot (and 
industrial) scale 
1.6.1. Upscaling challenges 
 
 Translating a microalgal growth system from lab scale to pilot or even industrial 
scale comes with several challenges that have to be considered carefully and that will 
vary drastically depending on the species and the system for growth used. The main 
challenges can be separated into: 
 
a) Engineering of the cultivation unit 
b) Physicochemical parameters 
c) Biological aspects 
 
On the engineering side, it is crucial to understand that the system has to be feasible 
and follow the basic laws of thermodynamics. When designing reactors (see section 
1.6.2.1), specifically for microalgae, a major constraint for upscaling of systems is light 
penetration and distribution in a culture vessel. Many factors relating to culture 
maintenance, control parameters for cultivation units and downstream processing need 
to be considered when upscaling and are normally neglected in small-scale studies. 
Physicochemical parameters include the distribution of light, pH control, temperature, 
aeration and degassing of the cultivation unit. Major challenges are also several 
biological aspects of the upscaling process – the choice of strain for upscaling will 
determine what cultivation unit is suitable to grow that specific strain (for example, 
fragile algae with flagella cannot be cultivated in the same systems as algae with thick 
cell walls resistant to shear stress). Factors such as inoculum size, formulation of 
cultivation medium, contamination management and biofilm formation control need to 








1.6.2. State of the art in industrial microalgae cultivation 
1.6.2.1. Cultivation Systems 
 
Cultivation systems for microalgae are separated into two major categories: 
open and closed systems. Whereas open systems such as floating devices in the ocean or 
lakes and ponds (including raceways and cascade systems) are most likely to be used 
mainly for agricultural purposes in the future, closed systems are of importance for 
various industrial applications (Verdelho Vieira, 2014). Closed systems include both, 
fermentation units for heterotrophic growth of algae and photobioreactors (PBR) of 
various designs, shapes and scale. The most popular design of a PBR is a horizontal 
tubular version, other designs include flat panel PBRs, airlift PBRs, vertical tubular 
PBRs, bubble column PBRs and stirred tank PBRs (Gupta et al., 2015). Advantages and 
limitations of the most common cultivation systems are summarised in Table 1.1. 
 
Table 1.1. Advantages and limitations of the most common cultivation systems for microalgae. 











None Poor, surface 
aeration 
Cost effective 
Simple, flexible design 
Beneficial for mass 
cultivation 
Lower biomass productivity 
Less control over culturing 
conditions 
High contamination risk 




























Build up of dissolved oxygen 
Susceptible to photo-inhibition 
Fouling, biofilm formation 
Requires large space  






None Open gas 
exchange at 
head space 
High mass transfer 
No internal structure 
Lack of moving parts 
Good mixing with low 
shear stress 
Lower photo inhibition 
Low surface area for 
illumination 
Expensive material 
















Little space needed 
High photosynthetic 
efficiency 
Cheap and economic 
Low O2 build up 
Short light penetration depth 
Not scalable 
Frequent fouling and clean up 
issues 
Poor temp. regulation 
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1.6.2.2. Downstream processing 
 
 The downstream processing of microalgae, i.e. the purification and extraction of 
algal products, can account for up to 60 % of the total production cost (calculated using 
EPA recovery from Phaeodactylum tricornutum as an example) (Molina Grima et al., 
2003), some estimations even stated 80 % of the total production costs (Rasala and 
Mayfield, 2015). The route chosen to process the algal biomass very much depends on 
the final product. In general, in a first step the biomass has to be harvested. Several 
methods can be used to concentrate algal biomass such as: centrifugation, filtration, 
flocculation, gravity sedimentation, flotation, magnetic separation, electrolysis and 
ultrasound (Kim et al., 2013). Typically a two-step process is used: first the biomass is 
separated from bulk suspension and secondly, the slurry is thickened (Brennan and 
Owende, 2010). After harvesting two major routes are used for further processing: the 
so-called dry and wet route. Again, the route chosen depends on the biomass 
characteristics and the end product. Via the dry route, the biomass is dried using e.g. 
spray drying or freeze drying. If the product needs to be extracted from algal biomass, a 
step of cell disruption can be necessary. The following methods are used for wet route 
processing: mechanical disruption (e.g. ultrasound or bead beating), chemical (e.g. 
organic solvents), biological (using enzymes) or by osmotic shock (Gangl et al., 2015a). 
 
 
1.6.3. Regulatory aspects of genetically modified algae 
 
 To date, there are no algal products on the market made in genetically modified 
(GM) microalgae. This is at least partly due to the current regulations not being clear on 
the cultivation of GM microalgae. The main risk associated with GM algae are potential 
adverse environmental consequences and harm to human and animal health (for food, 
feed and pharmaceutical applications) (Enzing et al., 2014). An overview of risk 
assessment for accidental release of GM algae from an enclosed system is shown in Fig. 
1.8. 
 The regulation of GM microalgae can be very different depending on the 
country – probably with the biggest differences existing between Europe and the USA 
(Hlavova et al., 2015). In the US the nature of the product rather than the way it is 
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produced is decisive for GM/non-GM classification: thus the crucial criterion lies on the 
final product being classified as safe. In contrast in Europe, products made in GM 
organisms have to be classified as GM food/ GM feed (EC 1829/2003). The cultivation 
of GM algae and cyanobacteria has to be in a closed system because open pond 
cultivation would be considered deliberate release (Directive 2009/41/EC, Article 2c) 
and the setting has to follow the safety level MI-I based on the concept of “Good 
Industrial Large Scale Practice” (Enzing et al., 2014).  
 It has been highlighted that avoiding the release of GM algae even in a 
contained unit will be almost impossible, giving rise to the need for sophisticated risk 
assessments (Gressel et al., 2013). It is also stressed that most GM algae are expected to 
have little chance of survival when released (Wijffels et al., 2013) even though others 
are more concerned about the release of GM algae based on in silico analysis and have 
asked for international regulations (Flynn et al., 2012). 
 
 
Fig. 1.8. Risk assessment of potential release of GM algae from a cultivation unit. HAB: 
harmful algal bloom; EDAB: ecosystem disruptive algal bloom; HGT: horizontal gene transfer. 





1.6.4. The current market for microalgal products 
 
 In 2012, the microalgae business was estimated at 1.325 Million USD per year 
targeting the aquaculture, food and feed and ceuticals markets (Verdelho Vieira, 2014). 
The market of microalgae is regarded to be still in its infancy but with a high growth 
observed since 1999 (Enzing et al., 2014). The worldwide production was estimated at 
9000 tonnes per year (Acién Fernández et al., 2013) and biomass costs are still high at 
30 to 300 EUR per kg (Brennan and Owende, 2010). The food and feed market is 
dominated by the production of Spirulina sp. and Chlorella sp., whereas high-value 
compounds such as PUFAs (DHA) and pigments (β-carotene, astaxanthin) also 
contribute majorly to the total market with considerable growth potential. Future 
developments of microalgae production are thought to be increasingly market driven 
with a rising need of algal production with a biorefinery concept in order to produce 
value added products which enable competitive pricing, quality and performance 
(Verdelho Vieira, 2014). 
 Over the next years further development can be expected and it remains to be 
seen if further market sectors, such as pharmaceuticals, can be entered by microalgal 
products and market segments like novel foods can be expanded. Many challenges 
including the feasible upscaling of a production system, reduction of biomass 
production costs and attraction of investment will need to be tackled and will decide 
about the future role of microalgae on the global market. 
  
 54 
1.7. Aims of this thesis 
 
In this thesis an attempt at exploring and expanding the potential of microalgae, 
more specifically the green alga Chlamydomonas reinhardtii, for biotechnological 
applications is made. Microalgae have been in the spotlight of development as a new 
biotechnological host for several years now. However, competing with already 
established platforms such as yeast or mammalian cell culture is still not possible. The 
idea of having a “green”, sustainable platform, a cell factory, which can essentially be 
driven by light seems attractive but a lot of challenges will have to be overcome to 
make this economically feasible. 
This thesis focuses on exploring unique properties of microalgae that are not 
found in existing biotechnological hosts. The study in chapter 2 looks at producing a 
terpene from the secondary metabolism of the conifer Abies balsamea in microalgae. 
Here, the idea is to scavenge the naturally abundant precursor molecule geranylgeranyl 
diphosphate, from isoprenoid synthesis, for producing high-value compounds using in 
the chloroplast recombinantly expressed enzymes. The specific terpene, cis-abienol is of 
significance for the perfume industry. In chapter 3 a novel approach of growing 
transgenic, wall-deficient Chlamydomonas strains at pilot scale is introduced. To date, 
there is only one publication on growth of C. reinhardtii at scale, although most studies 
of microalgae for biotechnological applications are conducted in this organism at lab 
scale. In this study we wanted to test if it is, at all, possible to grow a wall-deficient, 
transgenic Chlamydomonas strain at scale since there are obvious problems and hurdles. 
This is one of the first investigations trying to close the gap between lab scale studies 
and upscaling. 
In chapter 4 a closer look at utilising the thylakoid lumen for biotechnological 
purposes is taken. The thylakoid lumen is a unique compartment that, surprisingly, little 
is known about. It can offer conditions that are very different from classical 
biotechnological production platforms and using it effectively could significantly enrich 
the algal toolkit. Delicate proteins and compounds that are difficult to make in other 
environments and hosts could be a possible target for this new tool. 
Chapter 5 looks at the potential of light-driven product formation in the 
chloroplast. For this purpose, a model P450, CYP79A1, was chosen for its relocation to 
the thylakoid membranes in the C. reinhardtii chloroplast. The formation of the 
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product, in this case an oxime, is thought to be light-driven as it scavenges electrons 
from the photosynthetic electron transport chain, via ferredoxin, for product formation. 
All the experiments presented in this thesis have one common goal. The idea of 
using microalgae as a production host as such is not new, but so far the system is not 
able to compete with existing platforms and there will still be a long way to go. Rather 
than developing a “green yeast” the aim of this thesis is to emphasise some of the 
unique properties of microalgae over other hosts and target those for further 
investigations. The idea is to develop a biotechnological host that does not attempt to 
replace other hosts or reproduce what is already optimised in other systems, but rather 
fill a niche for production of proteins and compounds that can be integrated with the 







Chapter 2: Stable expression of a 
bifunctional diterpene synthase in the 




Zedler, J.A.Z., Gangl, D., Hamberger, B., Purton, S., and Robinson, C. (2015) 
Stable expression of a bifunctional diterpene synthase in the chloroplast of 
Chlamydomonas reinhardtii. J Appl Phycol 27: 2271–2277. 
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2.1. Author contribution 
 
I am the first author of this research article. I designed the experiment with the 
help of CR, SP and BH. I undertook all the experimental work and collected the data 
(cloning of the constructs, generation of chloroplast transformants, analysis of 
chloroplast transformants, purification of the TPS4 protein, growth studies). Trypsin in-
gel digestion of the purified TPS4 and MS analysis was done by Kevin Howland 
(University of Kent). All results and data were interpreted by me and discussed with the 
other authors of the research article. I wrote the manuscript together with CR and 
generated all figures apart from Supplementary Figure 2 (compiled by BH). The 
manuscript was edited and approved by all other authors of the research study. 
 
 
2.2. Aim of this study 
 
This study was designed as a proof of concept. To date, there were no studies 
about the synthesis of a diterpene in microalgae. Typically, the synthesis of a diterpene 
in plants is a complex metabolic pathway that requires several catalytic steps and 
involves multiple enzymes which represents a major challenge for genetic engineering 
of those pathways into a desired host (Pateraki et al., 2015). In this regard, the enzyme 
chosen for this study is rather unique. Cis-abienol synthase (TPS4) from Abies 
balsamea has previously been expressed recombinantly in E. coli. Due to its 
bifunctional catalytic activity only this single enzyme is required to catalyse the 
formation of cis-abienol from GGPP (Pateraki et al., 2015). GGPP is a precursor 
molecule abundant in the chloroplast of C. reinhardtii (see Section 1.5.1 for details). 
Therefore recombinant expression of TPS4 should be sufficient for in vivo cis-abienol 
synthesis.  
This proof of concept study aimed at setting the scene for terpene production in 
microalgae. Choosing a simple pathway from Abies balsamea allowed circumventing 
complex pathway engineering in the chloroplast and delivered at the same time a high-




2.3. Original research publication 
 
Remark: Here, the pre-proof version of the manuscript is presented. The references have 
been added to the bibliography in chapter 7, the figures and tables numbering and 
position as well as headings have been changed for consistent integration into this 





Chlamydomonas reinhardtii has been shown to hold significant promise as a 
production platform for recombinant proteins, but transformation of the nuclear genome 
is still a non-trivial process due to random gene insertion and frequent silencing. 
Insertion of transgenes into the chloroplasts is an alternative strategy, and we report 
here the stable expression of a large (91 kDa) protein in the chloroplast using a recently 
developed low-cost transformation protocol. Moreover, selection of transformants is 
based on restoration of prototrophy using an endogenous gene (psbH) as the marker, 
thereby allowing the generation of transgenic lines without the use of antibiotic-
resistance genes. Here, we have expressed a bifunctional diterpene synthase in 
C. reinhardtii chloroplasts. Homoplasmic transformants were obtained with the 
expressed enzyme accounting for 3.7 % of total soluble protein. The enzyme was 
purified to homogeneity and expression was shown to have a small but reproducible 
effect on growth rate at the end of log phase growth. These results demonstrate that 
large recombinant enzymes can be synthesised in the algal chloroplast, and serve to 
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A number of reports have demonstrated the potential of microalgae as 
biotechnological platforms for recombinant protein production. Chlamydomonas 
reinhardtii has been a popular host strain, because genetic tools are relatively advanced, 
and recombinant protein targets have included vaccines, antibodies, hormones and 
immunotoxins (Gregory et al., 2012; Demurtas et al., 2013; Gregory et al., 2013; Jones 
et al., 2013; Tran et al., 2013a; Tran et al., 2013b; Soria-Guerra et al., 2014). However, 
attempts have also been made to further develop the platform for other applications, 
such as industrial enzymes (Rasala et al., 2012; Pourmir et al., 2013) and functional 
food supplements (Campos-Quevedo et al., 2013) or the production of biodegradable 
plastics (Chaogang et al., 2010) (reviewed in (Rosales-Mendoza et al., 2012; Purton et 
al., 2013; Specht and Mayfield, 2014)). 
Many such studies have relied on transformation of the nuclear genome for 
recombinant protein expression, but DNA insertion into the genome is essentially 
random. Therefore, levels of transgene expression are variable and unpredictable owing 
to position effects, and frequently unstable because of gene silencing (Rosales-Mendoza 
et al., 2012). Furthermore, for metabolic engineering strategies where recombinant 
enzymes are required to localise to the chloroplast, nuclear transformation requires that 
cytoplasmically synthesised proteins are targeted into the chloroplast by means of a 
‘transit peptide’. Insertion of transgenes into the chloroplast genome is thus an attractive 
alternative approach, particularly since genes can be targeted to specific loci via 
homologous recombination and high-level and stable expression can be achieved 
without any evidence for gene silencing (reviewed in (Purton et al., 2013, Specht and 
Mayfield, 2014)). Genes are typically introduced by particle bombardment and, 
although chloroplast transformation by agitation with glass beads was reported some 
time ago (Kindle et al., 1991), very few studies have used this method (Demurtas et al., 
2013, Economou et al., 2014). 
Recently, a novel method of chloroplast transformation was reported, which 
combines a rapid and low-cost glass bead-based transformation approach with a novel 
selection method. In this approach, insertion of the transgene into the chloroplast 
genome is accompanied by restoration of an intact chloroplast psbH gene, and selection 
is based on restored photoautotrophic growth. The procedure uses a cell-wall mutant 
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recipient strain in which the chloroplast psbH gene is disrupted by an aadA antibiotic 
cassette and is incapable of photoautotrophic growth (Economou et al., 2014). The 
pASapI transformation vector bears a functional copy of psbH with the gene of interest 
inserted into an intergenic region immediately downstream, and integration into the 
chloroplast genome via homologous recombination simultaneously introduces both 
psbH and the gene of interest. Insertion of the transgene into the chloroplast genome is 
accompanied by restoration of an intact chloroplast psbH gene that encodes an essential 
subunit of photosystem II (O'Connor et al., 1998) with selection based on restored 
photoautotrophic growth. Importantly, the aadA cassette is removed during this process 
and is completely absent in transformants that have homoplasmic chloroplast DNA 
copies. This method thus represents a relatively simple transformation system, in which 
any gene of interest can be precisely inserted and expressed in a comparably short 
timeframe.  
In this study, we report the expression of a synthetic gene encoding a 
bifunctional diterpene synthase of 91 kDa. Diterpene synthases are key enzymes in the 
synthesis of a wide range of terpenes, many of which have been used for medical and 
other purposes, and in this study, we expressed cis-abienol synthase from Balsam fir. 
The enzyme catalyses the formation of cis-abienol from the abundant precursor mole- 
cule geranylgeranyl diphosphate (Zerbe et al., 2012) and cis-abienol has potential as a 
source for the synthesis of Ambrox, an important compound in the perfume industry. 
We show that the enzyme accumulates in the chloroplast stroma of transformed 
Chlamydomonas strains, accounting for approximately 3.7 % of total soluble protein, 
and expression has a minor but detectable effect on growth rate at the end of log phase 
growth. To our knowledge, this is the largest single protein produced to date in the 
C. reinhardtii chloroplast, and indicates that novel metabolic pathways using multi-
functional enzymes could be engineered into the organelle. 
 
 
2.3.3. Materials and methods 
2.3.3.1. Plasmid construction 
 
For plasmid construction, the vector pASapI was used (Economou et al., 2014). 
A synthetic TPS4 gene from Abies balsamea was designed using the primary sequence 
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reported for recombinant expression in Escherichia coli in which the mature sequence, 
lacking the plant chloroplast transit sequence, is predicted to start at residue 87 
(GenBank accession No. AEL99953.1; Zerbe et al., 2012). An HA tag was added at the 
C-terminus to allow detection of the protein. The gene sequence was codon-optimised 
for expression in the Chlamydomonas chloroplast using the software ‘Codon Usage 
Optimizer’ (codonusageoptimizer.org/download) and synthesised de novo by GenScript 
(USA). The TPS4-HA sequence was cloned into the pASapI vector at the SapI and SphI 
sites. The plasmid construct, termed pJZ2a, was confirmed by sequencing using the 
primers atpA.F and rbcL.R (Economou et al., 2014) amplified in E. coli DH5α cells and 
used for Chlamydomonas chloroplast transformation. 
 
 
2.3.3.2. Cultivation of Chlamydomonas strains and transformation 
 
The C. reinhardtii strain CC-125 (mt+), used as a wild-type control, was kindly 
provided by Alison Smith (University of Cambridge, UK). The C. reinhardtii strain 
TN72 (cw15, psbH::aadA, mt+) used for transformation was created in the Purton lab. 
All strains were cultivated at 25 °C with approx. 50 µmol photons m−2 s−1 continuous 
illumination on agar plates. Liquid cultures were incubated in a Multitron Pro Shaking 
Incubator (Infors Ltd.) at 110 rpm, 25 °C and approximately 15 µmol photons m−2 s−1. 
Cultures were grown mixotrophically in tris-acetate-phosphate (TAP) medium (Gorman 
and Levine, 1965) with a modified trace metal recipe (Kropat et al., 2011). 
A glass bead transformation method as described by Economou et al. 
(Economou et al., 2014) was used for transformation. Mid-log phase cells of the strain 
TN72 were transformed with the constructs pJZ2a or the pASapI vector lacking a gene 
insert. For selection of transformants, the minimal medium high salt medium (HSM) 
(Sueoka, 1960) with a modified trace metal recipe (Kropat et al., 2011) was used. After 
re-streaking the transformant to single colonies six times on HSM, homoplasmy of the 
cell lines was confirmed by PCR. An overview of the transformation procedure is given 





2.3.3.3. DNA extraction and PCR analysis of transformants 
 
Total genomic DNA of single colonies was extracted using a Chelex 100 Resin 
(Bio-Rad) using the protocol described in Economou et al. (2014). Homoplasmy was 
confirmed by PCR with three different primers using the principle described by 
Economou et al. (2014). For pASapI transformants, the primers used were: 
(i) FLANK1 (GTCATTGCGAAAATACTGGTGC). Anneals downstream of 
the gene of interest (GOI) insertion site, just beyond the 0.8-kb region of 
homology carried on the pASapI vector 
(ii) rbcL.F (CGGATGTAACTCAATCGGTAG). Anneals to the end of the aadA 
cassette inserted within the TN72 genome and gives a 0.85-kb product in 
conjunction with FLANK1 for the untransformed TN72 genome  
(iii) atpA.R (ACGTCCACAGGCGTCGTAAGC). Anneals to the atpA 
promoter/5′UTR element-driving expression of the GOI and gives a 1.20-kb 
product in conjunction with FLANK1 for the transplastomic genome 
 
A second PCR reaction was run to screen for the loss of the aadA cassette upon 
transformation using the primers atpA.F and rbcL.R (Economou et al., 2014). For all 
PCR reactions, a standard PCR protocol with Phusion Hot Start Flex Polymerase (New 
England Biolabs) was used. For the three primer PCRs, an annealing temperature of 
65.2 °C was used. In the aadA cassette PCR with the primers atpA.F and rbcL.R, the 
annealing temperature was 62 °C. 
 
 
2.3.3.4. Protein expression in E. coli and Chlamydomonas, SDS-PAGE and 
Western blot analysis 
 
For the preparation of Chlamydomonas lysates, cells were lysed by sonication in 
lysis buffer (20 mM HEPES pH 7.2, 5 % glycerol, 20 µg mL−1 DNAse (Roche), 1/2 
tablet EDTA-free protease inhibitor tablet (Roche) per 20 mL). Five equivalents of 
milligram chlorophyll per litre culture were separated on a 12 % sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotted with 
anti-HA-antibody (Sigma-Aldrich). The signal was detected with an ECL reagent 
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(Biological Industries) and imaged using a ChemiDoc XRS+ System (Bio-Rad). For 
expression studies in E. coli, pASapI and pJZ2a were transformed into E. coli MC4100. 
The TPS4-HA protein was expressed overnight at 16 °C in TB medium based on a 
protocol described elsewhere (Keeling et al., 2008). For cell lysis, the Chlamydomonas 
buffer was used, additionally containing 0.1 mg mL−1 lysozyme (Sigma-Aldrich). The 
further procedure was identical as for the algal samples.  
 
 
2.3.3.5. TPS4-HA purification 
 
The TPS4-HA protein was purified from 5 L of late log phase Chlamydomonas 
TN72-TPS4 culture. Cells were harvested at 4000 rpm, 4 °C for 20 min in a Beckman 
Coulter Avanti J-26SXP centrifuge and pellets were resuspended in lysis buffer (see 
above). Lysates were sonicated and cleared by ultracentrifugation at 70,000 rpm, 4 °C 
and 30 min (Beckman TL-100 ultracentrifuge). The soluble supernatant was loaded 
onto five 5-mL Q-Sepharose columns (Q-Sepharose Fast Flow, GE Healthcare), which 
were washed in 20 mM HEPES pH 7.2, 5 % glycerol, 1 mM MgCl2 and 5 mM 
dithiothreitol (DTT). The TPS4-HA protein was eluted using two column volumes of 
the same buffer containing 350 mM NaCl, which was specifically optimised for this 
protein. The elution fractions were concentrated using Vivaspin 20 columns (GE 
Healthcare) and subjected to affinity chromatography using 2 mL Pierce Anti-HA 
Agarose resin (Thermo Scientific) using the manufacturer’s protocol. The TPS4-HA 
protein was eluted with an HA competitor peptide (Thermo Scientific), and purity was 




2.3.3.6. Peptide mass fingerprinting: peptide preparation and analysis 
 
The purified TPS4-HA protein was run on a SDS-PAGE. After Coomassie 
staining, the TPS4-HA band was excised and dissected into approximately 1 mm-sized 
pieces. After reduction of disulphide bonds with DTT and alkylation of cysteine 
residues with chloroacetamide, the sample was digested overnight with trypsin. 
 64 
Generated peptides were extracted and analysed by matrix assisted laser desorption 
ionization time-of-flight (MALDI-TOF) mass spectrometry. The generated mass 
fingerprint was searched against the SWISS-PROT Database using the MASCOT 
search engine. The 15 most intense peptide masses were then subjected to further 
analysis by MS/MS and the obtained data searched against the same database. 
 
 
2.3.3.7. Protein quantitation 
 
Ten millilitres of late log phase cultures of the TN72-TPS4 strain were harvested 
and lysed. The total soluble protein content of these samples was determined using the 
DC Protein Assay Kit (Bio-Rad) following the manufacturer’s instructions. Bovine 
serum albumin (Bio-Rad) was used as a standard. The same lysate was subjected to 
SDS-PAGE and Western blot analysis. A recombinant human HA-tagged Ubiquitin 
protein (Boston Biochem) was loaded in known quantities as a calibration standard. 




2.3.4.1. Transformation strategy 
 
A synthetic gene encoding the mature sequence of the bifunctional cis-abienol 
synthase TPS4 from the balsam fir tree, A. balsamea, was designed based on optimal 
codon usage in the C. reinhardtii chloroplast, and with the 3′ end of the coding 
sequence extended to encode the hemagglutinin epitope. The gene was inserted into the 
chloroplast expression vector pASapI, generating construct pJZ2a as shown in Fig. 2.1, 
with the TPS4 gene driven by the chloroplast atpA promoter and 5′ untranslated region. 
A glass bead-based vortexing method was then used to transform the chloroplast 
genome of the photosynthetic mutant TN72 lacking an intact psbH gene as detailed in 
‘Materials and Methods’ and illustrated in Online Resource 1. Following selection for 
photoautotrophic growth on minimal medium, a transformed line with restored photo- 
autotrophic growth was obtained (termed TN72-TPS4). An additional strain with 
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restored photoautotrophy, TN72-RP, was created for control purposes by transformation 
using the pASapI vector lacking any insert. 
 
 
Fig. 2.1. Schematic map of the plasmid pJZ2a. The pJZ2a vector is based on the plasmid 
pASapI (Economou et al., 2014). A codon-optimised sequence of the abienol synthase gene 
tps4 was cloned into the vector using the SapI and SphI sites. An HA tag coding sequence was 
appended at the 3′ end of the tps4 gene. Successful transformation of Chlamydomonas is 
achieved upon homologous recombination of the psbH flanking regions. The heterologous gene 
is driven by the endogenous atpA promoter. The psbH upstream-flanking element has a 
functional copy of psbH. The pUC8 vector fragment allows replication of the plasmid in E. coli. 
This plasmid map was assembled using PlasMapper Version 2.0 (modified). 
 
Insertion of the gene into the chloroplast genome, and the resulting loss of the 
aadA cassette, was confirmed by PCR analysis as shown in Fig. 2.2. Panel A shows 
PCR reactions carried out using primers that amplify a 1.1-kb region of the ‘aadA 
cassette’ present in the genome of the TN72 recipient strain (Economou et al., 2014). 
This band is present in the TN72 sample but absent in the TN72-TPS4 transformant and 
TN72-RP restored wild type, suggesting that the cassette has been lost as a result of 
transformation. This is further confirmed in panel B where a combination of three PCR 
primers was used to test each strain for the presence of either type of genome. A primer 
to the downstream flanking region in combination with a primer to the aadA cassette in 
TN72 gives a 0.85-kb product, whereas the flanking primer together with one to the 
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atpA promoter/5′UTR element linked to the gene of interest gives a 1.2-kb product. The 
results show that the 1.2-kb band is seen for the TN72-RP and TN72-TPS4 
transformants, and the 0.85-kb band is seen for the host TN72 strain. Importantly, the 
absence of the 0.85-kb band in the transformants confirms that the chloroplast DNA 
copies are homoplasmic, such that all of the psbH::aadA copies have been replaced 





Fig. 2.2. Transformation results in homoplasmic insertion of the tps4 gene. Total DNA was 
extracted from TN72-TPS4 and TN72-RP cells and subjected to PCR analysis using primers 
that amplify a 1.1 kb region including the aadA cassette in the host strain (3), which was lost 
upon homologous recombination in the transformants TN72-TPS4 and TN72- RP (1, 2) (A). B 
shows the amplification of a 1.2-kb region including the restored psbH gene in transformed 
copies of the chloroplast genome, whereas a 0.85-kb fragment is amplified in untransformed 
copies of the chloroplast genome. The figure shows PCR data for the TN72-TPS4 and TN72-RP 
transformants (1, 2), the TN72 host strain (3), a positive control (4) and a control reaction using 
H2O in place of DNA (N). Mobilities of the 0.75, 1.0 and 1.5 kb marker bands are indicated. 
 
 
2.3.4.2. Expression of the TPS4 protein 
 
TPS4 expression in the transformant TN72-TPS4 was detected by immunoblot 
analysis using an anti-HA antibody (Fig. 2.3). The ‘TPS4’ lane shows the presence of 
an approximately 80-kDa band, which is smaller than the predicted size of the TPS4-
HA protein (around 91 kDa). A protein of the same size is also detected in the E. coli 
strain containing the pJZ2a vector (‘E. coli’ lane), strongly suggesting that the protein 

















cells (WT) or the control transformant generating restored photosynthetic competence 
(RP). The antibody does react with an endogenous protein of about 30 kDa in all 
Chlamydomonas samples tested, showing that this is a non-specific reaction. 
 
 
Fig. 2.3. Abienol synthase (tps4) is expressed in Chlamydomonas reinhardtii TN72-TPS4 cells. 
Extracts of Chlamydomonas cells, and of the E. coli strain expressing pJZ2a, were subjected to 
immunoblotting using antibodies to the C-terminal HA-tag. The blot shows data for TN72-RP 
strain (RP), the wild-type strain CC-125 (WT), E. coli host expressing pJZ2a (E. coli) and 
TN72-TPS4 transformant (TPS4). The TPS4-HA protein is indicated; NS non-specific reacting 
band. Mobilities of molecular mass markers (in kDa) are indicated on the left. 
 
To further confirm that the approximately 80-kDa protein does bear an HA tag, 
and is therefore TPS4-HA, we purified the protein as shown in Fig. 2.4. Soluble cell 
extracts were first subjected to ion exchange chromatography (Fig. 2.4a) and the panel 
shows an immunoblot of initial lysate (Lys), wash fractions (W) and the fraction eluted 
with 350 mM NaCl (E). The data show that the TPS4-HA protein is present in the 
elution fraction while the non-specifically reacting 30-kDa protein is present in the 
flow-through and wash fractions. The 350 mM NaCl eluate was then applied to an HA-
affinity column (Fig. 2.4b), and the panel shows an Oriole-stained gel of the flow-
through and wash samples, with the purified TPS4-HA present in the elution fractions. 
These data show that this protein can be expressed in Chlamydomonas chloroplasts and 















Fig. 2.4. Purification of TPS4-HA from total soluble protein. A Immunoblot analysis of ion 
exchange chromatography elution fractions; the panel shows results for the total cell lysate 
(Lys), column flow-through (F-T), wash fractions (W1, W2) and the 350-mM NaCl elution 
fraction (E) containing TPS4-HA. Mobilities of molecular mass markers (in kDa) are indicated. 
B OrioleTM-stained SDS gel of TPS4-HA affinity purification fractions showing column flow-
through (F-T), wash fractions (W1, W2) and elution fractions obtained using the competitor 
HA-peptide. Arrows denote TPS4 protein; an asterisk denotes non-specific reacting band in A. 
 
 
Furthermore, the purified TPS4-HA protein was subjected to peptide mass 
finger print analysis. The protein CAS_ABIBA was identified unambiguously (Score 
191 searched against the SWISS-PROT Database, p=4.3e−14). The heterologous TPS4- 
HA protein of this study is identical in its amino acid sequence to CAS_ABIBA (cis-
abienol synthase from Balsam fir), apart from removal of the N-terminal plastid transit 
sequence for expression in chloroplasts (shown in Online Resource 2, which also shows 
the homology exhibited between TPS4 and other diterpene synthases) and addition of a 
C-terminal HA tag. Details of the mass spectrometry analysis are given in Online 
Resource 3, where coverage of the protein sequence and details of the identified 
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2.3.4.3. Quantitation of protein levels 
 
In order to quantitate the levels of TPS4-HA in the transformant, we carried out 
densitometric analysis of immunoblots using purified HA-Ubiquitin (containing an 
identical HA tag to that of TPS4-HA) as a standard for the calibration curve. The 
expressed TPS4 enzyme was found to represent approximately 3.7 % of total soluble 
protein. In general, similar expression levels (in terms of percentage of total soluble 
protein) were obtained for both photoautotrophic growth on minimal medium and 
mixotrophic growth on TAP medium that contains acetate as a source of fixed carbon 
(data not shown). 
 
 
2.3.4.4. Expression of TPS4 has a minor adverse effect on growth rate 
 
 
Fig. 2.5. Expression of the tps4 transgene has a minor effect on culture growth. The graph 
shows growth curves for TN72-RP (circles, dashed line) and TN72-TPS4 cultures (boxes, 
continuous line) on TAP medium. The data are averages of three experiments. 
 
TPS4 catalyses the formation of cis-abienol using geranylgeranyl diphosphate 
(GGDP) as substrate (Zerbe et al., 2012), but we were unable to detect cis-abienol in the 
cultures of the transformant strain so it is unclear whether the enzyme is active in the 
transformed cells. However, expression of the enzyme may be expected to partially 
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deplete the GGDP pool in the chloroplast and therefore affect growth of the strain, and 
this was tested by directly comparing the growth of TN72-TPS4 and the TN72-RP 
control strain. The cultures were grown on TAP medium, and the growth curves are 
shown in Fig. 2.5. Both exhibit rapid initial log growth characteristics that appear to be 
identical; thereafter, the cultures enter a steady linear phase, which presumably occurs 
after depletion of the acetate. At this point, growth of the TN72-TPS4 culture is slightly 
slower than that of the TN72-RP culture, suggesting that TPS4 activity may indeed be 
depleting the GGDP pool and thereby inhibiting GGDP-dependent metabolic pathways 





A recent study has shown that a relatively simple method can be used to 
transform the chloroplast genome of C. reinhardtii (Economou et al., 2014). In the 
present study, we sought to test the utility of this method for the expression of 
heterologous proteins, using a plant diterpene synthase as target protein. For this study, 
a gene encoding the bifunctional enzyme TPS4 was integrated into the chloroplast 
genome and the cells were characterised once homoplasmy was achieved. 
Immunoblotting showed that the 91-kDa HA-tagged TPS4 protein is stably 
expressed, and it was furthermore shown that the protein can be purified to 
homogeneity from cell extracts. MALDI-TOF mass fingerprinting further confirmed the 
identity of the protein sequence. We calculated that the protein represents 3.7 % of total 
soluble protein. Together, these data show that the transformation method is suitable for 
expression at reasonably high levels of a heterologous protein and it should be possible 
to further enhance expression levels by manipulating promoter regions and other UTR 
elements. Importantly, the method does not result in the presence of an antibiotic 
cassette in the chloroplast genome of transformed cells and this may be an advantage in 
terms of minimising the effort needed to generate and maintain the cultures. The 
absence of such cassettes is also preferred for commercial production applications. 
No clear phenotype was observed for the transformant expressing TPS4 and we 
did not detect the reaction product, cis-abienol (Zerbe et al., 2012), using gas 
chromatography mass spectrometry. However, this product is not available in purified 
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form for control tests and the compound may well have been masked by other 
compounds in our tests. We did note that the transformed strain grew slightly more 
slowly than the mock-transformed control strain, which may be an indirect indication of 
enzyme activity, but this point remains to be resolved. This enzyme has been studied in 
E. coli but only using in vitro assays (Zerbe et al., 2012), and this is the first report of 
heterologous expression in photosynthetic hosts; it is therefore difficult to predict the 
effects of product accumulation. Other studies (Jin et al., 2014) have shown that 
synthesis of a variety of hydrophobic compounds can adversely affect growth of 
photosynthetic bacteria, and the observed change in growth of this TPS4 transformant 
may well reflect this trend. 
In summary, the result show that this recently developed transformation protocol 
is capable of generating strains that stably express a heterologous protein in the 
chloroplast at levels that are generally comparable with other studies using either 
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2.3.7. Supplementary material 
2.3.7.1. Online resource 1 
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2.3.7.2. Online resource 2 
  
Online Resource 2. Alignment of plant diterpene synthases of general and specialised metabolism. 
Shown are the monofunctional angiosperm Arabidopsis and gymnosperm Sitka spruce (Picea sitchensis) copalyl-diphosphate 
synthases (class II, AtCPS, PsCPS) and ent-kaurene synthases (class I, AtEKS, PsEKS), the bifunctional ancient progenitor, 
ent-kaurene synthase from the moss Physcomitrella patens (class II/I, PpEKS), as well as the gymnosperm balsam ir diter-
pene synthase (class II/I, AbTPS4). Indicated by the triangle is the predicted plastidial target sequence in AbTPS4, highlighted 
are the conserved aspartate rich domains characteristic for class II (DxDD) and class I diTPS (DDxxD). Both domains are 
present in the moss and balsam ir diterpene synthases.
10 20 30 40 50 60 70 80
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
AtCPS     MSLQYHVLNSIPSTT--------------------------------FLSSTKTTISSS------FLTISGSPLNVARDK
PsCPS     MKMSKSVEVQHCAVQ--------------------------------FLSSTTDQIE-------------------IRER
AbTPS4 MALPVYSLKSHIPITTIASA-------KMNYTPNKGMITANGRSRRIRLSPNKIVACAG--------EADRTFPSQSLEK
PpEKS     MASSTLIQNRSCGVTSSMSSFQIFRGQPLRFPGTRTPAAVQCLKKRRCLRPTESVLESSPGSGSYRIVTGPSGINPSSNG
PsEKS     MKREQYTILN----------------------------------------------------------------------
AtEKS     MSINLRSSGCSSPIS-----------------------------------------------------------------
90 100 110 120 130 140 150 160
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
AtCPS     SRSGSIHCSKLRTQEYINSQEVQHDLPLIHEWQQLQGEDAPQISVGSNSNAFKEAVKSVKTILRNLTDGEITISAYDTAW
PsCPS     N-----------------------------------------LQISTEAMKMKSWIETVKYILQSMEDGEITISAYDTAW
AbTPS4 TALFPDQFSEKNGTPSNFTPPNREFPPSFWNNDIINSITASHKVQTGDRKRIQTLISEIKNVFNSMGDGETSPSAYDTAW
PpEKS     HLQEGSLTHRLPIPMEKSIDNFQSTLYVSDIWSETLQRTECLLQVTEN-VQMNEWIEEIRMYFRNMTLGEISMSPYDTAW
PsEKS     ----------------------------------------------EKESMAEELILRIKRMFSEIENTQTSASAYDTAW
AtEKS     -----------------------------------ATLERRLDSEVQTRANNVSFEQTKEKIRKMLEKVELSVSAYDTSW
170 180 190 200 210 220 230 240
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
AtCPS     VALIDA--GDKTPAFPSAVKWIAENQLSDGSW---GDAYLFSYHDRLINTLACVVALRSWNLFPHQCNKGITFFRENIGK
PsCPS     IALVPALNGSSEPQFPSSLQWLINNQLQDGSW---GDPLMFLIRDRIINTLACVLALKTWNIYSLGVNKGLSFLQTYIPK
AbTPS4 VARIPAVDGSEQPQFPQTLEWILQNQLKDGSW---GEEFYFLAYDRLLATLACIITLTIWRTGNVQLHKGIEFFRKQVVR
PpEKS     VARVPALDGSHGPQFHRSLQWIIDNQLPDGDW---GEPSLFLGYDRVCNTLACVIALKTWGVGAQNVERGIQFLQSNIYK
PsEKS     VAMVPSLDSSQQPQFPQCLSWIIDNQLLDGSW---GIP-YLIIKDRLCHTLACVIALRKWNAGNQNVETGLRFLRENIEG
AtEKS     VAMVPSPSSQNAPLFPQCVKWLLDNQHEDGSWGLDNHDHQSLKKDVLSSTLASILALKKWGIGERQINKGLQFIELNSAL
250 260 270 280 290 300 310 320
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
AtCPS     LEDENDEHMPIGFEVAFPSLLEIARGINIDVPYDSPVLKDIYAKKELKLTRIPKEIMHKIPTTLLHSLEGMRD-LDWEKL
PsCPS     MNDEHDAHTPVGFEIVFPALMEDAKIMELDLPYDAEFLQKIYDERDLKMKRIPMKVLHEFPSTLLHSLEGLRDKVNWEEL
AbTPS4 MDDEADNHRPSGFEIVFPAMLNEAKSLGLDLPYELPFIEQMVKKREAKLKMITTNVLYTIQTTLLYSLEGLHEIVDFDKI
PpEKS     MEEDDANHMPIGFEIVFPAMMEDAKALGLDLPYDATILQQISAEREKKMKKIPMAMVYKYPTTLLHSLEGLHREVDWNKL
PsEKS     IVHED-EYTPIGFQIIFPAMLEEARGLGLELPYDLTPIKLMLTHREKIMKGKAIDHMHEYDSSLIYTVEGIHKIVDWNKV
AtEKS     VTDET-IQKPTGFDIIFPGMIKYARDLNLTIPLGSEVVDDMIRKRDLDLKCDSEKFSKGREAYLAYVLEGTRNLKDWDLI
330 340 350 360 370 380 390 400
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
AtCPS     LKLQSQDGSFLFSPSSTAFAFMQTRDSNCLEYLRNAVKRFNGGVPNVFPVDLFEHIWIVDRLQRLGISRYFEEEIKECLD
PsCPS     LKLQSKNGSFLFSPASTACALAQTSDTNCLRYLNEITKKYDGGAPNVYPVDLFERLWTVDRIERLGIARYFESEITDSLE
AbTPS4 IKLQSKDGSFLGSPASTAAVFMQTGNTKCLEFLEFVLRKFRNHVPSDYPLDLFERLWVVDTVERLGIDRHFKKEIKDALD
PpEKS     LQLQSENGSFLYSPASTACALMYTKDVKCFDYLNQLLIKFDHACPNVYPVDLFERLWMVDRLQRLGISRYFEREIRDCLQ
PsEKS     LKHQNKDGSLFNSPSATACALMHTRKSNCLEYLSSMLQKLGNGVPSVYPINLYARISMIDRLQRLGLARHFRNEIIHALD
AtEKS     VKYQRKNGSLFDSPATTAAAFTQFGNDGCLRYLCSLLQKFEAAVPSVYPFDQYARLSIIVTLESLGIDRDFKTEIKSILD
410 420 430 440 450 460 470 480
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
AtCPS     YVHRYWTDNGICWARCSHVQDIDDTAMAFRLLRQHGYQVSADVFKNFEKE-GEFFCFVGQSNQAVTGMFNLYRASQLAFP
PsCPS     YVYRYWTNQGIGWARDSPVKDVDDTSMAFRLLRSHGFDVTAEAFNHFKQD-DQFFCFFGQTKQTVTGMYNLYRASQFLFP
AbTPS4 YVYSCWDERGIGWAKDSPIADIDDTAMGLRILRLHGYNVSPDVLKTFKDENGEFFCFMGQTQRGVTDMLNVYRCSQVAFP
PpEKS     YVYRYWKDCGIGWASNSSVQDVDDTAMAFRLLRTHGFDVKEDCFRQFFKD-GEFFCFAGQSSQAVTGMFNLSRASQTLFP
PsEKS     DIYRYWMQKETSREGKSLTPDIVSTSIAFMLLRLHGYDVPADVFCCYDLH------SIEQSGEAVTAMLSLYRASQIMFP
AtEKS     ETYRYWLR-----GDEEICLDLATCALAFRLLLAHGYDVSYDPLKPFAEE-SGFSDTLEGYVKNTFSVLELFKAAQS-YP
490 500 510 520 530 540 550 560
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
AtCPS     REEILKNAKEFSYNYLLEKREREELIDKWIIMKDLPGEIGFALEIPWYASLPRVETRFYIDQYGGENDVWIGKTLYRMPY
PsCPS     GESILEEARVFTKNFLEEKRAEKQLRDKWIIAKGLKEEVEYALKFPWYASQPRIDTRMYINQYR-VDDVWIGKALYRMPI
AbTPS4 GETIMEEAKLCTERYLRNALENADAFDKWAIKKNIRGEVEYALKYPWHRSMPRLEVRSYIGNYG-PNDVWLGKSLYMMPY
PpEKS     GESLLKKARTFSRNFLRTKHENNECFDKWIITKDLAGEVEYNLTFPWYASLPRLEHRTYLDQYG-IDDIWIGKSLYKMPA
PsEKS     GETILEEIKTVSRKYLDKRKENGRIYDHNIVMKDLRGEVEYALSVPWYASLERIENRRYIDQYG-VNDTWIAKTSYKIPC


























117-125 1045.5594 R.IQTLISEIK.N (Deamidated (NQ)
126-148 2475.1128 K.NVFNSMGDGETSPSAYDTAWVAR.I
126-148 2491.109 K.NVFNSMGDGETSPSAYDTAWVAR.I + Oxidation (M)
174-188 1854.8182 K.DGSWGEEFYFLAYDR.L
212-218 896.5091 K.GIEFFRK.Q
223-247 2865.3047 R.MDDEADNHRPSGFEIVFPAMLNEAK.S + 2 Oxidation (M)
248-265 2108.1173 K.SLGLDLPYELPFIEQMVK.K + Oxidation (M)
309-330 2187.0603 K.DGSFLGSPASTAAVFMQTGNTK.C










446-455 1183.5941 R.GVTDMLNVYR.C+ Oxidation (M)





535-546 1507.7011 K.SLYMMPYISNEK.Y + 2 Oxidation (M)
535-552 2210.0945 K.SLYMMPYISNEKYLELAK.L + Deamidated (NQ); Oxidation (M)















804-817 1654.8197 R.MVNDLAELNSEYLK.S + Oxidation (M)
818-827 1280.6516 K.SNEMPQNCKR.L + Deamidated (NQ); Oxidation (M)
827-834 977.5655 K.RLVFDTAR.V
828-834 821.4633 R.LVFDTAR.V
Online Resource 3. Peptide mass ingerprint analysis of trypsin digested 
TPS4-HA by MALDI-TOF mass spectrometry.
a CAS_ABIBA protein sequence identiied by mass ingerprint analysis of TPS-HA in 
the SwissProt database by Mascot Search. Peptides identiied with MS are highlighted 
in bold. Peptide sequences additionally observed in MS/MS analysis are highlighted in 
bold and are underlined. The CAS_ABIBA protein was unambigously identiied with a 
score of 191 (Expect: 4.3e-014). Protein Sequence Coverage MS: 50%. Protein Se-
quence Coverage MS/MS: 12%. The protein sequence of TPS4-HA is identical to CAS_
ABIBA with an additional C-terminal HA-tag (YPYDVPDYA) and lacks the N-terminal 
predicted plastidial target sequence (highlighted in Italics, further details are given in 
Online Resource 2).
b Peptide sequences identiied by MALDI-TOF mass spectrometry of trypsin digested 
TPS4-HA matching CAS_ABIBA in the SWISS-PROT database. The peptides additio-
nally identiied with MS/MS are marked in bold letters. Peptides observed in the protein 
sequence of CAS_ABIBA are given (Start - End of sequence, irst column). The obser-
ved peak mass (m/z) of identiied peptides is shown in the second column. Column 3 
gives the protein sequence and modiications (if any).
MS:   Score: 191 Expect: 4.3∙10–14 Sequence Coverage: 50%
MS/MS: Score: 392    Sequence Coverage: 12%
CAS_ABIBAa b
MALPV YSLKS HIPIT TIASA KMNYT PNKGM ITANG RSRRI RLSPN KIVAC 
AGEAD RTFPS QSLEK TALFP DQFSE KNGTP SNFTP PNREF PPSFW NNDII 
NSITA SHKVQ TGDRK RIQTL ISEIK NVFNS MGDGE TSPSA YDTAW VARIP 
AVDGS EQPQF PQTLE WILQN QLKDG SWGEE FYFLA YDRLL ATLAC IITLT 
IWRTG NVQLH KGIEF FRKQV VRMDD EADNH RPSGF EIVFP AMLNE AKSLG 
LDLPY ELPFI EQMVK KREAK LKMIT TNVLY TIQTT LLYSL EGLHE IVDFD 
KIIKL QSKDG SFLGS PASTA AVFMQ TGNTK CLEFL EFVLR KFRNH VPSDY 
PLDLF ERLWV VDTVE RLGID RHFKK EIKDA LDYVY SCWDE RGIGW AKDSP 
IADID DTAMG LRILR LHGYN VSPDV LKTFK DENGE FFCFM GQTQR GVTDM 
LNVYR CSQVA FPGET IMEEA KLCTE RYLRN ALENA DAFDK WAIKK NIRGE 
VEYAL KYPWH RSMPR LEVRS YIGNY GPNDV WLGKS LYMMP YISNE KYLEL 
AKLDF NSVQS LHQEE IRELV RWCKS SGFTE LKFTR DRVVE TYFAV ASSMF 
EPEFS TCRAV YTKIS VLLVI LDDLY DGYGS PDEIK LFSEA VKRWD LSLLE 
QMPDH MKICF LGLYN TVNEV AEEGR KTQGH DVLGY IRNLW EIQLA AFTRE 
AEWSQ GKYVP SFDEY IENAQ VSIGV ATILL ITILF TEEDD ILSHI DYGSK 
FLRLA SLTAR LANDI KTYQE ERAHG EVVSA IQCYM KDRPE ITEEE ALKYV 
YGRMV NDLAE LNSEY LKSNE MPQNC KRLVF DTARV AQLFT MEGDG LTYSD 




Chapter 3: Pilot-scale cultivation of wall-
deficient transgenic Chlamydomonas 
reinhardtii strains expressing 
recombinant proteins in the chloroplast 
 
Zedler, J.A.Z.*, Gangl, D.*, Guerra, T.*, Santos, E., Verdelho, V., and 
Robinson, C. (2016a) Pilot-scale cultivation of wall deficient transgenic 
Chlamydomonas reinhardtii strains expressing recombinant proteins in the 
chloroplast. Appl Microbiol Biotechnol. doi: 10.1007/s00253-016-7430-y 
  
 76 
3.1. Author contribution 
 
This publication has three first authors: myself, DG and TG. I have provided the 
TN72-TPS4 strain and did preliminary work for the upscaling study. Together with DG 
and TG I have set up the reactors with technical assistance of staff at A4F. I planned 
and designed the experiment together with DG taking advice from TG and CR into 
consideration. I produced and analysed all the data together with DG at A4F in Lisbon 
and later on at the University of Kent (follow up processing of samples after the 
experiment). I wrote parts of the materials and methods, the results and the discussion 
section of the manuscript and edited it. I compiled the following figures in the 
manuscript: Fig. 2 (with DG), Fig. 3 (with DG), Fig. 4, Fig. 5 (with DG), Fig. 6 (with 
DG), Fig. 7B, Fig. 8 (with DG). 
 
 
3.2. Aim of this study 
 
This study was based on the opportunity for a secondment at the industrial 
partner A4F in Lisbon as part of the EU FP7 project PHOTO.COMM. The company is 
certified to grow genetically modified organism in their contained greenhouse R&D 
facility in Lisbon. Chlamydomonas reinhardtii is a model organism, but it is not used in 
an industrial setting to date. To my knowledge only one study reported cultivation of 
C. reinhardtii at pilot scale (Gimpel et al., 2015b). Traditionally, cell wall-deficient 
strains are used for transformation and there are no reports on growing transgenic wall-
deficient strains although there are a lot of studies reporting recombinant protein 
production base on those mutant strains (see chapter 1.4). We tested if the, compared to 
in industrial settings usually used microalgae, fragile algae are scalable (at all) and what 
growth characteristics they exhibit. For this purpose we grew two transgenic strains, 
TN72-TPS4 (q.v. chapter 2) and TN72-CYP79A1 (q.v. chapter 5) and a CW-15 strain 
as a negative control in parallel in 100 L photobioreactors over a period of ten days in 
the green house in June 2015 at the R&D facility of A4F in Lisbon (Portugal). We 
monitored the culture and recombinant protein expression characteristics during the 
whole upscaling process. 
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3.3. Original research publication 
 
Remark: Here, the pre-proof version of the manuscript is presented. The references have 
been added to the bibliography in chapter 7, the figures and tables numbering and 
position as well as headings have been changed for consistent integration into this 





Microalgae have emerged as potentially powerful platforms for the production 
of recombinant proteins and high-value products. Chlamydomonas reinhardtii is a 
potentially important host species due to the range of genetic tools that have been 
developed for this unicellular green alga. Transformation of the chloroplast genome 
offers important advantages over nuclear transformation and a wide range of 
recombinant proteins have now been expressed in the chloroplasts of C. reinhardtii 
strains. This is often done in cell wall-deficient mutants that are easier to transform. 
However, only a single study has reported growth data for C. reinhardtii grown at pilot 
scale and the growth of cell wall-deficient strains has not been reported at all. Here, we 
report the first pilot scale growth study for transgenic, cell wall-deficient C. reinhardtii 
strains. Strains expressing a cytochrome P450 (CYP79A1) or bifunctional diterpene 
synthase (cis-abienol synthase, TPS4) were grown for 7 days under mixotrophic 
conditions in a tris-acetate-phosphate medium. The strains reached dry cell weights of 
0.3 g L-1 within 3-4 days with stable expression levels of the recombinant proteins 
during the whole upscaling process. The strains proved to be generally robust, despite 
the cell wall-deficient phenotype, but grew poorly under phototrophic conditions. The 
data indicate that cell wall-deficient strains may be highly amenable for transformation 









Microalgae have considerable potential as biotechnological platforms for 
recombinant protein production. Many microalgae can be grown to high densities under 
controlled conditions (Adarme-Vega et al., 2012; Borowitzka, 2013) and an attractive 
bonus is that sunlight can be used as an alternative or additional energy source in 
photobioreactors (PBRs). 
Chlamydomonas reinhardtii has been a popular host strain for biotechnological 
applications. Genetic tools for this alga are relatively advanced and recombinant protein 
targets have included vaccines, antibodies, hormones and immunotoxins (Gregory et al., 
2012; Demurtas et al., 2013; Gregory et al., 2013; Jones et al., 2013; Tran et al., 2013a; 
Tran et al., 2013b; Soria-Guerra et al., 2014). Attempts have also been made to further 
develop the platform for other applications such as industrial enzymes (Rasala et al., 
2012; Pourmir et al., 2013), biodegradable plastics (Chaogang et al., 2010) and others 
(reviewed in (Rosales-Mendoza et al., 2012; Purton et al., 2013; Specht and Mayfield, 
2014)). 
Many studies on transgenic C. reinhardtii have relied on transformation of the 
nuclear genome for recombinant protein expression but DNA insertion into this genome 
is essentially random. The levels of transgene expression are unpredictable, owing to 
position effects, and frequently unstable because of gene silencing (Rosales-Mendoza et 
al., 2012). Insertion of transgenes into the chloroplast genome is an attractive alternative 
approach, particularly since genes can be targeted to specific loci via homologous 
recombination and high-level and stable expression can be achieved without evidence 
for gene silencing (reviewed in (Purton et al., 2013; Specht and Mayfield, 2014)). 
Genes are typically introduced by particle bombardment (Boynton et al., 1988) or 
agitation with glass beads (Kindle et al., 1991). A recently developed chloroplast 
transformation procedure involves the use of glass beads to introduce the gene of 
interest and transgenic strains are selected on the basis of restoration of photosynthetic 
competence. This protocol has the added advantage that the antibiotic resistance gene in 
the host strain is removed upon integration of the gene of interest (Economou et al., 
2014; Gangl et al., 2015b; Zedler et al., 2015). A potential disadvantage is that this 
mode of transformation relies on the use of cell wall-deficient host strains. 
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To date, transgenic C. reinhardtii strains have been used in a large number of 
studies, and this alga is rapidly gaining attention as a potential chassis for large-scale 
industrial production purposes. In this context, it is perhaps remarkable that only a 
single report has described cultivation of this alga in industrial PBRs; indeed this is all 
the more surprising given that many transformation procedures involve the use of cell 
wall-deficient strains that are inherently more fragile. Gimpel et al. described the 
production of bovine Milk Amyloid A in a transformed strain (possessing a normal cell 
wall) that expressed the protein in the chloroplast (Gimpel et al., 2015b). They used 100 
L hanging polybags in a greenhouse and reported expression levels of 3.28 mg L-1 of 
the target protein. Here, we describe pilot-scale culture of strains expressing a soluble 
protein (cis-abienol synthase (TPS4) from Abies balsamea) in the chloroplast stroma 
and a membrane-bound enzyme (a cytochrome P450 termed CYP79A1) in the 
chloroplast membrane. Bench scale studies on these strains have been recently 
described (Gangl et al., 2015b; Zedler et al., 2015) and our aim in the present study was 
to test whether they could be grown at scale under industrial conditions. We show that 
the strains grow rapidly under mixotrophic conditions and that they produce the target 
proteins at high levels. The strains do not, however, grow well under phototrophic 
conditions and we, therefore, conclude this type of strain offers high potential as a cell 




3.3.3. Materials and methods 
3.3.3.1. Chlamydomonas reinhardtii strains and preparation of inoculum 
 
The transgenic Chlamydomonas reinhardtii strains TN72-CYP79A1 and TN72-
TPS4 (henceforth CYP79A1 and TPS4, respectively) have been previously 
characterised in (Gangl et al., 2015b) and (Zedler et al., 2015) respectively. The 
C. reinhardtii strain CC-400 (cw15, mt+) was used as an untransformed control 
(referred to as CW-15). For inoculation of the green walls pre-cultures of each strain 
were grown in tris-acetate-phosphate medium (TAP) (Gorman and Levine, 1965) with a 
modified trace element recipe (Kropat et al., 2011). The cultures were bubbled with air 
(supplemented with 0.5 % CO2), at 25 °C, and an illumination intensity of 
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170 µmol m - 2  s - 1 . 24 hours before inoculation cultures were supplemented with 
0.1 g L-1 ampicillin to minimise bacterial contamination. 
 
 
3.3.3.2. Pilot scale cultivation set up and sampling 
 
 
Fig. 3.1. PBRs used in this study. The Glass Green Wall PBRs used in this study were custom 
made from stainless steel with one side of glass and an optic path length of 9 cm. The GGW 
contains a lower inlet valve for air and CO2, together with ports for sampling and thermal 
regulation. The GGWs were sterilised before use and used in a GM-certified outdoor facility; 
cultures were grown in 100 L Tris-acetate-phosphate medium as detailed in Materials and 
Methods. A is a schematic presentation of the PBR set up. B Picture of the PBR taken during 
this study. 
 
Pilot scale cultivation was carried out in Glass Green Wall (GGW) PBRs 
installed inside a greenhouse of the Experimental Unit of A4F in Lisbon, Portugal. The 
GGWs were custom made from stainless steel with one side of glass and an optic path 
length of 9 cm. The maximum capacity was 120 L (Fig. 3.1). The three GGWs were 
filled with 100 L of TAP medium (as used for inoculation cultures). After chlorination 
with 50 ppm sodium hypochlorite, overnight, the reactors were boiled for 40 min to 
further decontaminate the culture medium. After cooling to 25 °C, the GGWs were 
supplemented with 0.1 g L-1 ampicillin to minimise bacterial contamination. The three 
GGWs were inoculated simultaneously with stationary phase cultures of the 
transformant strains (TPS4 and CYP79A1) and the CW-15 control strain on 30 June 
2015 to an initial OD750nm of 0.08 to 0.1. The GGWs were maintained at a temperature 
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of 25 °C. In addition, they were bubbled with air supplemented with 0.5 % CO2 to 
maintain the pH levels of the cultures between 7 and 8 and irradiated by natural 
sunlight. The cultures were initially shaded with plastic sheets to allow for adjustment 
to the new light intensities. The sheets were removed on the second day of the 
experiment. Samples from the cultures were taken daily in the morning between 09.00 
and 10.00. Additionally, in the afternoon between 16.00 and 17.00, the pH was 
measured and cell growth was analysed by cell counting and optical density 
measurements. The viability of the cultures was monitored by microscopy until 
stationary phase was reached. 
 
 
3.3.3.3. Monitoring of morphology and growth 
 
The cultures were observed daily using an Olympus BX53 upright microscope. 
Cell growth was analysed by cell counting with a Muse® Cell Analyser (Merck 
Millipore, USA). Optical density was measured at 750 nm with a GENESYS UV-Vis 
spectrophotometer (Thermo Scientific, USA). Dry weight was determined by filtration 
of 50 – 100 mL of culture through 1.2 µm glass fibre filters (Merck Millipore, USA) 




3.3.3.4. Monitoring of culture medium parameters 
 
The pH of the cultures was measured twice daily. Ammonium (NH4
+) levels in 
the culture supernatant were analysed daily using a Nutrafin ammonium test kit (Hagen, 
Canada) following the manufacturer’s instructions. The acetate content in the culture 
medium was determined using an Acetic Acid Assay Kit (Megazyme, Ireland) 






3.3.3.5. Pigment analysis 
 
Pigments were extracted from 5 mL of culture. The culture pellets were 
resuspended in 5 mL 100 % acetone. Approx. 1 mL of beads were added to each 
sample. The mixture was then subjected to vortexing for 1 minute and the extracts were 
centrifuged for 10 minutes, 3000 rpm at 4 °C. The pigment extracts were directly 
analysed by recording a wavelength scan using a GENESYS UV-Vis spectrophotometer  
(Thermo Scientific, USA) from 380 nm to 700 nm. Samples for day 7 were diluted 1:1 
to obtain measurements in the linear range of absorption. For baseline correction, pure 
100 % acetone was measured prior to the samples. 
 
 
3.3.3.6. Homoplasmy analysis 
 
Total genomic DNA was extracted from 20 µL to 2 mL of liquid culture 
following the protocol described in (Economou et al., 2014). The extracts were 
subjected to a homoplasmy analysis by a three-primer PCR method to analyse genetic 
stability of the strains. Details of the experimental procedures have been described 
previously in (Zedler et al., 2015). 
 
 
3.3.3.7. Protein expression analysis: western blotting and densitometry 
 
At each time point the same quantity of cells (2 x 107 cells) was spun down and 
resuspended in the same amount of medium. The samples were boiled with 0.1 mM 
DTT and 5 % SDS for 5 minutes at 95 °C for cell lysis. For each sample an equivalent 
of 4.8 x 105 cells was subjected to electrophoresis on a 12 % sodium dodecyl sulphate-
polyacrylamide gel and subsequently immunoblotted with an anti-HA antibody. Details 
of western blotting have been previously described in (Gangl et al., 2015b). 
Densitometry was performed using the Image Lab Software (V4.1, Bio-Rad 
Laboratories). A dilution series of HA-ubiquitin was loaded on the same gel as the 
CYP79A1 and TPS4 samples. We have assumed that transfer onto the membrane was 
uniform and that the affinity of the HA-antibody was equal for samples and standards 
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since they share the same epitope. After separation of known molar amounts of HA-
ubiquitin a calibration curve was generated and the molar equivalent of CYP79A1 and 
TPS4 were determined. 
 
 
3.3.3.8. Lab scale cultivation and generation of growth curves 
 
CW-15, CYP79A1, TPS4 and TN72-RP strains were grown in TAP medium 
(Gorman and Levine, 1965) or high salt medium (HSM) (Sueoka, 1960) with a 
modified trace element recipe (Kropat et al., 2011) at 25 °C in approximately 40 µmol 
m-2 s-1 constant light with shaking at 110 or 120 rpm. Samples were taken daily at the 
same time and the optical density was measured at 750 nm using a DU 730 UV/Vis 
Spectrophotometer (Beckman Coulter, UK). The experiments were performed in 





We previously generated two transgenic, cell wall-deficient C. reinhardtii 
strains designated TN72-TPS4 (TPS4) and TN72-CYP79A1 (CYP79A1), which 
express a soluble diterpene synthase, TPS4, and a membrane-bound cytochrome P450, 
CYP79A1, respectively. Both strains, described in (Gangl et al., 2015b) and (Zedler et 
al., 2015) expressed the transgenes in the chloroplast following transformation using a 
relatively straightforward protocol (Economou et al., 2014). In the present study we 
tested the feasibility of growing those strains in a greenhouse at pilot scale in industrial 
PBRs. As a control, the two transgenic strains were compared to a cell wall-deficient 
mutant, CW-15.  However, it should be noted that only two transgenic strains could be 
run simultaneously in the contained PBR facilities, therefore it was not possible to grow 
the recipient TN-72 strain used for transformation, since it is itself transgenic (the psbH 
gene is disrupted and it expresses an aadA cassette). The CW-15 strain is similar, but 
not identical, to the TN-72 strain used for transformation (see discussion). All three 
strains were cultivated for seven days, in 100 L GGW PBRs, using TAP medium and 
natural sunlight. The PBR setup is shown in Fig. 3.1. 
 84 
3.3.4.1. Growth characteristics observed in GGW PBRs 
 
 
Fig. 3.2. Growth curves for transgenic strains and a cell wall-deficient control strain. The TPS4 
and CYP79A1 transgenic C. reinhardtii cultures, plus a cell wall-deficient non-transformed 
strain termed CW-15, were grown in the PBRs over a 7-day period. At the indicated times, 
samples were removed from the PBRs and used to count cell numbers (A) and measure OD750 
values (B). Arrows indicate points where additional acetate (50 mL glacial acetic acid) was 
added to the cultures 
 
The growth monitored by cell counts and optical density measurements in the 
PBRs is shown in Fig. 3.2. An initial exponential growth phase was followed by a 
stationary phase, which all strains reached between day 3 and day 4 of the culture 
period. OD750 values reached 0.5 – 0.6 corresponding to cell counts of 4-8 x 10
6 per mL 
for the transformants. This stationary phase remained unchanged until the end of the 
growth period. In general, the CW-15 strain performed better than both transformants, 




























































TPS4 strain demonstrated stronger growth compared to the CYP79A1 expressing strain 
as evidenced by cell counting (Fig. 3.2 A), although optical density measurement 
suggested a similar growth rate for both transgenic lines (Fig. 3.2 B). Dry weight 
measurements corresponded to the growth curves with a maximum yield of 0.438 g L-1 
observed for the control strain CW-15 and 0.311 g L-1 versus 0.289 g L-1 for the TPS4- 
and CYP79A1-expressing strains, respectively (Fig. 3.3). Culture samples from all three 
PBRs were observed under the microscope daily to assess motility and general cell 
fitness. Throughout the culture period all three strains appeared ‘healthy’, in general 
terms, and were of regular size and shape (Fig. 3.4). Absorption spectra of pigment 
extracts from time points taken over the whole culture period showed that the pigment 
composition pattern was overall the same for all strains at all stages of growth 




Fig. 3.3. Productivity of the cultures. The graph shows dry weights of the three PBR cultures 
over a seven-day period. The TPS4 and CYP79A1 transgenic algal cultures reached dry weights 





























Fig. 3.4. Analysis of the C. reinhardtii cells by microscopy. Samples of the TPS4, CYP79A1 
and CW-15 cultures were removed at days 2, 3 and 6 (D2/3/6) and analysed by microscopy as 




Fig. 3.5. Absorption spectra of pigment extracts from the GGW PBR cultures. Absorption 
spectra were recorded from pigment extracts in 100 % Acetone from 380 nm to 700 nm. The 
figure shows spectra recorded for the three cultures in the GGW PBRs: CW-15, TPS4 and 
CYP79A1 at three time points respectively: day 1, day 3 and day 7 of growth in the PBRs. 
 
 
3.3.4.2. Nutrient metabolism in GGW PBRs 
 
Daily measurements of acetate and NH4
+ levels in the culture medium were 
conducted to obtain an insight into the cultures’ carbon and nitrogen metabolism. NH4
+ 



































































+ increase observed on day 6 (Fig. 3.6 A). Acetate measurements 
revealed that essentially all of the acetate in the culture medium had been consumed 
after four days (Fig. 3.6 B). This corresponded with cultures reaching stationary phase 
around the same time. To investigate this apparent dependence on organic carbon 
further, we added fresh acetate to the cultures on day 8 of the experiment. As shown in 
Fig. 2, all three cultures resumed growth, the most dramatic effect being observed in the 
CYP79A1 expressing strain, which now reached similar cell numbers to TPS4. 
 
 
Fig. 3.6. Ammonium and acetate values in the culture medium. A NH4
+ concentrations 
throughout the 7-day culture period. B Measurements of the acetate (CH3COO
-) levels. Values 












































































3.3.4.3. Growth characteristics in PBRs are similar to those observed at lab 
scale 
 
Fig. 3.7. Growth curves of wall-deficient strains at lab scale. A shows typical growth curves of 
CW-15 and CYP79A1 grown in TAP and minimal medium (HSM) in shake-flasks under 
laboratory conditions. At the indicated time points optical density measurements were 
conducted at 750 nm. The experiment was performed in triplicates and the average was 
calculated. Error bars display the standard error. For details see Material and methods. B shows 
the differences of growth of CW-15, TPS4 and TN72-RP (RP) at lab scale in TAP medium. 
 
Growth curves obtained from shake-flask cultures of CW-15 and TN72-
CYP79A1 in TAP and minimal medium (HSM) showed that both strains grow very 
rapidly in TAP medium (i.e. mixotrophically) but much slower in minimal medium 
(Fig. 3.7 A). This suggests that while the described transgenic strains are capable of 
autotrophic growth, there is a strong preference for mixotrophic growth both at lab scale 
and pilot scale. The overall growth pattern observed in the PBRs (Fig. 3.2) is very 
similar to those obtained in lab scale studies. 
We have also compared the growth of the control strain CW-15 used in the 
PBRs with the transgenic strain TN72-RP. TN72-RP is essentially the same strain as 
CYP79A1 and TPS4, but lacking a gene of interest, because it was transformed with an 
empty pASapI vector (details are given in Zedler et al 2015). The differences in growth 
between TN72-RP and CW-15 observed at lab scale are very similar to the differences 
we found for the transformants and CW-15 in the PBRs. However the growth 




















































3.3.4.4. Stable expression levels of transgenes at pilot scale 
 
 
Fig. 3.8. TPS4 and CYP79A1 are produced continuously throughout the 7-day culture period. 
Samples were removed from the three cultures at the times indicated and analysed by 
immunoblotting using antibodies to the C-terminal HA tag on the TPS4 and CYP79A1 proteins. 
The mobilities of these proteins are indicated. N.s: protein that reacts non-specifically with the 
anti HA tag antiserum. Additional control (Ctr.) samples were run at the right hand side of each 
gel; these were samples of the CYP79A1 culture for the blot of the CW-15 culture, and samples 
of CW-15 culture for the blots of CYP79A1 and TPS4 cultures. In each case a sample of the 
inoculum was also taken 24 h before inoculation of the GGWs (Day -1 lanes). 
 
PCR analysis of transformed culture samples at the beginning and end of the 
culture period confirmed that the transgenes remained stably integrated in the 
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shown). This indicates that the engineered lines remain genetically stable even under the 
stresses of prolonged large-scale growth in an industrial PBR. 
Western blotting was carried out to detect the HA-tagged TPS4 and CYP79A1 
proteins, and Fig. 3.8 shows that both proteins are detected throughout the culture 
period. The data show the presence of the 62-kDa CYP79A1 protein and the 91-kDa 
TPS4 protein at all sampling points. A non-specific band of approximately 32 kDa was 
observed in all of the samples including the CW-15 control. This band was also detected 
in the previous shake-flask studies by Gangl et al. (Gangl et al., 2015) and Zedler et al. 
(Zedler et al., 2015), who showed that this band results from non-specific reaction with 
the anti HA tag antiserum. A calibrated immunoblot for both proteins, CYP79A1 and 
TPS4, with increasing loadings of a reference protein (HA-ubiquitin) allowed an 
approximation of protein expression levels. We estimated that the expressed proteins 






In this study we have grown transgenic wall-deficient C. reinhardtii strains at 
pilot scale (100 L) using GGW PBRs. The results show that these strains can grow 
effectively over a 10-day period and this in itself is an important finding; these are cell 
wall-deficient strains that are inherently less robust than true wild type strains. Prior to 
this study, it was not clear whether the strain would withstand the stresses involved in 
large-scale cultivation in a PBR with constant air/CO2 bubbling. We now conclude that 
this cell wall-deficient strain can indeed be used for the production of recombinant 
proteins and derived products using industrial PBRs under the conditions described in 
this study. This is a first step to enable the transition from lab scale experiments to large 
scale cultivation and a basis for developing an industrial platform using this type of 
strain. 
Gimpel et al. have previously shown that Chlamydomonas reinhardtii can be 
grown at pilot scale, however they used strains with a functional cell wall (Gimpel et 
al., 2015b). Our data therefore represent an additional demonstration of pilot-scale 
C. reinhardtii cultivation, using a very different form of strain and under rather different 
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growth conditions (see below). It has been suggested that C. reinhardtii strains in 
general may be difficult to culture in industrial systems, due to low temperature 
tolerance (Hlavova et al., 2015) and there is a clear need for pilot scale studies to assess 
these strains' characteristics under production conditions. Several points of interest have 
emerged from the present study. 
 
 
3.3.5.1. Growth differences in mixotrophic and phototrophic regimes 
 
The growth data from the GGW PBRs illustrate key points regarding these 
strains. Whereas the strains initially grew rapidly in TAP medium, they entered 
stationary phase after 3-4 days at a point that corresponded closely to depletion of the 
acetate in the medium. After several days in this condition the cultures again grew 
rapidly when more acetate was added. These data show quite clearly that while the 
cultures can be grown quickly in the presence of an organic carbon source under a 
mixotrophic regime, they grow slowly under phototrophic conditions. These findings 
are in reasonable agreement with results from laboratory-scale cultures. Although only a 
few reports have emerged using the TN72 strain, Young et al have recently 
demonstrated weaker growth of transformants based on this strain under phototrophic 
conditions compared to mixotrophic conditions (Young and Purton, 2015). We 
conclude that these strains are most effectively grown at pilot scale under mixotrophic 
growth conditions rather than phototrophic growth regimes. This has also been 
suggested for other green microalgae of industrial interest such as Chlorella sp. (Liang 
et al., 2009; Kong et al., 2011; Cheirsilp and Torpee, 2012) and Scenedesmus sp. 
(Girard et al., 2014). 
 
 
3.3.5.2. Growth differences between the transformants and the control strains 
 
Our growth data show that the control strain CW-15 grew consistently better 
than the transformed strains. Here it should be noted that this is most likely due to a 
different genetic background rather than a transgenic phenotype. The transformants 
TPS4 and CYP79A1 are based on the strain TN72 (cw15, psbH::aadA, mt+) (described 
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in (Economou et al., 2014)) which, although a CW-15 derivative, is not identical to the 
CW-15 strain used for control growth tests. This idea was supported by findings at lab 
scale (shown in Fig. 3.5 B) where the differences in growth of TN72-RP and CW-15 are 
shown. We therefore conclude that the observed differences between the transgenic 
strains and CW-15 are due to a slightly varied genetic background. However, at the 
same time we cannot exclude the possibility that the expression of the transgenes has an 
effect on cellular metabolism. The transformed strains express enzymes that utilise 
endogenous metabolites as their substrates. TPS4 converts geranylgeranyl diphosphate 
to cis-abienol and CYP79A1 catalyses the formation of p-hydroxyphenylacetaldoxime 
from tyrosine. This could potentially lead to the depletion of metabolites in the cell or to 
an adverse or toxic effect of the expressed compounds. However, as mentioned above 
we do not see any evidence of this on a lab scale. It is more likely that the different 
growth rates observed for the transformants is due to variabilities between the cultures 
in the PBRs. 
 
 
3.3.5.3. Comparison of culture conditions and yields  
 
Our findings differ from those reported by Gimpel et al. (2015b) in their pilot-
scale study since their cultures were grown in HSM medium, without added acetate, and 
phototrophic growth was observed throughout the growth period. However, several 
points are relevant. First, they transformed a wild type (walled) C. reinhardtii strain 
rather than a cell wall-deficient strain, which may be more adept at growing 
phototrophically under these conditions. Secondly, the Gimpel et al. study involved 
growth in hanging polybags with frequent (every 30 min) bubbling with 5 % CO2, 
which can boost photosynthesis to a considerable extent. In contrast, our study involved 
bubbling with 0.5 % CO2 and this lower concentration may have contributed to the poor 
phototrophic growth performance after the acetate was depleted. On the other hand, it is 
notable that much more rapid growth rates are obtained under mixotrophic conditions; 
as an example, our transgenic cultures reached dry weights of around 0.3 g L-1 by day 4, 
whereas the cultures in the Gimpel et al. study only reached 0.267 +/- 0.011 g L-1 after 
12 days (Gimpel et al., 2015b). 
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We also found higher expression levels of the recombinant proteins in our 
cultures. Densitometry of calibrated blots gave estimates of 6.77 mg L-1 protein for 
CYP79A1 and 22 mg L-1 for TPS4 in these strains, compared to 2.27 +/-0.88 mg L-1 
reported for MAA expression in the (Gimpel et al., 2015b) study using transgenic 
strains with an intact cell wall. The reason for higher expression levels might be due to 
the different expression system used, to the nature of the target protein or to the culture 
conditions. 
CYP79A1 and TPS4 are enzymes involved in the synthesis of secondary plant 
metabolites. The expression of many recombinant proteins in the C. reinhardtii 
chloroplast has been reported, but to our knowledge only one study investigated the 
expression of recombinant enzymes. Xylitol reductase from the fungus Neurospora 
crassa was expressed in the chloroplast of C. reinhardtii and up to 0.38 g L-1 xylitol 
was produced when xylose was supplemented to the medium (Pourmir et al., 2013). In 
comparison, our preliminary data show that the CYP79A1 product p-
hydroxyphenylacetaldoxime accumulates to levels of only 0.293 mg L-1 in the pilot 
scale experiment (data not shown). However, this oxime is an intermediate in a 
biosynthetic pathway and it may well be short-lived in this host strain. 
 
 
3.3.5.4. Implications for using Chlamydomonas wall-deficient strains in an 
industrial setting 
 
We have shown that transgenic, cell wall-deficient C. reinhardtii can be 
effectively cultured at pilot-scale in GGW PBRs, and that they can produce recombinant 
proteins in the chloroplast over the entire growth period. We have also shown that, 
while these strains are best used in mixotrophic growth regimes, they can reach high 
cell densities within a few days, and there is a clear potential for even higher densities 
by repeated addition of acetate to the culture (i.e. sustaining mixotrophy over the whole 
growth period). Given these strains' ability to express a cytochrome P450 and a 
diterpene synthase in the chloroplast at high levels, they may represent attractive 
platforms for the production of not only recombinant proteins but also high-value 
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Chapter 4: Efficient targeting of 
recombinant proteins to the thylakoid 
lumen in Chlamydomonas reinhardtii 
using a bacterial Tat signal peptide 
 
 
Zedler, J.A.Z., Mullineaux, C.W., and Robinson, C. (2016b) Efficient targeting 
of recombinant proteins to the thylakoid lumen in Chlamydomonas 
reinhardtii using a bacterial Tat signal peptide. Algal Res, submitted. 
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4.1. Author contribution 
 
I am the first author of this research article. The experimental design was 
planned by me and CR. I did all the experimental work (synthetic gene design, construct 
assembly, chloroplast transformation, characterisation of transformants). The confocal 
images were obtained by CWM from cells I prepared. CWM did the analysis of the 
confocal images. I drafted the manuscript and prepared all the figures, figure 4 was 
compiled with input from CWM and edited to its final version by CR. CR and CWM 




4.2. Aim of this study 
 
To date, many studies have reported the expression of recombinant proteins in 
the chloroplast of C. reinhardtii. However, all recombinant proteins other than one 
study (see chapter 5) have expressed the protein in the stroma. The thylakoid lumen is a 
unique compartment that could be a valuable addition to the chloroplast toolkit for 
establishing microalgae as a cell factory. In this study the potential of utilising the 
intrinsic protein translocation system for lumen targeting in microalgae was 
investigated. Translocation to the thylakoid lumen was tested using a simple bacterial 
export signal peptide (TorA signal peptide). A fluorescent reporter gene, pHRed and a 
simple model protein of biotechnological relevance, an scFv antibody fragment, was 
used to test the targeting to the lumen in a first proof of concept study. 
 
 
4.3. Original research publication 
 
Remark: the manuscript is inserted as it has been submitted for publication. The 
references have been added to the bibliography in chapter 7, the figures and tables 
numbering and position as well as headings have been changed for consistent 




Interest in the exploitation of microalgae for biotechnological applications has 
increased over the last decade, and microalgae are now viewed as offering a sustainable 
alternative to traditionally used host chassis. A number of recombinant proteins have 
been expressed in genetically modified algal strains, with the green alga 
Chlamydomonas reinhardtii being a particularly popular host strain. While nuclear 
transformation is possible with this organism, chloroplast transformation offers more 
reliable expression, and several proteins have been expressed in the stroma. Here we 
present the first utilisation of the thylakoid lumen for recombinant protein production in 
microalgae. A bacterial export signal peptide was used to efficiently translocate two 
recombinant proteins, a fluorescent reporter protein (pHRed) and a biopharmaceutical 
model substrate (scFv) into the thylakoid lumen. This approach expands the algal 
chloroplast genetic toolkit and offers a means of expressing proteins that are difficult to 
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The green alga Chlamydomonas reinhardtii has been used as a host for the 
expression of a variety of recombinant proteins, and its biotechnological potential has 
been explored in many studies over the last decade. A number of heterologous proteins 
have been expressed, including vaccines, antibody fragments and terpene synthesis 
enzymes for recent reviews see (Almaraz-Delgado et al., 2014; Gangl et al., 2015a; 
Rasala and Mayfield, 2015). Tools for the genetic engineering of this green microalga 
have advanced remarkably, and it is now possible to transform both the nuclear and 
chloroplast genomes with reasonable efficiency. Chloroplast transformation offers the 
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advantage that gene integration occurs by homologous recombination at specific sites, 
whereas nuclear transformation is essentially random with frequent gene silencing, e.g. 
(Potvin and Zhang, 2010; Purton et al., 2013). However, all of the chloroplast 
transformants reported to date have involved expression of the target protein in the 
stroma, with the exception of a study in which the target protein, a cytochrome P450, 
was targeted into a membrane (probably the thylakoid membrane) (Gangl et al., 2015b). 
In this study we present a novel approach to expand the genetic tool kit of the 
algal chloroplast involving targeting to the thylakoid lumen. The thylakoid lumen is an 
important compartment playing a key role in photosynthesis and energy generation in 
chloroplasts. However, it has a relatively small proteome (Kieselbach et al., 1998) and it 
offers a very different environment compared to the stroma: for example, the pH is 
lower and the lumen is an oxidising environment that is conducive to disulphide 
bonding. This could have advantages for the expression of some proteins and enrich the 
potential of the algal chloroplast as a production platform. In chloroplasts, proteins are 
naturally targeted across the thylakoid membrane by the Sec or Tat pathways, and 
attachment of a Sec or Tat signal peptide to a heterologous protein often results in 
correct targeting and maturation (reviewed in (Albiniak et al., 2012)). Here, we used the 
TorA Tat signal peptide from Escherichia coli which has been used to direct the export 
of biotechnologically relevant proteins to the periplasm in E. coli (reviewed in (Walker 
et al., 2015)) as a targeting peptide to translocate recombinant proteins into the 
thylakoid lumen of the C. reinhardtii chloroplast. We show that the Tat signal peptide 
can target and translocate both a fluorescent reporter protein, pHRed, and a 
biopharmaceutical (scFv antibody fragment) into the thylakoid lumen of C. reinhardtii. 
 
 
4.3.3. Material and methods 
4.3.3.1. Plasmid construction 
 
 The sequence for the pHRed fluorescent protein was obtained from the plasmid 
GW1-pHRed (ORF3, addgene plasmid 31473) (Tantama et al., 2011). The sequence for 
scFvIL1B (scFv) was obtained from the plasmid pYU49 (Matos et al., 2014). An HA-
tag (amino acid (AA) sequence YPYDVPDYA) was added at the C-terminus of every 
synthetic gene for detection by western blotting. Two constructs were made for each 
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protein, pHRed and scFv respectively: one stroma control (sequence encoding mature 
protein only) and one with a bacterial Tat export signal peptide from TMO reductase 
(AA sequence: NNNDLFQASRRRFLAQLGGLTVAGMLGPSLLTPRRATAAQAA 
inserted after the methionine start codon and the first amino acid of the mature protein 
sequence) referred to as “TorA signal peptide” (Méjean et al., 1994). All genes were 
codon-optimised for chloroplast expression in C. reinhardtii using the software ‘Codon 
Usage Optimizer’ (codonusageoptimizer.org/download/). The synthetic genes were 
custom synthesised by GenScript (USA). All constructs made for this study were based 
on the vectors pASapI (Economou et al., 2014) and pSRSapI (Young and Purton, 2014) 
for chloroplast expression in C. reinhardtii. An overview of the constructs made for this 
study is given in Table 4.1. Plasmid pJZ19 was assembled with the Gibson assembly 
method (Gibson et al., 2009). All other constructs were made by cutting with the 
restriction enzymes SapI and SphI (NEB) and subsequent ligation into 
pASapI/pSRSapI. All constructs were sequenced to confirm the correct nucleotide 
sequence of the synthetic gene. 
 
Table 4.1. Overview of constructs described in this study. All constructs were made using the 
transformation vectors pASapI (atpA 5’UTR) (Economou et al., 2014) or pSRSapI (psaA 
5’UTR) (Young and Purton, 2014) for integration downstream of psbH in the chloroplast 
genome. The predicted location of the protein in the chloroplast (*) is based on the presence or 
absence of a TorA signal peptide in the presequence of the protein. 










tag) against interleukin 1β 
(Wilkinson et al., 2009; 








































4.3.3.2. Cultivation and chloroplast transformation of C. reinhardtii 
 
 All C. reinhardtii strains were cultivated in TAP medium using the recipe as 
described by Gorman and Levine (Gorman and Levine, 1965) with modified trace 
element solutions (Kropat et al., 2011). For selection of chloroplast transformants and 
confocal imaging (see section 2.6. for details) HSM medium (Sueoka, 1960) with the 
modified trace element solutions (Kropat et al., 2011) was used. The protocol for 
chloroplast transformation was used as described in Economou et al. (Economou et al., 
2014) using the strain TN72 (cw15, psbH::aadA, mt+) as a recipient. Further details of 
the cell line generation were as previously described in Zedler et al. (2015). Other than 
the cell lines generated in this study by transformation with the plasmids as shown in 
Table 4.1, a strain with a restored functional psbH gene was made by transforming 
pSRSapI (Young and Purton, 2014) without any synthetic gene integrated into TN72. 
This strain was named TN72-RP* and served as a negative control for transformants 
based on the pSRSapI vector. The strain TN72-RP (TN72 transformed with pASapI) 
(Zedler et al., 2015) was used as a negative control for pASapI based transformants. 
 
 
4.3.3.3. Homoplasmy analysis of transformants by PCR 
 
 A Chelex-100 resin (Bio-Rad) was used to extract total genomic DNA from 
C. reinhardtii using a protocol described elsewhere (Economou et al., 2014). 
Transformants generated with the pASapI vector were analysed by PCR as described in 
Zedler et al. (2015). The same protocol was used for transformants generated with 
pSRSapI-based constructs. The primers FLANK1, rbcL.F (both previously described 
(Zedler et al., 2015)) were used in conjunction with the primer psaA.R (5’-
GGATTTCTCCTTATAATAAC-3’) in a standard PCR protocol with an annealing 
temperature of 54 °C. Sequences for the primer design were kindly provided by Saul 






4.3.3.4. Cell lysis, SDS-PAGE and western blotting 
 
 Crude cell lysates for protein expression analysis were prepared from 
C. reinhardtii cells that were grown in 6 well plates in TAP medium at 25 °C, 110 rpm 
shaking and approx. 50 µE. A volume of cells equivalent to 0.5 mL of a culture with an 
optical density of OD750=1 measured on a DU 730 UV/Vis Spectrophotometer 
(Beckman Coulter) were harvested from each sample and resuspended in 0.1 mL 
10 mM Tris-HCl (pH 8.0). 0.025 mL 5x SDS protein gel loading buffer (containing β-
mercaptoethanol as a reducing agent) were added to the samples and then boiled at 
95 °C for 5 minutes. The crude lysates were separated and analysed by SDS-PAGE on a 
15 % sodium dodecyl sulphate-polyacrylamide gel and immunoblotted. An HA-
antibody (Sigma-Aldrich) was used to detect the target protein and an AtpB-antibody 
(Agrisera, Sweden) as a loading control. 
 
 
4.3.3.5. Chloroplast isolation and fractionation 
 
Chloroplasts were isolated from 1 L liquid cultures that were grown in TAP 
medium to mid log phase at 25 °C, 120 rpm shaking and constantly illuminated with 
approx. 50µE. The protocol described by Mason et al. (Mason et al., 2006) was used for 
chloroplast isolation. After washing the isolated chloroplasts in 0.1 % BSA isolation 
buffer, the chloroplasts were directly resuspended in hypotonic lysis buffer for 
fractionation into stroma and thylakoids (a membrane fraction also including the 
chloroplast envelope membranes) as described in Balczun et al (Balczun et al., 2006). 
The lysate loaded on 1 M Sucrose cushions was centrifuged in a Beckman TL-100 
ultracentrifuge at 95 000 rpm, 4 °C for two hours using a TLA100.3 rotor (Beckman). 
The thylakoid fraction was then resuspended in 1x lysis buffer (Balczun et al., 2006). 
Samples were boiled at 50 °C for 10 minutes and subjected to SDS-PAGE and Western 
Blotting as described in Section 2.4. The samples were immunoblotted with the HA-
antibody and with a PsbO antibody kindly provided by Saul Purton (University College 




4.3.3.6. Confocal imaging of Chlamydomonas cells 
 
 C. reinhardtii cells were taken from liquid cultures in HSM medium, spotted 
onto glass microscope slides and covered with glass cover-slips. Cells were imaged 
using a Leica TCS SP5 laser-scanning confocal microscope, using a 63x oil-immersion 
objective (NA 1.4) and excitation with a 561 nm laser line. Fluorescence emission was 
detected simultaneously at 600-620 nm for pHRed and 670-720 nm for chlorophyll. The 
confocal pinhole was set to give a z-axis resolution of about 1.5 µm. Images were 
recorded with scanning at 400 Hz, with each line generated by an average from 6 scans. 




4.3.4. Results and discussion 
4.3.4.1. pHRed and an scFv are robustly expressed in the chloroplast 
 
 The aim of this study was to test for targeting of a reporter protein, pHRed, and 
a biotechnologically relevant protein (an scFv) to the thylakoid lumen by the Tat 
pathway. For comparisons of expression levels, and for control purposes, we also 
expressed the mature-size pHRed protein in the stroma. Screening relied on the 
restoration of phototrophic growth after transformation, as homologous recombination 
restores the intactness of the psbH gene (see (Economou et al., 2014) for details). One 
series of constructs was cloned into the plasmid pASapI, which uses the atpA promoter, 
and a second series of transformations was carried out using constructs based on the 
plasmid pSRSapI, which uses the psaA promoter. C. reinhardtii chloroplast 
transformants expressing the constructs detailed in Table 4.1 were successfully 
generated using the recipient strain TN72 as detailed in Economou et al. (2014). 
Homoplasmy analysis by PCR confirmed that all strains were homoplasmic ensuring 
stable integration of the gene into the chloroplast genome (Fig. 4.1). 
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Fig. 4.1. Homoplasmy analysis of transformants expressing pHRed and scFv constructs. PCR 
for homoplasmy analysis was carried out on the TN72 strains transformed with constructs based 
on pASapI (A) and pSRSapI (B). All lanes indicate the construct that was used for 
transformation (details shown in Table 4.1) to generate the respective strain. pJZ26a/26b 
represent two separate transformants expressing TorA-pHRed. N denotes the strain TN72, used 
as a negative control for the PCR reaction (i.e. with no gene integrated), P denotes a positive 
control (i.e. gene has been integrated). In the lanes ‘MQ’ water was used instead of a DNA 
template as a negative control for the PCR reaction. 
 
 Further analysis of the transformants by SDS-PAGE and western blotting of 
crude cell lysates showed that the cells were expressing the respective protein, i.e. scFv 
or pHRed, in the chloroplast at stable levels (Fig. 4.2). Fig. 4.2 A shows (from left to 
right) blots of stromal pHRed and TorA-pHRed (in 2 different transformants), 
expressed from the same psaA promoter. The protein is clearly detected as a band of ca. 
27 kDa and the levels of the stromal and lumen-targeted versions are reasonably similar. 
The next lane shows that lower TorA-pHRed levels were obtained when expressed from 
the atpA promoter, and the band is absent from the control strains transformed with 





























































Fig. 4.2. Expression of pHRed and scFv with and without TorA signal peptide in the chloroplast 
of C. reinhardtii. A shows an immunoblot of cell lysates from strain TN72 transformed with the 
following constructs from left to right: pJZ25 (pHRed); JZ26a, pJZ26b, pJZ19 (TorA-pHRed); 
pSRSapI (RP*); pASapI (RP). The blot was probed with antibodies to the HA tag on the C-
termini of the target proteins, and the arrow indicates the mature protein size of pHRed. 
B shows a blot of cell lysates from TorA-scFv and mature-size scFv constructs. The TN72 
transformant strains from left to right are: pJZ21, pJZ20 (scFv); pJZ23, pJZ22 (TorA-scFv); 
pSRSapI (RP*), pASapI (RP). The mature-size scFv protein is marked with an arrow. N.S. 
indicates a non-specifically reacting band that has been previously observed (Zedler et al., 
2015). In both A and B the promoter used to drive expression is shown below the blot. The blots 
below the anti-HA blot were probed with an anti-AtpB antibody showing approximately equal 
loading of lysates in all lanes; the AtpB protein is marked with an arrow.  
 
 Fig. 4.2 B shows blots of transformants expressing the 28-kDa scFv in the 
stroma from the psaA or atpA promoter, with slightly higher levels detected in the 
former. Slightly surprisingly, expression of TorA-scFv yields somewhat different 
results, with protein levels higher when expressed from the atpA promoter.  
 In both the A and B panels, the blots were reprobed using antibodies to AtpB as 
loading controls. It is also notable that in Fig. 4.2 B we detect a band of about 34 kDa 
which has previously been shown to stem from non-specific reaction of an unknown 





































4.3.4.2. The precursor proteins TorA–pHRed and TorA–scFv are processed 
efficiently 
 
 Interestingly, in the strains expressing TorA-pHRed and TorA-scFv (Fig. 4.2), 
only the mature protein sizes 27/28 kDa were detected, with the same molecular 
weights as the stromal versions. No precursor protein, which would be expected to be 
around 32 kDa for both proteins, was observed in our experiments. Lumen-targeted 
precursor proteins are processed to the mature size after translocation by a lumen-facing 
processing peptidase (Albiniak et al., 2012), so this provides preliminary evidence that 
both proteins may be targeted to the thylakoid lumen and processed to the mature size. 
 
 
4.3.4.3. The TorA export signal peptide enables protein translocation to the 
thylakoid lumen in the algal chloroplast 
 
 
Fig. 4.3. Fractionation of chloroplasts into stroma and thylakoids (including envelope 
membranes). Whole chloroplast lysates (C), the stroma fraction (S) and the thylakoid fraction 
(T) are shown. A shows an Anti-HA immunoblot of chloroplast fractions from strain TN72 
transformed with pJZ25 (pHRed) and pJZ26 (TorA-pHRed). B shows the fractions of TN72 
transformed with pJZ23 (TorA-scFv). RP denotes the negative control showing that the band 
indicated with N.S. is a non-specific reacting band present in the negative control. A second 
immunoblot probed with an PsbO antibody, shown in A and B respectively, serves as a control 

































Although the absence of the precursor protein is indirect evidence of targeting to 
the lumen, fractionation studies were deemed essential to confirm this point, and 
chloroplasts were therefore isolated and fractionated into stroma and thylakoids by 
hypotonic lysis. The results of the fractionation are shown in Fig. 4.3, with the target 
proteins again detected by immunoblotting with antibodies to their C-terminal HA tags. 
Both TorA-pHRed (Fig. 4.3 A) and TorA-scFv (Fig. 4.3 B) were translocated into the 
thylakoids, with the mature-size proteins ('mat') clearly detected in the thylakoid 
fraction (T) but not the stroma (S). The stromal pHRed is detected in the stroma as 
expected (Fig. 4.3 A) as was the stromal scFv (data not shown). The 34 kDa band from 
non-specific binding of the anti-HA antibody is also apparent. 
The fractions were also probed with a PsbO antibody as a control for the fractionation; 
PsbO is a well-known lumenal protein that forms part of the photosystem II oxygen-
evolving complex. This control confirms that the targeted proteins are indeed in the 
thylakoid fraction. From these results, it is apparent that a bacterial Tat export signal 
peptide is suitable for translocation of proteins to the thylakoid lumen in C. reinhardtii.  
 
 
4.3.4.4. TorA–pHRed is specifically targeted to the thylakoids 
 
 Representative confocal images of the strains expressing the fluorescent reporter 
gene pHRed are shown in Fig. 4.4. All images were recorded with 561 nm excitation 
and emission at 600-620 nm, a combination which proved to give the most selective 
visualisation of pHRed relative to the background fluorescence from the photosynthetic 
pigments. However, even at these wavelengths there was significant non-pHRed 
fluorescence from the thylakoid membranes (see right-hand panels of Fig. 4.4, showing 
the control strain), which complicates analysis of the distribution of pHRed. For 
quantitative comparison of fluorescence yields we manually selected either the whole 
cell or the pyrenoid region in the chloroplast (see Fig. 4.4) and measured the mean 
fluorescence in these regions, a procedure which automatically corrects for differences 
in cell size. For cells expressing stromal pHRed, mean fluorescence at 600-620 nm was 
36 % higher than in the control strain (n = 20, p = 0.00013 from a Student’s t-test). The 
difference was even more pronounced when fluorescence was measured only from the 
pyrenoid region, an area of the chloroplast stroma where there is an optically-resolvable 
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gap between the thylakoid membranes so that the background fluorescence from the 
photosynthetic pigments is lower in this region (see Fig. 4.4). In the pyrenoid region, 
600-620 nm mean fluorescence from cells with stromal pHRed was 65 % higher than in 
the control strain (n = 20, p = 0.000087), and most cells with stromal pHRed showed an 
obvious fluorescence signal from the pyrenoid that was absent from the other strains 
(Fig. 4.4).  
 
 
Fig. 4.4. Representative confocal fluorescence images of C. reinhardtii cells expressing pHRed 
and TorA-pHRed, with cells having the empty transformation plasmid integrated (RP*) as a 
control. Top: images of fluorescence in the pHRed region 600-620 nm, shown in green. Bottom: 
the same images merged with chlorophyll fluorescence at 670-720 nm, shown in red. The white 
arrow highlights stromal pHRed fluorescence from the pyrenoid region. Scale bar: 10 µm. 
 
 Cells expressing TorA-pHRed) showed mean cell fluorescence only marginally 
(6 %) higher than the control strain, without compelling statistical significance for a 
difference (n = 20, p = 0.24). Western blots indicate that TorA-pHRed protein is present 
at similar levels to stromal pHRed (Fig. 4.2), so it appears that fluorescence from 
lumenal pHRed must be somewhat quenched relative to stromal pHRed. This quenching 
cannot be a simple consequence of pH difference, since pHRed should show enhanced 
fluorescence with excitation at 561 nm at the lower pH expected in the thylakoid lumen 
pHRed (stromal) TorA-pHRed (lumenal) control (RP*) 
 109 
(Tantama et al., 2011). Our fluorescence images confirm different distributions of 
stromal and lumenal pHRed demonstrated by the fractionation experiments (Fig. 4.3A). 
Lumenal pHRed appeared largely absent from the pyrenoid region of the stroma, since 
fluorescence in this region was 28 % lower than in the strain expressing stromal pHRed 
(n = 20, p = 0.00038) and only marginally higher than in the control strain (18 % 
higher, n = 20, p = 0.026). 
 
 
4.3.4.5. Potential of lumen targeting in microalgae for biotechnology 
 
The Tat machinery is specialised for the translocation of fully folded proteins 
and it has previously been shown that the bacterial Tat system has quality control 
(proofreading) capabilities, such that correctly-folded proteins are preferentially 
transported (reviewed in (Robinson et al., 2011)). Correct protein folding is highly 
advantageous for recombinant protein production, and if the thylakoid Tat system has 
similar properties, the lumen may therefore offer certain advantages over the stroma; 
with the transported proteins exhibiting high folding fidelity. The lumen may also 
represent a beneficial environment for the production of disulphide-bonded proteins. In 
tobacco chloroplasts, disulphide bond formation tested with a recombinant protein 
(alkaline phosphatase) was reported to be more efficient in the thylakoid lumen than in 
the stroma (Bally et al., 2008). This supports the idea of the thylakoid lumen as a novel 
compartment for recombinant protein production. Finally, a number of potential target 
proteins may be toxic in the stroma, or may catalyse unwanted metabolic processes, and 





 We have shown that a bacterial Tat export signal peptide is capable of directing 
the translocation of model and biotechnologically relevant recombinant proteins into the 
thylakoid lumen of the C. reinhardtii chloroplast. The thylakoid lumen may therefore 
provide a protective environment for delicate proteins that require tight folding, 
especially for proteins that are potentially toxic or which are more stable at a lower pH. 
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This process thus represents an addition to the 'algal chloroplast toolkit' with potential 
for enhancing the competitiveness of microalgae as production platforms. 
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 JAZZ designed the experiments, acquired and analysed the data, drafted and 
approved the manuscript. CWM acquired the confocal images, analysed the images, 
wrote and approved the manuscript. CR designed the experiments together with JAZZ, 
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5.1. Author contribution 
 
I am the second author of this research study. Together with DG I set up the 
cultivation and transformation unit in the lab of CR at the University of Kent that 
allowed this work to be carried out. My experimental contribution to this study was to 
generate the strain TN72-RP that was used as a control for this study. This consisted of 
chloroplast transformation, screening for positive transformants and confirming the 
strain identity by PCR. I discussed and analysed the research data with the other authors 
of this manuscript and helped with editing and proof reading of the manuscript. 
 
 
5.2. Aims of this study 
 
A more recent aspect of microalgae exploitation is the synthesis of high-value 
compounds such as terpenes rather than commodities by genetically modified algae. 
The synthesis of these terpenes in plants typically requires multiple enzymes and 
complex pathways in the host plant cell. Transferring those pathways into microalgae is 
therefore very challenging: (1) the pathway has to be well characterised to provide the 
needed background information, (2) usually several genes have to be inserted into the 
microalgal genome, (3) those genes have to be expressed at decent levels, (4) the 
enzyme must be in an active form, and (5) the expressed enzymes have to be able to 
work together, i.e. “form a metabolic pathway” to produce the desired molecule. 
Terpene synthesis will typically involve several cytochromes P450 (Lassen et al., 
2014b). In plants, these are located in the ER. It has previously been shown that it is 
possible to relocate a cytochrome P450 from the ER into the chloroplast and essentially 
scavenge reducing power from photosynthesis to drive the P450 (Nielsen et al., 2013; 
Lassen et al., 2014a; Wlodarczyk et al., 2016). 
This study is a proof of concept investigating if P450s, that are essential 
components of terpene synthesis, can be relocated to the chloroplast of a eukaryotic 
microalga, C. reinhardtii, and be expressed in an active form. A simple model 
cytochrome P450 from the dhurrin pathway, CYP79A1 (Sibbesen et al., 1995) was 
expressed chosen for this proof of concept study and the significance for high-value 
compound production in microalgae is discussed. 
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5.3. Original research publication 
 
Remark: Here, the pre-proof version of the manuscript is presented. The references have 
been added to the bibliography in chapter 7, the figures and tables numbering and 
position as well as headings have been changed for consistent integration into this 





The unicellular green alga Chlamydomonas reinhardtii has potential as a cell 
factory for the production of recombinant proteins and other compounds, but 
mainstream adoption has been hindered by a scarcity of genetic tools and a need to 
identify products that can be generated in a cost-effective manner. A promising strategy 
is to use algal chloroplasts as a site for synthesis of high-value bioactive compounds 
such as diterpenoids since these are derived from metabolic building blocks that occur 
naturally within the organelle. However, synthesis of these complex plant metabolites 
requires the introduction of membrane-associated enzymes including cytochrome P450 
enzymes (P450s). Here, we show that a gene (CYP79A1) encoding a model P450 can be 
introduced into the C. reinhardtii chloroplast genome using a simple trans- formation 
system. The gene is stably expressed and the P450 is efficiently targeted into 
chloroplast membranes by means of its endogenous N-terminal anchor domain, where it 
is active and accounts for 0.4 % of total cell protein. These results provide proof of 
concept for the introduction of diterpenoid synthesis pathways into the chloroplast of 












The green alga Chlamydomonas reinhardtii has served as an important model 
organism for studies on photosynthesis, chloroplast biology and cell physiology. 
However, this freshwater alga has also evoked interest as a production platform for 
recombinant proteins and other products; heterologous genes can be expressed in both 
the nuclear and chloroplast genomes (Purton et al., 2013; Rasala et al., 2014), and the 
organism grows rapidly and is relatively inexpensive to culture. These factors raise the 
possibility that cultures can be grown in large-scale photobioreactors, which 
significantly reduces the risk of contamination and the escape of genetic modified 
strains to the environment, and makes rapid scale-up possible. In addition, green algae 
fall into the GRAS (generally regarded as safe) category, potentially eliminating some 
downstream processing steps associated with transgenically produced therapeutics 
(Specht et al., 2010; Rasala and Mayfield, 2011). 
The chloroplast of C. reinhardtii has been a preferred site for the expression of 
commercially attractive products since it offers a number of advantages compared to the 
transformation of the nuclear genome. In the chloroplast, high gene expression levels 
can be achieved and it is possible to target transgenes to defined sites using homologous 
recombination. In contrast, genes introduced into the nuclear genome integrate 
randomly and are therefore prone to position effects and RNA silencing (Day and 
Goldschmidt-Clermont, 2011). 
In recent years several advances have been made in the field of Chlamydomonas 
chloroplast transformation (Purton et al., 2013). Nevertheless, most transformation 
protocols still rely on antibiotic resistance for selection. A commonly used selectable 
marker is the aadA gene (bacterial aminoglycoside 3’-adenyl transferase), which 
confers resistance to spectinomycin and streptomycin (Goldschmidt-Clermont, 1991). 
Alternatively, cloned variants of the endogenous ribosomal RNA genes rrnS and rrnL 
can be used as markers. These carry point mutations rendering the ribosomes insensitive 
to certain damaging antibiotics (Newman et al., 1990). However, such antibiotic 
selection is prone to high rates of false positives, and in the latter case results in a 
mutant ribosome in which translation of a highly expressed transgene is potentially 
compromised. Furthermore, ensuring that transgenic lines are homoplasmic (i.e., that all 
⁓80 copies of the polyploid chloroplast genome carry the introduced transgene) requires 
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multiple rounds of single colony isolation under antibiotic selection. A more elegant 
method is to rely on the restoration of photosynthetic growth using a Chlamydomonas 
chloroplast mutant defective in an essential photosynthesis gene such as atpB, or psbH 
(Boynton et al., 1988; Economou et al., 2014). Importantly, the gene of interest remains 
the only segment of foreign DNA in the transformed genome. A similar strategy has 
been described earlier by (Cheng et al., 2005). 
To-date, over 50 different recombinant proteins have been synthesised 
successfully in the C. reinhardtii chloroplast, including markers, reporters, enzymes, 
and proteins of therapeutic value such as antibodies, hormones and vaccines (Purton et 
al., 2013). A fully functional human IgG1 monoclonal antibody against anthrax 
protective antigen 83 was expressed from two separate genes and assembled into a fully 
active antibody (Tran et al., 2009). In addition, immunotoxins for cancer therapeutics 
(Tran et al., 2013b) as well as vaccine candidates against malaria or foot-and-mouth-
disease virus have been produced in the chloroplast (Gregory et al., 2013; Jones et al., 
2013). However, most of the recombinant proteins produced, have been soluble 
proteins, and furthermore have generally been proteins that can be considered ‘benign’ 
in that they have no effect on chloroplast metabolism. To-date there has been only a few 
reported attempts to express membrane-associated proteins, or enzymes that introduce 
novel metabolic pathways (Wu et al., 2010; Blatti et al., 2012).  
As a consequence, C. reinhardtii has yet to compete effectively with other, 
heterotrophic production hosts for the production of recombinant biopharmaceuticals. 
Here, we have taken the approach that algae may be preferentially suited for the 
production of plant-specific compounds. One such class of compounds is terpenoids. 
These are large, structurally-complex plant metabolites that include a range of very 
high-value examples including paclitaxel, artemisinin and ingenol-3-angelate (Wang et 
al., 2005). Importantly, their complex structures almost invariably mean that efficient 
chemical synthesis is extremely difficult, and usually impossible. In principle, it should 
be possible to introduce novel terpenoid biosynthesis pathways into the plant or algal 
chloroplast, but this would require re-targeting of the key enzymes in their synthesis, 
cytochromes P450, into the chloroplasts in an active form. Nielsen et al. have reported 
the successful synthesis of Dhurrin in tobacco chloroplasts and showed that synthesis is 
light-driven using native ferredoxin as the electron donor (Nielsen et al., 2013). Dhurrin 
is a plant defense compound found in Sorghum bicolor. While Dhurrin is not a 
terpenoid, it is synthesised from tyrosine by the means of two ER localised cytochrome 
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P450 enzymes, CYP79A1 (Sibbesen et al., 1995), CYP71E1 (Kahn et al., 1997) and 
POR (NADPH cytochrome P450 oxidoreductase), as well as the soluble cytosolic UDP 
glucosyl transferase UGT85B1 (Jones et al., 1999). 
As a first step in introducing such a pathway into a phototrophic microorganism 
suitable for industrial cultivation (Specht et al., 2010), we report the stable expression 
of the cytochrome P450 CYP79A1 in the chloroplast of C. reinhardtii using a simple 
transformation method that results in a transgenic line with the CYP79A1 synthetic 
gene as the only foreign DNA. The enzyme is targeted into the organelle membrane by 
means of its endogenous N-terminal region, accumulates to 0.4 % of total cellular 
protein and is shown to be active in the conversion of tyrosine to p-
hydroxyphenylacetaldoxime. The work paves the way for the introduction of additional 
components of the Dhurrin pathway. 
 
 
5.3.3. Results and discussion 




Fig. 5.1. Strategy for driving cytochrome P450 activity by photosynthetic electron transport. A 
Normal action of P450s. Typical P450s have an N-terminal transmembrane span that anchors 
the protein in the ER membrane. Reducing power is provided by NADPH via NADPH-
cytochrome P450 oxido-reductases (NADPH-P450 ox-red). B Strategy for driving activity by 
photosynthetic electron transport: the P450 is synthesised in the chloroplast, targeted into the 
























The overall strategy for this study is shown in Fig. 5.1. In the ER, P450s are 
located in the ER membrane by means of an N-terminal transmembrane span; they drive 
reactions using reducing power from NADPH but the immediate electron donor is 
cytochrome P450 reductase (POR). While the chloroplast does contain imported P450s 
that are involved in carotenoid biosynthesis (Quinlan et al., 2012) the vast majority are 
located in the ER and we deemed it important to determine whether such proteins can 
be expressed in chloroplasts and targeted to membranes in an active form. In this study 
the aim was to express a model P450, CYP79A1, in C. reinhardtii chloroplasts, target 
the enzyme to the thylakoid membrane and drive the reaction using reduced ferredoxin 
(Fd). This has been shown to be possible in transiently transfected tobacco chloroplasts 
(Nielsen et al., 2013) and our aim was to determine whether algal chloroplasts are a 
viable production base for stable expression of these enzymes. 
A recently developed method for chloroplast transformation (Economou et al., 
2014) uses a C. reinhardtii strain in which the chloroplast psbH gene has been replaced 
by the aadA antibiotic resistance cassette. The vector pASapI is used to introduce the 
gene of interest and restore photosynthetic growth. The expression cassette of pASapI is 
comprised of the promoter, the 5’UTR and the start codon of atpA, a multiple cloning 
site, and the stop codon and 3’ UTR of rbcL. Upon homologous recombination the aadA 
cassette is replaced with both a functional copy of psbH and the gene of interest (in this 
case the coding sequence for CYP79A1; see Fig. 5.1). Importantly, the gene of interest 
remains the only segment of foreign DNA in the transformed genome. 
The CYP79A1 coding sequence was synthesised de novo, incorporating the coding 
sequence for a C-terminal HA tag to facilitate identification and analysis. The 
synthesised CYP79A1 construct was cloned into pASapI as indicated in Fig. 5.2, and 
C. reinhardtii chloroplast transformation was performed by rapid agitation of a 
DNA/cell mixture with glass beads and selection for photoautotrophic growth. After 
approximately four weeks transformant colonies were obtained and subjected to further 




Fig. 5.2. Chloroplast transformation strategy. A The vector pASapI uses the essential 
photosynthesis gene psbH as a selection marker for the targeted integration of a gene of interest 
(in this case CYP79A1) into the chloroplast genome. The expression cassette is located in the 
psbH-trnE2 intergenic region and contains the promoter, 5’untranslated region and start codon 
of atpA, a multiple cloning site and the stop codon as well as the 3’ untranslated region of rbcL. 
An aadA cassette replaces psbH in the recipient strain rendering it unable to grow on minimal 
medium lacking acetate. After transformation a functional copy of psbH together with the GOI 
is introduced back into the genome by homologous recombination. B pASapI vector design. 
The pASapI vector was constructed using pUC8 as a backbone. It contains psbH flanking 
elements, the promoter and 5’ untranslated region (UTR) of atpA, a polylinker with SapI and 
SphI sites to introduce the gene of interest and the 3’UTR of rbcL (Economou et al., 2014). 
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5.3.3.2. Integration of the CYP79A1 construct into the chloroplast genome 
 
Correct integration of the CYP79A1 gene into the chloroplast genome was 
confirmed using a PCR approach. Primers were designed to amplify a 1200 bp fragment 
from transformed lines (containing an intact restored psbH gene).  
Fig. 5.3 shows a PCR analysis of the transgenic line (CYP79A1) with the 1200 bp band 
clearly visible; control PCR reactions using primers for the disrupted psbH gene 
confirmed the homoplasmic integration of the CYP79A1 construct into the chloroplast 
of C. reinhardtii. 
 
 
Fig. 5.3. Integration of the CYP79A1 construct. Genomic DNA was isolated from transformed 
cultures (CYP79A1) and subjected to PCR analysis to test for integration of the CYP79A1 
construct. As a control the same was done with untransformed cells (TN72 psbH–) and restored 
wild type cultures (TN72-RP). The figure shows the presence of a 1200 bp band in the 
transgenic lines, which confirms the integration of the expression cassette into the chloroplast 























5.3.3.3. Accumulation and localisation of the recombinant CYP79A1 protein 
in the chloroplast 
 
 
Fig. 5.4. CYP79A1 is expressed in the chloroplast of C. reinhardtii. Total cell protein samples 
of restored wild type (TN72-RP) and transformant strains (CYP79A1) were separated using 
SDS–PAGE and subjected to immunoblot analysis using an anti-HA antibody. Known amounts 
of a reference protein (HA-ubiquitin) were loaded on the same gel. CYP79A1 band is indicated; 
‘n.s.’ denotes non-specific cross-reacting band found in both cultures; HA-Ub denotes HA-
Ubiquitin.  
 
The expression of CYP79A1 was tested by immunoblotting of C. reinhardtii 
samples using antibodies to the HA tag as shown in Fig. 5.4. A clear protein signal of 
58 kDa, close to the expected size of CYP79A1 (62 kDa) was detected in samples from 
transgenic cells (CYP79A1 lane) but not in samples from the restored wild type (TN72-
RP). The anti-HA antibody also detects a smaller polypeptide, but this is also present in 
control samples indicating a non-specific reaction (band is denoted n.s.). 
To estimate the amount of protein expressed in the chloroplast of Chlamydomonas we 
used a HA-tagged reference protein, HA-Ubiquitin. Fig. 5.4 shows the signals obtained 
with increasing loadings of this protein and densitometric analysis of calibrated 
immunoblots revealed an accumulation of approximately 900 ng of protein per mL of 
culture. We calculated that the expressed CYP79A1 corresponds to 0.4 % of total cell 
protein.  
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Fig. 5.5. Membrane targeting of CYP79A1. Cells of the CYP79A1 transformant and restored 
wild type (TN72-RP) cultures were lysed by sonication and the membrane (M) and soluble (S) 
fractions were separated by ultracentrifugation. Total protein in the fractions was subjected to 
SDS–PAGE and immunoblotting with an antibody against the HA-tag (A) or SufD (B). The 
band corresponding to CYP79A1 is found in the membrane fraction of the transgenic line 
confirming that CYP79A1 is targeted into the membranes of C. reinhardtii. A non-specific 
cross-reacting band is denoted by n.s.  
 
Since CYP79A1 is a membrane-bound enzyme in its natural environment (the 
plant ER) we investigated its location in algal cells to confirm membrane targeting and 
insertion. TN72-RP and CYP79A1 cells were lysed by sonication and the soluble and 
insoluble fractions were separated by ultracentrifugation. Immunoblotting shows that 
the CYP79A1 signal is almost exclusively detected in the membrane fraction (lane M in 
Fig. 5.5 A) of the transgenic cell line. As a control for lysis of soluble proteins, we 
blotted the same fractions with an antibody to SufD, a component of the chloroplastic 
FeS cluster synthesis pathway, and Fig. 5.5 B shows this protein to be localised in the 
soluble fraction as expected. As a control for the pelleting of thylakoids membranes, we 
confirmed that essentially all of the chlorophyll (over 98 %) was pelleted by this 
procedure (data not shown). These data show that the CYP79A1 protein is efficiently 























targeted into membranes during or after synthesis in the chloroplast by means of its 
endogenous N-terminal transmembrane span. The data also show that the band 




5.3.3.4. Enzymatic activity of CYP79A1 
 
 
Fig. 5.6. Expressed CYP79A1 is active. The product of CYP79A1, p-hydroxy-
phenylacetaldoxime, was extracted from the culture medium of CYP79A1 transformant or 
restored wild type cultures with ethyl acetate after pelleting the cells by centrifugation. The 
samples were analysed by liquid chromatography–mass spectrometry and compared to an 
oxime standard as described in Section 5.3.5.7. 
 
CYP79A1 is the first enzyme in the Dhurrin synthesis pathway and it converts 
tyrosine to p-hydroxyphenylacetaldoxime. To test whether the enzyme is active in the 
Chlamydomonas transformant chloroplasts, we subjected samples of the transgenic 
strain and restored wild type to LC-MS analysis. A comparison of the mass spectrum to 
that of an oxime standard revealed that the enzyme is active in the CYP79A1 
transformant (Fig. 5.6); as expected, the restored wild type sample does not exhibit any 
oxime-related peaks. Interestingly, the oxime was detected in the culture medium of 
unlysed transformant cells, but was absent in extracts of both the soluble or insoluble 























cells, presumably by diffusion since the cells are unlikely to contain an efflux system 
for this compound. The much smaller volume of the cells (compared to the culture 
medium) probably explains why the product is not detected in those samples. 
 
 
5.3.4. Concluding remarks 
 
Cytochrome P450 monooxygenases catalyse key reactions in the biosynthetic 
pathways of many complex natural products including terpenoids. They are normally 
located in the endoplasmic reticulum by means of N-terminal transmembrane spans 
(Frear et al., 1969; Zhao et al., 2014). However, these NADPH requiring pathways 
usually proceed inefficiently, and plants additionally contain numerous other P450s 
(typically around 300, although not all are expressed at the same time). A given P450 is 
usually present at relatively low levels, and, in general, any single P450-dependent 
pathway usually catalyses low-level synthesis of a given product. It is therefore highly 
attractive to relocate the cytochrome P450-dependent steps from the ER to the 
chloroplast of C. reinhardtii; the key P450s may then be present in higher amounts and 
able to use reducing power supplied by photosynthesis to drive their reactions. In this 
proof of concept study we have tested whether CYP79A1, the first enzyme in the 
biosynthetic pathway of Dhurrin, can be expressed in the chloroplast membranes of 
C. reinhardtii in an active form. CYP79A1 was chosen because it is easily assayed and 
has been transiently expressed in tobacco and targeted to the chloroplast (Nielsen et al., 
2013). The enzyme has also been expressed in cyanobacteria (Lassen et al., 2014a). The 
results show that the enzyme is indeed expressed, targeted into membranes and active. 
The protein levels (0.4 % of total protein) are sufficiently high to readily detect 
enzymatic activity, the reaction product being detectable in the culture medium where it 
is relatively dilute.  
There are good reasons to believe that the CYP79A1 is driven directly by 
reducing power supplied by photosynthesis. P450s do not oxidise NADPH themselves, 
and in the ER, they are driven by a set of specific enzymes termed NADPH cytochrome 
P450 oxido-reductases, which transfer reducing power from NADPH. When CYP79A1 
was expressed transiently in tobacco chloroplasts, it was shown to use electrons from 
photosynthetically reduced Fd (Nielsen et al., 2013). It is therefore assumed that the 
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algal-expressed CYP79A1 in this study is similarly driven by reduced Fd, but we should 
emphasise that this has not been shown directly. The highly negative redox potential of 
Fd and its high abundance raises the possibility that the cytochrome P450 may work 
very efficiently in the chloroplast, but we have not compared the specific activities of 
the ER- and plastid-localised forms and this will be a priority for future studies. 
While the primary aim of this study was to test the feasibility of expressing 
cytochrome P450 enzymes in algal chloroplasts, the results have relevance for the wider 
field of microalgal biotechnology. To date, chloroplast transformation of C. reinhardtii 
has been used to express soluble proteins such as antibodies or vaccine candidates (Tran 
et al., 2009; Demurtas et al., 2013), but to our knowledge no membrane-bound protein 
has been expressed in an active form. Moreover, there are reasons to consider that this 
may be intrinsically difficult to achieve; the thylakoid and envelope membranes differ 
radically in lipid composition when compared to other membranes (ca. 80 % 
galactolipids, whereas the ER is primarily composed of phospholipids). In addition, we 
assume that the CYP79A1 is targeted into the thylakoid membrane which accounts for 
the vast majority of chloroplast membrane surface area (although some CYP79A1 may 
be targeted to the envelope membranes), and proteins are targeted into this membrane 
by mechanisms that differ in fundamental respects from those used for insertion of 
proteins into other membranes, including the ER (Woolhead et al., 2001). It was 
therefore important to confirm that an ER membrane protein can be targeted into 
chloroplast membranes at reasonably high levels, in an active form.  
To summarise, we show here the first relocation of an active, ER membrane-
bound cytochrome P450 to the chloroplast of C. reinhardtii. A simple chloroplast 
transformation method and selection strategy was used to create a transformant strain 
that lacks any antibiotic resistance markers. The enzyme almost certainly uses reducing 
power from photosynthesis to drive the conversion of endogenous tyrosine to an oxime 
that appears to diffuse from the cell into the medium. This study thus represents a first 









5.3.5.1. Chlamydomonas cultures 
 
Strains were grown in acetate-containing (TAP) medium or minimal (HSM) 
medium as described in (Harris, 2009), however a revised trace metal recipe was used 
as found in (Kropat et al., 2011). Cells were grown in 100 mL cultures, at 25 °C, 
shaking at 110 rpm using illumination at 15 µmol photons m-2 s-1. 
 
 
5.3.5.2. Plasmid design 
 
The pASapI vector, described in Economou et al. (Economou et al., 2014), was 
used for the introduction of the CYP79A1 coding sequence into the chloroplast genome. 
The CYP79A1 amino acid sequence (accession number XP_002466099) was codon 
optimised using the Codon Usage Optimizer (http://codonusageoptimizer.org/down- 
load/) with codon frequency-, pair- and weight tables of highly expressed chloroplast 
genes handpicked by the developer. The optimised sequence was synthesised using 
GenScript (Piscataway, USA). The gene was cloned into pASapI using the restriction 
enzymes SapI and SphI (New England Biolabs) to create pASapI- CYP79. 
 
 
5.3.5.3. Chloroplast transformation 
Chloroplast transformation of C. reinhardtii was based on a previously 
described method (Kindle, 1990; Kindle and Sodeinde, 1994) and involved the agitation 
of an algal/DNA suspension with glass beads of 400–625 µm diameter (Sigma, St 
Louis, USA). A 400 mL culture grown to early log phase (approx. 2 x 106 cells/ mL) 
was concentrated by centrifugation and resuspended in HSM to 4 mL. 300 µL of these 
cells (at approx. 2 x 108 cells/mL) was added to a sterilised 5 mL test tube containing 
300 mg sterile glass beads, followed by 5–10 µg circular plasmid DNA (either pASapI-
CYP or the empty pASapI vector as a control). The mixture was agitated vigorously at 
the maximum speed of a Vortex Genie II (Fisher, Loughborough, UK) for 15 s. The 
cells were spread on HSM selective agar plates after mixing with 0.5 % molten (42 °C) 
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agar of the same selective medium. The plates were incubated at 25 °C covered with 
tissue paper (20 µmol photons m-2 s-1) overnight then transferred to a moderate light (50 
µmol photons m-2 s-1) the next day. Transformant colonies were picked after 
approximately 4 weeks and restreaked from single colonies three times on selective 
medium to ensure homoplasmy. The transgenic lines were subjected to PCR analysis to 
confirm correct integration of the transgene (principle described in (Economou et al., 
2014)). A representative line was chosen and termed TN72-CYP79A1, together with a 
pASapI transformant as a negative control (=TN72-RP). 
 
 
5.3.5.4. Cell disruption 
 
Culture cell pellets were resuspended in sonication buffer (10 mM Tris-HCl 
pH 8, 5 mM MgCl2) and lysed by sonication (MSE Soniprep150 plus, amplitude 8 lm, 2 
times 20 s with 30 s cooling on ice in-between). The membrane and soluble fractions 
were separated by ultracentrifugation (70,000 rpm, 1 h, 4 °C, TL- 100 ultracentrifuge, 
Beckman, Pasadena, USA). 
 
 
5.3.5.5. SDS-PAGE and immunoblotting 
 
Total chlorophyll content of cultures was determined by extracting chlorophyll 
with 80 % acetone and measuring absorbance at 645 and 663 nm (Arnon, 1949). An 
amount of culture equivalent to 5 µg chlorophyll was separated by SDS–PAGE (15 % 
acrylamide) at 40 mA using a Bio-Rad Mini-PROTEAN® Tetra cell system. Proteins 
were blotted onto PVDF (BioTraceTM, Pall Corporation, Port Washington, USA) 
membranes using a Bio-Rad Mini-PROTEAN® Tetra cell system according to 
manufacturer’s instructions. The membranes were blocked overnight with 5 % skimmed 
milk powder (Thermo Scientific, Waltham, USA) in PBS (Formedium, Norfolk, UK) 
+0.01 % Tween-20 (Sigma, St Louis, USA) (PBS-T) at 4 °C, washed with PBS-T and 
incubated with anti-HA primary (Sigma, St. Louis, USA) antibody or an antibody to 
SufD (kindly supplied by Dr. A. Tsaousis, University of Kent) at a concentration of 
1:1000 in PBS-T shaking for 1 h at room temperature. After PBS-T washes they were 
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incubated with an HRP coupled secondary anti-rabbit antibody (1:5000 in PBS-T, 
Promega) for 1 h shaking at room temperature. The membranes were washed once 
again and visualised by enhanced chemiluminescence (Clarity Western ECL Substrate, 
Bio-Rad) according to manufacturer’s instructions. The chemiluminescent signal was 
recorded using a Bio-Rad ChemiDoc XRS+ system. The exposure time was set to 2 min 
with pictures being taken every 4 s. The marker was recorded and overlaid with a 
selected blot image.  
 
 
5.3.5.6. Protein determination 
 
Protein determination was performed using the Bio-Rad DC Protein assay 
according to manufacturer’s instructions. Following cell lysis by sonication and 
ultracentrifugation, the soluble fraction was taken directly for protein determination. 
The membrane fraction was first solubilised in 50 mM Tris–acetate pH 8.2, 2.5 mM 
EDTA pH 8 and 1 % (w/v) SDS and then subjected to the assay. 
 
 
5.3.5.7. Oxime-extraction and LC-MS analysis 
 
5 mL of transformed and restored wild type cultures were centrifuged to 
separate cells from the medium. The cell pellet was resuspended in 200 µL 50 mM 
Tris–HCl pH 8.0 and lysed by sonication (Qsonica, amplitude 100 %, 15 cycles, pulse-
on time 30s, pulse-off time 90 s). Broken cells were mixed with 200 µL ethyl acetate 
and vortexed for 10 min. The samples were then centrifuged at 10000 g for 10 min, the 
supernatant was collected and evaporated completely. Media samples were mixed with 
2 mL ethyl acetate and shaken for 1h. After centrifugation (10000×g for 10 min) the 
upper ethyl acetate phase was collected and evaporated. The dried samples from pellet 
and media extractions were resuspended in 100 µL 80 % MeOH and 50 µL were mixed 
with 150 µL Milli-Q water. The samples were then subjected to liquid chromatography–
mass spectrometry analysis as described in (Saito et al., 2012). The analysis was carried 
out using an Agilent 1100 Series LC (Agilent Technologies, Germany) coupled to a 
Bruker HCT-Ultra ion trap mass spectrometer (Bruker Daltonics, Bremen, Germany). 
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A Zorbax SB-Aq column (Agilent; 3.5 µM, 2.1×150 mm) was used at a flow rate of 
0.2 mL min–1. The oven temperature was maintained at 35 °C. The mobile phases were: 
(A) 2 mM ammonium acetate; (B) methanol. The gradient program was: 0–1 min, 
isocratic 25 B; 1–11 min, linear gradient 25–60 % B; 11–12 min, isocratic 98 % B; 12–
20 min, isocratic 25 % B. The mass spectrometer was run in positive APCI mode and 
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 In this thesis, several aspects of high-value compound and recombinant protein 
production in the chloroplast of C. reinhardtii have been investigated. In chapter 2, a 
simple chloroplast transformation method was used to generate stable transformants 
expressing comparably high levels of a diterpene synthase, TPS4. Homoplasmy of the 
generated transformants and stable expression levels were demonstrated and the protein 
identity was confirmed by a two-step purification of the protein and subsequent mass 
fingerprint analysis. In chapter 5 a further proof of concept is shown investigating the 
potential of relocating P450s to the thylakoid membranes allowing light-driven product 
synthesis (see chapter 1.5.2). A well-characterised P450, CYP79A1, was chosen as a 
model protein and expressed in the chloroplast using the same approach as in chapter 2. 
It was shown that the enzyme was not only expressed in the homoplasmic transgenic 
strains, but it was also active in vivo. The product, p-hydroxyphenylacetaldoxime, was 
excreted to the culture medium as LC-MS analysis of the culture supernatant showed. 
Both these studies aimed at setting the scene for development of the Chlamydomonas 
chloroplast as a biotechnological terpene production platform. 
In this context, it is crucial to be able to grow the transgenic strains at larger 
scale. This was investigated in chapter 3. Three Chlamydomonas reinhardtii strains, the 
TPS4 and CYP79A1 transgenic strains and a CW-15 negative control strain were grown 
in 100L PBRs in a GMO certified greenhouse facility in Lisbon, Portugal. We were able 
to show that the strains can be cultivated at this scale and stable expression levels of the 
recombinant proteins were observed, but they exhibited rather poor autotrophic growth 
capabilities. 
 In chapter 4 a closer look at novel tools for recombinant protein production in 
general was taken. Localised expression and targeting of recombinant proteins to the 
thylakoid lumen were examined using two model substrates – a fluorescent protein, 
pHRed, and a simple antibody fragment of biopharmaceutical relevance, an scFv. We 
demonstrated efficient translocation to the thylakoid lumen facilitated by expression 
with a bacterial Tat export signal peptide.  
 
All studies presented in this thesis aimed at a better understanding of the 
potential of the algal chloroplast as a host for recombinant protein and high-value 
compound production. One way of making microalgae a viable biotechnological 
platform could be to integrate product synthesis within algal metabolism and scavenge 
intrinsic unique properties such as isoprenoid precursor molecules or coupling of 
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synthesis to the PET. It will be difficult to compete with existing eukaryotic 
biotechnological platforms, such as CHO cells or yeast, because the synthesis of 
conventional recombinant proteins in these organisms has clear advantages. These 
include higher yields and a longer history of research in process and product 
optimisation. Thus, for developing a competitive microalgal platform, products of 
industrial interest will have to take advantage of the unique characteristics of 
microalgae. Here, potential developments into this direction are shown. How the 
experiments presented in this thesis are expanding the toolkit of the C. reinhardtii 
chloroplast and how they can be significant for future biotechnological applications will 
be discussed in more detail in the following sections. 
 
 
6.1. A proof of concept: terpene production in Chlamydomonas 
6.1.1. Cis-abienol synthesis in C. reinhardtii 
 
 The synthesis of terpenes is usually a very complex process operated by multi-
enzyme pathways. From a genetic engineering perspective, this makes it a difficult task 
in microalgae because the tools for multiple gene expression are still rare and poorly 
developed (see Section 1.3.5). The bifunctional diterpene synthase TPS4 from Abies 
balsamea (Zerbe et al., 2012) is therefore a rather unique enzyme as it allows the 
catalysis of the diterpene, cis-abienol, directly from the universal diterpene precursor 
molecule GGPP. As outlined in Figure 1.4, GGPP should be available in the chloroplast 
of C. reinhardtii and the enzyme had previously been expressed recombinantly in 
E. coli (Zerbe et al., 2012), providing a good setting for a proof of concept study in the 
Chlamydomonas chloroplast. 
 In chapter 2, a crucial step for in vivo diterpene synthesis was described: the 
stable expression of the recombinant enzyme TPS4 was demonstrated, but activity 
could not be detected. Purification of the TPS4 enzyme from transgenic algal culture 
was successful, but the yield was too low for in vitro activity assays. Several attempts at 
extracting the compound directly from the culture and also from lyophilised material 
with various organic solvents and subsequent GC-analysis remained unsuccessful. 
Unfortunately, a commercial standard for cis-abienol is not available which made 
product detection very difficult. Later on, the headspace of the transgenic strain was 
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captured and analysed by GC-MS in collaboration with Kamil Bakowski and Trine 
Bundgaard Andersen at the University of Copenhagen. An experiment using SPME 
(Solid-phase microextraction) indicated the presence of cis-abienol in the headspace 
after heating the culture. These data are in line with GC-MS data from a previous in-
vitro study (Zerbe et al., 2012). Problems with product extraction are not surprising due 
to the lack of a standardised extraction protocol and most likely very low yields of cis-
abienol. The low yield can be attributed to several factors including low catalytic 
activity of the TPS4 enzyme or degradation of the product. Product toxicity seems 
rather unlikely as no distinct phenotype was observed in the TPS4 strain in comparison 
with the control (Fig. 1.5, Fig. 3.7B). It is also possible that the GGPP pool is regulated 
very tightly in the chloroplast limiting the availability of the precursor molecule. 
To test the hypothesis of limited precursor availability, a follow-up experiment 
was developed to increase the GGPP pool in the chloroplast of C. reinhardtii. A study 
by Fukasaki et al. reports the expression of GGPP synthase, from a thermophilic 
archaeon, in C. reinhardtii for potential secondary metabolite synthesis in the alga. 
However, a thermophilic protein was chosen and at moderate temperatures no 
additional prenyl transferase activity was found (Fukusaki et al., 2003). A similar 
approach seems sensible for an increased intra-plastidal GGPP pool, but the enzyme 
must be able to operate at feasible growth conditions. A genome-based analysis of 
carotenoid and chorophyll biosynthesis came to the conclusion that GGPP synthesis, via 
the MEP pathway, is probably limited by the steps catalysed by deoxy-xylulose-5-
phosphate synthase (DXS) and geranylgeranyl pyrophosphate synthase (GGPPS) (Lohr 
et al., 2005). Overexpression of these specific enzymes has previously been shown to 
improve yields of engineered manoyl oxide, a diterpene, in Synechocystis sp. PCC 6803 
(Englund et al., 2015). Due to the limited multiple gene expression tools in the 
C. reinhardtii chloroplast, a fusion construct of DXS and GGPPS with a polylinker has 
been designed and transformants have been shown to express the construct (data not 
shown), however, no activity was tested yet. This is a first attempt at improving the 
yield of cis-abienol produced in the microalgal chloroplast.  
A microalgal production platform for the high-value compound cis-abienol is of 
true industrial interest. Cis-abienol can be used for the synthesis of Ambrox®, a 
synthetic replacement of Ambergris which is widely used in the perfume industry. 
Currently, Ambrox® is synthesised from sclareol which is extracted from 
Salvia sclarea. However, yields in the plant are very low and can vary with seasonal 
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conditions. There is evidence that suggests cis-abienol is a better and more efficient 
precursor molecule for chemical Ambrox® synthesis (Barrero et al., 1993) and its 
potential for metabolic engineering has been highlighted several times (Sallaud et al., 
2012; Zerbe et al., 2012). The study presented in chapter 2 offers a solid basis for 
further improvement of yield and product recovery in order to develop a viable 
microalgal production platform for cis-abienol synthesis. 
 
 
6.1.2. Paving the way for light-driven terpene synthesis: P450 relocation 
 
 The biosynthesis of a terpene typically involves several P450s (Lassen et al., 
2014b). Relocation of those enzymes to the chloroplast can facilitate localised and light-
driven product synthesis. To date, this has only been demonstrated in tobacco 
chloroplasts (Nielsen et al., 2013; Gnanasekaran et al., 2015) and cyanobacteria (Lassen 
et al., 2014a; Wlodarczyk et al., 2016). The study described in chapter 5 shows that this 
is also possible in eukaryotic microalgae. It has to be highlighted that the model P450 
chosen is not of interest for terpene production. CYP79A1 catalyses the rate-limiting 
step of tyrosine to p-hydroxyphenylacetaldoxime as part of the dhurrin pathway, a 
cyanogenic glucoside found in plants (Busk and Møller, 2002). The extensive 
accumulated knowledge about this enzyme and the dhurrin pathway combined with the 
simple transformation method (Economou et al., 2014) enabled straight forward genetic 
engineering of the chloroplast of C. reinhardtii. Not only could the P450 be expressed 
in the chloroplast and targeted to the membranes (most likely the thylakoids), but an 
established protocol for oxime extraction and detection also enabled us to demonstrate 
activity.  
 The project clearly showed that P450s can be translocated to the chloroplast and 
thus enable light-driven, localised product synthesis. It paves the way for engineering 
other P450s of relevance for high-value compound production such as terpenes. Future 
work will also need to address the issue of P450s co-localisation when several P450s 
are needed for product synthesis. In the case of CYP79A1, the product was found in the 
culture medium. If further catalysis of the intermediate is necessary this could constitute 
a major engineering challenge. It may be worthwhile to explore coupling of P450s that 
are part of one biosynthetic pathway for a desired product. This might be achievable 
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via, for example, an engineered shared membrane anchor bringing the P450s in close 
proximity. To address these advanced engineering tasks, considerable further 
improvements of the chloroplast toolkit will be necessary. It would also be interesting to 
further investigate the localisation of the CYP79A1 in the chloroplast. The experiments 
presented in chapter 5 could not exclude insertion into the envelope membrane although 
most likely the thylakoid membranes were targeted. Classic labelling experiments could 
give further insight into this matter. 
 
 
6.1.3. Implications for Chlamydomonas as a terpene production platform 
 
 Chapters 2 and 5 have addressed important, basic questions crucial for 
developing the chloroplast of C. reinhardtii for terpene production. The need for a 
biotechnological terpene production platform is evident; these high-value compounds 
are of high demand as pharmaceuticals, fragrances, flavours, food supplements and 
pesticides (Bohlmann and Keeling, 2008). Due to their complexity, chemical synthesis 
is usually not possible and the compounds have to be extracted from their natural source 
at low yields and subjected to environmental, seasonal and regional variation 
(Marienhagen and Bott, 2013). A remarkable success of metabolic engineering was 
achieved with engineering artemisinin, a sesquiterpene used for malaria treatment in 
baker’s yeast (Ro et al., 2006; Paddon et al., 2013), demonstrating the astonishing 
potential of microbial platforms for terpene synthesis. A major limitation of terpene 
synthesis in microbes is that genetic engineering requires a fully elucidated biosynthetic 
pathway and genetic information. Often terpene pathways have not yet been 
characterised, thus making a genetic engineering approach impossible. Research into 
unravelling biosynthetic pathways tackles this problem and will facilitate an increasing 
diversity of engineered products. 
The need for a microbial platform for sustainable and large-scale terpene 
production is evident given its wide range of potential products. Photosynthetic 
microbial platforms, such as microalgae, could be an even more attractive host than 
classical microbial platforms such as E. coli or yeast. One reason is their “solar-to-
biofuel” generation (Davies et al., 2015) capabilities indicating that very little material 
input is needed to produce these molecules in a biological system. Additionally, the 
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cellular context of the production platform chosen has to be considered (Marienhagen 
and Bott, 2013). Here, microalgae have a clear advantage for recombinant plant terpene 
synthesis over other classical microbial production systems as they have similar 
metabolic pathways to higher plants that play a role for terpene synthesis. However, the 
limited availability of engineering tools in photosynthetic hosts is still a major 
drawback. With advanced genetic tools available, C. reinhardtii is therefore one of the 
most sensible engineering targets at the moment.  
In this thesis several aspects paving the way for terpene synthesis in 
C. reinhardtii were addressed. These confirmed the potential of microalgae for terpene 
production. Future research will be needed to address low yields, metabolic flux 
regulation and tackle further biosynthetic pathways of interest for biotechnological 
applications to unravel the full potential of this photosynthetic microbial host. 
 
 
6.2. Sophisticated recombinant protein production: expanding 
the spectrum by protein targeting. 
 
 No matter what high-value product the engineering target is, a secondary 
metabolite or a protein itself, a sophisticated system for protein expression, stability and 
targeting is of great importance. Tools for protein expression have advanced remarkably 
(see Section 1.3.). Therefore, we decided to address more basic questions of protein 
targeting in C. reinhardtii with the aim of expanding the chloroplast toolkit. In chapter 4 
a closer look at the thylakoid lumen was taken which no study has yet, to my 
knowledge, utilised for biotechnological applications. The thylakoid lumen is an 
exciting compartment that surprisingly little is known about. Its significance for 
photosynthesis regulation is undoubted (Järvi et al., 2013), but further physiological 
functions have only been hinted at, for example with the help of proteomics (Kieselbach 
and Schröder, 2003). The thylakoid lumen could provide a novel environment for 
recombinant protein expression that is rather different from classical expression in the 
stroma.  
The study described in chapter 4 shows that translocation to the thylakoid lumen in the 
chloroplast of C. reinhardtii can be facilitated using a bacterial Tat export signal 
peptide, ‘TorA’, as a N-terminal leader peptide. Two model substrates, an scFv and a 
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fluorescent protein were translocated. The translocation of TorA-scFv is promising for 
looking at further substrates of biotechnological relevance that might, for example, need 
a lower pH, as typically found in the lumen. The lumen environment can also provide a 
higher level of protection and increase stability for substrates of a very delicate nature. 
Admittedly, the imported pHRed is not a biotechnologically relevant protein as the scFv 
is. However, a proof of concept requires an iterative approach and fluorescent proteins 
are useful tools to test a novel system as this one is. pHRed is not an ordinary 
fluorescent protein, it was made by mutagenesis from mKeima enabling in vivo pH 
detection (Tantama et al., 2011). This is a very interesting tool for in vivo pH 
measurements in C. reinhardtii. Unfortunately low expression levels and chlorophyll 
autofluorescence in the transgenic strains hindered further investigations with 
conventional confocal imaging tools that were available to us. A customised setup with 
more precise (single wavelength) excitation lasers and a more sensitive detection system 
could, however, allow in vivo measurements in the generated strains. These 
measurements would be of interest for fundamental research far beyond the scope of 
this proof of concept study. 
The study shown in chapter 4 specifically targets translocation to the thylakoid 
lumen via the Tat pathway, but this is only a first attempt at exploring the potential of 
utilising protein targeting for biotechnological applications in microalgae. Depending 
on the nature of the substrate and the compartment targeted, other translocation 
pathways will be of interest. In this case, the limiting factors are not necessarily genetic 
engineering tools but the lack of knowledge regarding the translocation machinery in 
microalgae. For example, it is not even entirely clear what drives translocation via Tat 
to the thylakoid lumen. Initially, the process was though to be ∆pH dependent (based on 
mainly in vitro studies), but an in vivo study in C. reinhardtii suggested no ∆pH 
dependence in the thylakoids (Finazzi et al., 2003) and later on in tobacco protoplasts 
the process was found to be also ∆Ψ independent (Di Cola et al., 2005). This is only one 
example showing that progress in genetic engineering and a better understanding of 
microalgal cell biology and physiology will be of greater importance with increasing 
complexity of the engineered systems. Otherwise, our knowledge of the intrinsic 
properties of the engineering target can become the limiting factor for advancing 
microalgae for biotechnological applications. 
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6.3. Scalability is crucial for industrial interest 
 
 Recombinant proteins and other products expressed and synthesised in 
Chlamydomonas, outlined in Section 1.4.1 and 1.4.2, are very diverse and at a first 
glance seem impressive and promising. Most of these studies aim at or at least mention 
the significance of the finding for biotechnological applications or so-called “molecular 
farming”. However, there is a clear gap between the potential shown in proof of concept 
studies and the transition of these to scale. If the strains cannot be cultivated or produce 
the product in an industrial setting, it is not a viable system and the implication for its 
use in biotechnology cannot be justified. In the case of Chlamydomonas this missing 
link between lab scale studies and scale up is particularly noticeable. Only one study has 
reported the growth of Chlamydomonas at pilot scale (Gimpel et al., 2015b) which can 
be considered a first test of scalability. One reason for this gap might be that 
Chlamydomonas is not an “ideal” organism for an industrial setting – its flagella and 
low temperature tolerance (Hlavova et al., 2015) make it a less robust organism 
compared to other microalgae that are already successfully cultivated at industrial scale. 
Given its potential for genetic engineering and the array of modified strains available it 
is however crucial to examine ways of making Chlamydomonas scalable and to also 
know the limitations of its scalability. Therefore we tested our genetically modified 
strains, expressing CYP79A1 and TPS4, at pilot scale in 100L PBRs as shown in 
Chapter 3. The marker-free engineering approach of these strains (see Section 1.3.5) 
makes it particularly attractive for scale-up as no antibiotics are necessary to sustain 
gene expression. This is not only beneficial for cutting costs but also important to 
minimise environmental hazards. A disadvantage is, however, the wall-deficient nature 
of the strains resulting in a higher degree of fragility. Given the fact that most 
engineered C. reinhardtii strains are based on wall-deficient mutant strains it was 
reassuring that, without a thorough upscaling optimisation, we successfully cultivated 
the strains in the 100 L PBRs. This also implies that considerable improvement might 
be possible and, at least at a semi-industrial pilot scale, the strains can be cultivated. The 
next step would have to involve a larger culture volume although the logistics of this 
operation present several problems. Bigger cultivation vessels would have to be 
enclosed due to the GM nature of strains. The PBRs used in our study cannot be used at 
much bigger volumes due to limitations of various kinds (for example light penetration 
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and aeration). To increase the scale in closed PBRs, a tubular reactor design could be 
beneficial. These however require the operation of pumps that would potentially cause 
too much shear stress to the fragile algae. This can be overcome by utilisation of low-
shear pumps or innovative flat panel designs (Tredici et al., 2015). Nonetheless, growth 
of these strains at 100 L scale is promising and might even be sufficient for several 
applications of these microalgae.  
The production of high-value compounds, such as recombinant proteins or 
terpenes, does not necessarily require the production of a large amount of biomass and 
cultivation costs are a much less important factor than for low-value commodity 
production. A system with a scale-out rather than scale-up process might be, especially 
for systems like diterpene production, thoroughly viable. ‘Scale-out’ could be achieved 
by a modular unit design where a larger culture volume is handled by increasing the 
number of modules instead of increasing the volume of the culture unit (‘scale-up’). 
Some targets to be produced in these microalgal systems have market values over 10 
Million EUR per kg (Verdelho Vieira, 2014) making it a very attractive target of further 
research and transition to industry. 
 
 
6.4. The toolkit of the Chlamydomonas chloroplast: status and 
perspectives 
 
 The Chlamydomonas chloroplast has attracted a lot of interest for 
biotechnological applications in the last years. In this thesis, several proof of concept 
studies are presented that aim at expanding the already existing capabilities of this 
toolkit and also at making it industrially relevant. Several aspects of developing a 
sustainable photosynthetic platform for diterpene production have been investigated and 
a first pilot scale project also validated the transition into a more industrial setting. All 
experiments presented aimed at using simple and easily reproducible techniques that are 
available to a broader research community. A straightforward protocol was used for 
transformation that does not need any expensive equipment other than common 
facilities found in a standard molecular biology lab. Marker-free, genetically stable 
strains were generated that do not need to be supplemented with antibiotics. The proof 
of concepts confirmed that the development of the C. reinhardtii chloroplast for 
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diterpene production is reasonable and justified, the prerequisites set in this thesis. A 
simple approach of utilising a bacterial export signal peptide for lumen targeting also 
showed that the chloroplast still has a lot of untapped potential. Further work, exploring 
novel ways of utilising the chloroplast, is to be expected. 
Although all the experiments presented here are at the proof of concept stage 
there is good reason to believe that this is a further important step in the right direction 
of developing microalgae for biotechnological applications. It will now be crucial to 
build on the knowledge acquired and to integrate the different studies. This could pave 
the way for improving yields of products already produced in microalgae, enable the 
engineering of further interesting high-value compounds and ensure the scalability of 
the system which will facilitate the transition into an industrial setting. A stepwise 
approach to tackle limitations of the current microalgal systems will help to improve the 
platform gradually and hopefully, also make it a viable system that can compete at the 
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